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Résumé 
 
Les polymersomes, obtenus par auto-assemblage en solution aqueuse de copolymères à blocs 
amphiphiles en structure vésiculaire, sont présentés comme d’excellents mimes synthétiques des 
virus, dont les propriétés membranaires – principalement élasticité, perméabilité, fonctionnalité-  
peuvent être très proches. Il y a ainsi un fort engouement quant à leur utilisation en biotechnologie 
et surtout en vectorisation d’actifs pharmaceutiques ou cosmétiques. Afin d’aller encore plus loin 
dans le biomimétisme ou la bio-inspiration, une étape devait être franchie : encapsuler ces 
polymersomes les uns dans les autres. Ce cloisonnement ou multi-compartimentalisation permet de 
mimer cette fois la structure d’une cellule dite eukaryote, elle-même constituée de compartiments 
internes (organelles) et d’un cytoplasme (lui conférant entre autres une certaine stabilité mécanique) 
contenues dans le compartiment externe représenté par la membrane cellulaire. Toutefois, 
l’obtention d’un simple mime structural d’une structure si complexe représente déjà un challenge en 
soi, nécessitant maîtrise de la physico-chimie des systèmes, de la stabilisation des interfaces et des 
outils de formulation. Une méthode d’émulsion-centrifugation a été développée et a permis 
d’obtenir de telles structures compartimentalisées (mimes d’organelles) à cavité gélifiée (mime de 
cytoplasme). Finalement, différentes voies d’exploitation de ces systèmes sont présentées, allant de 
l’encapsulation multiple, la libération contrôlée jusqu’au développement de réactions enzymatiques 
en cascade confinées, mimant ainsi le métabolisme cellulaire. 
 
Mots-clés : Vésicules, polymères, polymersomes, biomimétisme cellulaire,  
multicompartimentalisation, mimes d’organelles, vectorisation, auto-assemblage 
 
Summary 
 
Amphiphilic block copolymers self-assemble in water into vesicles, coined “polymersomes”; these 
vesicles are described as excellent synthetic mimics of viral capsids due to the resemblance of their 
respective membrane properties (in terms of elasticity, permeability, and functionality). As a result, 
they were massively investigated over the last years regarding applications in biotechnology and 
more particularly for the targeted delivery of pharmaceutical or cosmetic actives.  
In order to go further towards bio-inspiration and cell biomimicry, the next step required the 
encapsulation of polymersomes in other polymersomes. This multicompartmentalization indeed 
enables to mimic the structure of an eukaryotic cell; an outer cellular membrane compartment 
encloses internal compartments (organelles) and a cytoplasm responsible amongst others for a 
certain mechanic stability. However, alone the controlled formation of a system mimicking such a 
complex structure represents a technological challenge in terms of control over the physical 
chemistry of these systems, the stabilization of their interfaces and their formulation. A formation 
method based upon an emulsion-centrifugation has been developed and enabled the formation of 
such multicompartmentalized structures (organelle mimics) with a gelified lumen (cytoplasm 
mimic). Finally, various potential applications of these systems are presented: from multiple 
encapsulation, controlled drug release, to the development of enzymatic and confined cascade 
reactions that mimick the cellular metabolism. 
 
Keywords: Vesicles, Polymer, Polymersomes, Cell Biomimicry,  
Multicompartmentalization, Organelle mimics, Drug delivery, Self-assembly 
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Résumé étendu  
 
 
Le challenge de ce projet de thèse résidait en la formation contrôlée de mimes structuraux de 
cellules eukaryotes, grâce à des polymersomes et des matériaux polymères en général. Tout 
d’abord, une méthode de préparation adéquate devait être pensée et développée. Ensuite, cette 
méthode a permis l’élaboration des objets désirés ainsi que l’établissement des diverses 
preuves de concept, grâce aux outils de caractérisation appropriés. Enfin, la maîtrise des outils 
de formulation a permis d’étendre le projet au-delà du mimétisme structural, au mimétisme 
fonctionnel, avec l’incorporation de réactions enzymatiques en cascade, confinées in situ dans 
les mimes structuraux. 
La stratégie repose sur une formation par lot (batch) en deux étapes (Chapitre 2) ; tout 
d’abord des polymersomes nanométriques de poly(triméthylène carbonate)-b-poly(L-acide 
glutamique) (PTMC-b-PGA) biodégradable, sont formées par nanoprécipitation, comme 
développé précédemment au laboratoire. Puis, ils sont encapsulés dans des vésicules 
micrométriques (géantes) de poly(butadiène)-b-poly(ethylène oxide) (PB-b-PEO) pendant 
l’assemblage de ceux-ci par la méthode d’émulsion-centrifugation. Cette méthode est basée 
sur une émulsion inverse (la suspension aqueuse des polymersomes internes nanométriques 
de PTMC-b-PGA constituant les gouttes d’eau), ce qui laisse supposer une efficacité 
d’encapsulation de 100%, ainsi que le groupe de Weitz, à Harvard l’a démontré. Le 
copolymère à bloc PB-b-PEO est dissous dans la phase organique et stabilise les gouttes 
d’émulsion à l’interface (constituant ainsi le feuillet interne de la bicouche polymère finale 
des vésicules). Une petite fraction de cette émulsion inverse est ensuite versée au-dessus 
d’une interface solution organique/eau. Dans une dernière étape, la force centrifuge force les 
gouttes à traverser l’interface et à être enveloppées par un second feuillet de copolymère à 
bloc amphiphile de PB-b-PEO, donnant ainsi lieu aux polymersomes géants attendus. Grâce à 
la maîtrise offerte par ce procédé, la structure des polymersomes multicompartimentalisés ou 
de «polymersomes dans des polymersomes» (PiPs) a pu être validée par des marquages 
fluorophores spécifiques et par microscopie confocale à disque rotatif (spinning disk) ; les 
tailles des diverses vésicules ont en effet été choisies pour être visible par cette technique. 
Nous avons ainsi pu obtenir un film où des polymersomes nanométriques rouge fluorescents 
sont en effet visiblement en mouvement dans la cavité du polymersome géant vert 
fluorescent
1. Le mouvement 2D de ces mimes structuraux d’organelles a été suivie dans ce 
film, ce qui a permis de confirmer qu’il restait Brownien (étant donné que le mouvement reste 
isotrope et que les données respectent une distribution gaussienne, aléatoire) dans la cavité de 
                                                 
1
 Movie s1, http://onlinelibrary.wiley.com/doi/10.1002/anie.201106410/suppinfo 
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ce polymersome d’à peu près 20 µm. Par ailleurs, le rayon hydrodynamique et le coefficient 
de diffusion de ces vésicules internes nanométriques étaient les mêmes, avant encapsulation 
par diffusion dynamique de la lumière, et après, par cette méthode de suivi du mouvement 
particulaire. Ces résultats prouvent la validité de cette étude de suivi et confirme que le 
mouvement des vésicules n’a pas été perturbé par leur encapsulation. En ce qui concerne le 
biomimétisme cellulaire, le confinement dans le cytoplasme joue un rôle important pour 
l’activité et la régulation des cellules. Bien sûr, il y a certainement de nombreuses propriétés 
intéressantes découlant de la présence d’un mime cytoplasmique; la première réside dans une 
meilleure protection et donc stabilité mécanique et intégrité de forme, par absorption de stress 
mécanique. Le très complexe cytosquelette n’est pas simple à mimer, puisqu’il est composé 
de filaments protéiques d’actine, de microtubules et de filaments intermédiaires formés par 
nucléation-élongation. La croissance des filaments protéiques du cytosquelette est due à des 
interactions non covalentes, avec des procédés d’association/dissociation permanents et ce qui 
les rend dynamiques. En plus des propriétés mécaniques évidentes conférées par le 
cytosquelette à la cellule, les concentrations intracellulaires fort élevées en macromolécules 
sont la cause d’un effet nommé «encombrement (crowding) macromoléculaire». En 2001, 
R.J.Ellis a ainsi enjoint la communauté scientifique des biochimistes à arrêter de négliger cet 
effet pour leurs études, qui correspond à l’effet bien connu du volume exclu en science des 
polymères. Globalement les macromolécules du cytoplasme, cytosquelette et des 
compartiments internes représentent 20 à 30 vol.% d’une cellule, générant ainsi une forte 
répulsion stérique entre elles. Les conséquences sur la machinerie cellulaire avaient en effet 
rarement été prises en compte ; la plupart des réactions chimiques sont par exemple étudiées 
en solution diluée (idéale), alors que pour une cellule, il faudrait prendre en considération les 
coefficients d’activité pour les études cinétiques et thermodynamiques. Afin de répondre à ce 
problème, une suspension de polymersomes internes nanométriques de PTMC-b-PGA a cette 
fois été co-encapsulée avec des solutions d’alginate et de dextrane très concentrées, grâce au 
procédé d’émulsion-centrifugation. Là encore, les structures finales ont été filmées en 
microscopie confocale et le mouvement des vésicules internes a été suivi et analysé. Leur 
mouvement est ralenti de manière efficace comme le confirme un coefficient de diffusion 6.6 
fois plus petit. De plus, la concentration de travail en polysaccharide dextrane de 300 mg/mL 
génère une viscosité au-delà de 0.01 Pa.s, dans la gamme de viscosité du cytoplasme des 
globules rouges, une fraction volumique proche de 30% et une pression osmotique au-delà de 
1 MPa, conditions reproduisant l’effet d’encombrement macromoléculaire des protéines 
cellulaires. Etant donné l’importance de cet effet sur la machinerie cellulaire, nous pensons 
ainsi avoir créé un mime de cytoplasme approprié avec cette approche synthétique 
extrêmement simplifiée. Jusque là étaient parues des publications concernant séparément des 
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structures de liposomes dans des liposomes, des mimes cytoplasmiques dans des vésicules 
lipidiques ou polymères, ou dans des capsules LbL, et même des capsules dans une capsule en 
présence d’un mime cytoplasmique (voir Chapitre 1). Cependant, il nous semble que la 
combinaison des deux types de mimes, n’avait jamais été signalée jusqu’à maintenant dans 
des structures entièrement polymersomes. 
Dans le Chapitre 3, nous étudions les avantages en termes d’applications, qui résultent de 
telles structures multicompartimentalisées pour la vectorisation d’actifs et la recherche 
biomédicale en général.  
En principe, une telle structure devrait présenter un grand intérêt pour la délivrance de 
multiples actifs. Pour répondre à cette problématique, un mélange de deux suspensions 
différentes de vésicules PTMC-b-PGA (marquées respectivement avec des fluorophores 
rouges et verts) a été encapsulé dans une géante. Les deux types de polymersomes 
nanométriques sont clairement localisés dans la même vésicule micrométrique
2
. Tant que les 
suspensions de polymersomes internes sont assez concentrées, on peut potentiellement 
encapsuler bien plus que deux suspensions. 
Pour finir, nous avons pu complexifier encore ce system en co-encapsulant un  polymère de 
forte molaire et fluorescent, du FITC-dextrane, avec une suspension de vésicules internes 
marquées par des flurophores rouges. Comme le FITC-dextran fluoresce dans le vert, la 
membrane externe a cette fois été marquée par un fluorophore bleu, permettant d’imager 
séparément les vésicules géantes (bleues), les vésicules internes nanométriques (rouges) et le 
dextrane emplissant la cavité géante (vert). Une telle encapsulation dans trois compartiments 
différents, n’a jamais été signalée auparavant à notre connaissance, en particulier dans des 
vésicules polymères. Ces stratégies d’encapsulation multiple ouvrent la voie pour des 
applications futures en vectorisation multiple simultanée. Ceci est particulièrement important  
pour l’oncologie entre autres, avec l’encapsulation donc la délivrance potentielle de divers 
principes actifs, même incompatibles, dans un vecteur plus grand : cela rend ainsi possible 
une concentration délivrée assez élevée en principe actif pour avoir une réponse thérapeutique 
importante et synergétique (cf cocktails de principes actifs en oncologie). 
Dans une approche de libération contrôlée et prolongée en vectorisation, nous avons pu mener 
à bien une étude in vitro de libération du principe actif anticancéreux doxorubicine encapsulé 
dans les vésicules nanométriques. Comme l’on pouvait s’y attendre, les cinétiques de 
libération étaient significativement ralenties lorsque les vésicules nanométriques étaient 
protégées par une couche supplémentaire de membrane polymère de PB-b-PEO, donc par une 
barrière de diffusion supplémentaire in fine. Dans le dernier cas, la perméation de la 
doxorubicine par les membranes polymères, induite par un gradient chimique dû au montage 
                                                 
2
 Movie s3, http://onlinelibrary.wiley.com/doi/10.1002/anie.201106410/suppinfo 
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de libération, ne pouvait que prendre plus de temps. En représentant les données avec une loi 
établie par Peppas et Ritger et en extrayant les constantes cinétiques k pour chaque système, 
nous avons même pu déterminer de façon quantitative que la vitesse de libération était à peu 
près deux fois (≈2.3) plus lente avec cette barrière de diffusion supplémentaire. Cette 
multicompartimentalisation, et en particulier cette membrane additionnelle nous a donc 
permis de démontrer les propriétés suivantes qui en découlent : un meilleur contrôle des 
cinétiques de libération grâce à une modulation de la perméabilité globale donc également 
théoriquement une meilleure protection des actifs encapsulés. De plus, de par leur nature 
polymère, ces deux membranes successives pourraient être pensées de telle sorte à avoir des 
stabilités spécifiques, différentes, et être désassemblées dans des milieux différents, de 
manière orthogonale. De telles conceptions sont vitales pour répondre à des moyens de 
délivrance nouveaux et stimulants, autre que l’injection intraveineuse classique en 
nanomédecine ; la délivrance transcutanée et l’administration orale pourraient en effet 
répondre à des grandes attentes en vectorisation et oncologie. Notre stratégie constitue donc 
une approche facile et présente de nouvelles opportunités pour l’utilisation de ces 
polymersomes dans le biomédical ou en cosmétique, où l’encapsulation d’ingrédients 
multiples, différents, et fragiles est parfois requise, avec des conditions de libération 
spécifiques à chaque membrane. 
Une telle structure pourrait aussi impacter la façon dont une réaction chimique est pensée, ou 
induite dès le mélange de différents composés (confinés dans des compartiments internés) 
relargués sur commande. Dans un dernier chapitre (Chapitre 4), nous avons donc cherché à 
remplacer dans nos mimes cellulaires, nos mimes structuraux d’organelles par des mimes 
fonctionnels, dans lesquels des réactions enzymatiques se produisent. Choisir des réactions 
enzymatiques complexes au lieu de réactions chimiques plus classiques, était pertinent dans 
une problématique de thèse portant sur le Biomimétisme cellulaire, et également par rapport 
au contexte de « Chimie verte » développé au laboratoire. En effet, dans les environnements 
confinés, et macromoléculairement encombrés d’une cellule, les réactions ne se passent pas 
comme en solution diluée (idéale). Nous avons voulu répondre à cela en produisant un 
modèle cellulaire adéquat, allant d’un Biomimétisme cellulaire structural à fonctionnel. 
Une réaction en  cascade à trois enzymes (encapsulées dans trois populations de 
polymersomes nanométriques différents) a donc été élaborée en collaboration le groupe du 
Professeur J. van Hest. L’objectif final consistait à encapsuler le mélange réactionnel 
(nanoréacteurs, substrat et cofacteurs enzymatiques) dans les vésicules de PB-b-PEO, en 
démarrant idéalement la réaction par «décageage» d’un substrat photocagé (illumination laser 
avec microscopie confocale), et en suivant l’augmentation attendue d’intensité de 
fluorescence du produit final fluorescent. Ce chapitre se concentre principalement sur 
 15 
l’optimisation de la cascade complexe des nanoréacteurs ; en effet ces organelles artificielles, 
ces mimes fonctionnels constitués de polymersomes de poly(styrene)-b-poly(L-
isocyanoalanine (2-thiophen-3-yl-ethyl) amide) PS-b-PIAT encapsulant des enzymes et dont 
la membrane possède une porosité intrinsèque, ont besoin de communiquer entre eux dans les 
bons rapports de concentration pour une réaction optimale. Cette étape s’est en effet révélée 
très complexe et problématique au regard de notre objectif final. Malgré cela, nous avons été 
en mesure de fournir une preuve de concept convaincante : en observant les mimes cellulaires 
fonctionnels par microscopie confocale, à partir d’une réaction démarrée avec un substrat non 
cagé, une fluorescence rouge était détectable après quelques heures seulement. Ce projet 
ambitieux n’en est cependant pour l’heure qu’à ses débuts et de plus amples études sont 
nécessaires. Maîtriser des réactions à partir de volumes de l’ordre de l’attolitre constitue 
certainement un challenge pouvant susciter un grand intérêt dans les développements 
industriels à long terme (notamment en terme de production biotechnologique, s’il s’agit de 
réactifs fragiles, chers, polluants, etc). De telles études ne peuvent donc qu’ouvrir des 
perspectives nouvelles en biotechnologie et dans la création de cellules artificielles 
thérapeutiques ou de thérapies complexes. De tels systèmes peuvent également contribuer à 
une meilleure compréhension par l’Homme de l’une des plus belles et des plus complexes 
créations de la Nature, la cellule biologique eukaryote. 
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General introduction 
Nanomedicine is the application of nanotechnology in medicine with the aim of developing 
especially drug delivery, diagnostic and therapeutic tools. To be more precise, according to a 
Forward Look Report on Nanomedicine
1
 published by the European Science Foundation, 
nanomedicine aims at "ensuring the comprehensive monitoring, control, construction, repair, 
defense and improvement of all human biological systems, working from the molecular level 
using engineered devices and nanostructures, ultimately to achieve medical benefit." 
Ultimately, estimated 130 nanotechnology-based drugs and delivery systems are currently 
being developed worldwide.
2
 A number of crucial issues related to toxicity and environmental 
impact of nanoscale materials will however have to be solved before regulatory agencies can 
approve further products for sure. This field is only blooming yet; it was born in academia 
where it is currently in its golden age, before interesting industries not that long ago.
2
 Indeed, 
liposomes that have been discovered by the scientist Bangham in the middle of the sixties,
3, 4
 
are only available today under five different commercial pharmaceutical formulations for 
cancer therapy (Myocet™, Doxil™/Caelyx™, LipoDox™, Lipoplatin™). However, if 
enough time and funding is devoted to this area, who knows how tremendous the results, 
success stories, and the size of resulting industrial markets may become.
1
  
 
This PhD project was related more particularly to the subfield of drug delivery polymeric 
nanomaterials, a research specialty of the laboratory. Most of existing strategies are based 
upon organic or inorganic nanoparticles encapsulating contrast agents for detection, diagnosis 
and/or delivery of therapeutic actives for severe diseases. The group Polymer Nanotechnology 
and Life Sciences in which this work was conducted, is specialized in the design of 
amphiphilic block copolymers (i.e. with a hydrophilic and a hydrophobic block) able to self-
assemble in polymer vesicles in water (non-solvent for the hydrophobic block). Such 
polymeric structures, discovered in the late 90’s have been coined “polymersomes”5 by 
structural analogy with liposomes. The membrane of these vesicles generally is a bilayer of 
assembled amphiphilic copolymers, enclosing a water pool, thus protected from the external 
aqueous solution. Ever since their discovery, many research groups over the world found 
interest in polymersomes because of their high mechanical and colloidal stability, and their 
potential ability to control the loading properties and release kinetics of different species. 
These delivery vectors may be of particular appeal for the Biomedical, Pharmaceutical and 
Cosmetic fields. Indeed, various formulation processes enable to get sizes ranging from 100 
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nm to 100 µm, whilst loading various (bio)molecules, like therapeutic drugs, both in the 
hydrophilic lumen and simultaneously in the hydrophobic membrane.
6-11 
It is their 
macromolecular nature that confers them a thicker membrane, partly responsible for this high 
colloidal stability and high hydrophobic molecule loading capability (as hydrophobic 
components will go in the hydrophobic membrane). Furthermore, as for liposomes, between 
other delivery vectors, it is possible to functionalize their surface with ligands targeting a 
specific diseased organ or cell. This should enable a selective accumulation of polymersomes 
in targeted tissues (such as tumors or inflammatory sites), to locally increase drug payload 
thus treatment efficacy, while decreasing side effects due to intrinsic drug toxicity.
12
 The 
main idea of drug delivery is indeed to improve bioavailability, which is a current challenge 
for pharmaceutical industries. The bioavailability represents the fraction of an active that will 
really be available in vivo, go where needed and used in vivo as intended. On top of the fact 
they can target specific locations, this is made possible by the typical sizes (in the range of 
hundred of nanometers) of drug delivery nanomaterials that allow them to be injected 
intravenously (the most efficient way, as 100% of active goes directly in blood circulation) on 
one hand. On the other hand, this drug delivery vectors or carriers can also be functionalized 
to be “invisible” to the immune system seeking to clear them from blood circulation (they are 
then called “stealth”, which is traditionally reached by decorating them with hydrophilic 
polymer chains, mostly poly(ethylene oxide) chains). Going further, the concept of “smart”, 
in other words, stimuli-responsive, materials has been launched a few years ago, enabling 
polymer-based materials to achieve their full potential. The goal is to reach a better control on 
the release properties of an active molecule by using polymers designed to respond to various 
stimuli (pH, temperature, ions,…) by a variation in behavior (mechanical, solubility, 
conformation, …).7 
 
This PhD project was also strongly related to another research area, Biomimicry. The idea is 
to find inspiration in Nature (bio-inspiration), in biological existing systems that demonstrate 
attractive properties, to study the structure/property relationships enabling those attractive 
properties and with this new knowledge, to transfer them to technological reality. This should 
enable new methods, or synthesis pathways, or the design of new biomimetic materials, 
improved compared to already existing non biomimetic materials. The most ancient and 
known example, is the lotus leave, which presents a particular surface in terms of structure, 
conferring it a super hydrophobicity; water glides off of it. This concept has been applied to 
industrial applications, the first of them being Lotusan™, a self-cleaning paint. Related to the 
biomedical field, liposomes have been ascribed as biomimetic as their phospholipidic 
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membrane resembles that of the biological cell. The structure of polymersomes as for them, 
has been described as resembling that of viral capsids,
13, 14
 highly efficient thus interesting 
biological systems. 
 
For this PhD project, the main objective was to achieve the formation of materials mimicking 
the structure of a cell, one of Nature’s most complex designs, able of a level of control and 
computing irreproducible with our current technologies. We wanted to push the borders from 
Biomimicry one step further, from the structural virus mimic (classic single polymersome) to 
a structural eukaryotic cell-like system, eukaryotic cell mimic. Briefly, a eukaryotic cell is 
made of an outer cellular membrane, in part constituting of phospholipids, enclosing and 
protecting a very complex system and machinery described as the “cytoplasm”. Some of the 
components of the cytoplasm are various inner compartments also called organelles (the 
organelle is to the cell what the organs are to the body, examples being mitochondria, golgi 
apparatus, chloroplasts, etc). These organelles are hosting thousands of interactions and 
reactions essential to cells’ every day life, protecting with their membrane their confined 
contents from the cytoplasm, or oppositely. Such a structure is hence described as 
multicompartmentalized. For clarity, in this manuscript the word cytoplasm refers to the 
intracellular compartment lacking organelles. Going further, these organelles are in their turn 
enclosed in the cytoplasm, that we will summarize by two components, the cytoskeleton and 
the cytosol. The ordered and dynamic one-dimensional supramolecular assembly defining the 
cytoskeleton, plays an important role in the way a cell functions. Long ordered filaments of 
protein monomers form and depolymerize (reversible phenomenon) dynamically for vital cell 
functions; allowing cell migration, attachment and division, and even serves as highway for 
internal transport of molecules to specific compartments. The cytosol plays also an important 
part in the cell’s life; intracellular macromolecular crowding, confinement and adsorption 
between individual macromolecules and their immediate surroundings in the cellular interior, 
are inherent properties of biological systems, influencing of course everything occurring in 
them. More basically and globally, the cytoplasm confers the cell a certain mechanical 
robustness. 
A structural mimic of such complex structure represents a scientific and technologic 
challenge, in terms of control over physical chemistry, stabilization of interfaces and 
formulation. Another fundamental justification of such a challenge lies in the generation of 
more accurate artificial cell models (more or less elaborate) that could provide a better 
understanding of the complex cell machinery. A cell is indeed a very peculiar system with a 
complex intracellular content, which is why it may be relevant to work on the closest possible 
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model in order to better study what happens in it (in terms of equilibria and rates of reactions 
for examples instead as opposed to studying them in dilute (ideal) solutions. On the other 
hand, a complete understanding of cell function was not yet accomplished, which is why 
synthetic models can help to get a better comprehension as they allow to dissociate 
parameters closely correlated in nature.
15
 Furthermore, the sole building of such models is 
also relevant in that perspective, after all as Feynman used to say, “what I cannot create, I do 
not understand”.15, 16 
Finally, by mimicking Nature, and building biomimetic materials, we should get access to a 
whole new range of properties. Some of them will be illustrated throughout this manuscript. 
Such concrete industrial applications can only arise once proofs of concept have been 
established through controlled lab-scale production. 
 
The choice of polymersomes and polymer-based materials in general, to achieve such 
structures is motivated by the fact that the state of the art in block copolymer synthesis allows 
a perfect control over molar masses, generating a better mechanical properties’ tuning and 
self-assembly properties and formation. Moreover, their polymeric nature can or will 
eventually in further projects, enable specific design for specific targeting (via facile 
functionalization) or release upon trigger. 
 
The design strategy to reach the desired cell-mimicking, multicompartmentalized structure, 
involved the ability to afterwards prove the structure. Hence, we decided to make both kinds 
of vesicles, inner and outer, large enough to be visible by confocal microscopy. The choice of 
confocal microscopy particularly, is motivated by the fact it represents a slice of the object, a 
thin confocal volume, which enables to prove the inner polymersomes actually are in the 
volume of the outer one. Another important risk to solve lied in quantitative encapsulation of 
hydrophilic solutions. Indeed, we needed at least one polymersome (organelle mimic) in 
another polymersome (outer cell membrane mimic), as well as introducing a massive 
viscosification or gelation in the lumen of the outer polymersome (cytoplasm mimic). To 
address this challenge, the safe, maybe the only option, lies in using emulsion-based 
processes. Initially, we planned to work with microfluidics. However, microfluidics involve 
several issues still needing to be solved before high throughput production of polymersomes 
can be achieved, the most important being the elimination of organic solvent from the 
vesicles.  It is also rather time-consuming and needs quite a lot of inner hydrophilic solution 
to load (which may be problematic if containing rare components, like expensive enzymes, 
actives, etc). The method we finally chose for the second step, loading of inner polymersomes 
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into outer polymersomes via their formation by a process called emulsion-centrifugation, 
seemed us the safer and the better option. 
After the success of this formation had been assessed with poly(butadiene)-b-poly(ethylene 
oxide) PB-b-PEO, we were planning to use the biodegradable synthesized poly(trimethylene 
carbonate)-b-poly(ethylene oxide). This proved however to be impossible which is why we 
decided to work throughout the project with the model PB-b-PEG, enough in itself for the 
proof of concepts we wanted to establish. Finally, in collaboration with the van Hest group in 
the Netherlands, we were able to investigate one of the possibilities arising from this 
multicompartmentalization, coming again closer to the eukaryotic cell; the conduction of 
enzymatic reactions (cellular function) in polymersomes in a polymersome, combination of 
structural and functional/metabolic cell mimicry. 
 
This PhD manuscript is organized in four chapters. The first is a state of the art of polymeric 
structural and or functional cell mimics, with a special focus on polymersomes. The second 
chapter presents the method to reach our structural cell mimics, thoroughly assessed. The 
third chapter presents some applications of these cell mimics in drug delivery, particularly 
multiple simultaneous loading (hence future multiple delivery) and controlled, sustained drug 
release due to permeability tuning. Finally, the fourth chapter presents a tentative work about 
enzymatic reactions in the multicompartmentalized scaffold, with a special focus on the 
difficult development of the single inner polymersome reactors. In a last chapter, we will 
conclude on this PhD work and offer perspectives for future developments. 
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1. Introduction 
How life arose from its prebiotic origins remains a deep mystery, possibly even one that 
Science will not be able to solve.
1, 2
 In nature, the cell is the basic structural and functional 
unit of all known living organisms. The way we understand nowadays a living cell may be 
simplified as “a sack containing a number of reacting chemicals, studded with environmental 
sensors, allowing heat and certain chemicals to cross its walls”.3 The scientific community 
seems to agree upon a more precise definition of the cell as a “structure that is enclosed, self-
replicating, energy dissipating and adaptive”.3 But which were the successive steps to get 
there? Synthetic biologists or protocell creationists
1
 (proto from the ancient Greek “first”) 
seek to build a minimally autonomous synthetic cell, coined minimal or artificial cell.
4
 To 
reach this goal, the needed requirements to build minimal life have to be defined. Such a 
research should thus help to evaluate plausible scenarios of the origin of cellular life on the 
early Earth,
1, 5
 which constitutes its first benefit or application. In a more concrete and 
industrial perspective, such engineered artificial minimal cells could open many prospects for 
therapy as biomedical devices
1, 5
 (and even further, to test new artificial metabolisms
5
) and in 
biotechnology
1, 5
, as bioreactors synthesizing pure proteins, only if at reasonable costs. 
 
 Materials scientists, and especially soft matter scientists, pursue other goals with other tools 
and disciplines and are highly excited by the relatively young field of biomimicry.
6
 
Biomimicry or biomimetics is “the study of the formation, structure, or function of 
biologically produced substances and materials (such as enzymes or silk) and biological 
mechanisms and processes (such as protein synthesis or photosynthesis) especially for the 
purpose of synthesizing similar products by artificial mechanisms which mimic natural 
ones”.7 Biomimetic materials science involves three steps:8 1) observing and studying mother 
Nature to understand structure-function relationships in natural systems that demonstrate 
attractive, inspirational properties, 2) extracting physical/chemical principles of these 
structure-function relationships by using theory and experiments to make them available as a 
concept useful in materials science and engineering, 3) developping new methods for the 
synthesis and the manufacturing of “biomimetic” materials based on these physical/chemical 
principles, which extend the scope of properties of existing non biomimetic materials,
9
 taking 
into account the existing capabilities and constraints imposed by engineering and economy. 
To summarize, the idea is to borrow Nature’s design strategies to achieve novel functional 
materials, with highly useful properties exceeding by far those available by current 
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methods.
9
 Finally, Antonietti et al.
10
 quote another interesting definition: “Not to copy 
Biology: to learn in modesty from her principles and to transfer it to materials space and 
conditions previously not accessible to biology”. To be more specific, butterfly wings, 
mollusk shells, bones, spider silk, gecko feet, plant cell walls, mussel byssi, Venus’s Flower 
Basket, brittle star optics, and lotus leaves, are just some of the examples that have inspired 
materials scientists so far.
8
 This field can naturally only exist at crossroads between materials 
science, chemistry, physics, biology, nanotechnology, and engineering. If we take a close look 
at the most complex machine there is, the cell, how could scientists not be challenged by it, 
not want to reproduce its perfection? How could researchers not be envious of what it is 
capable of and try to achieve the same formidable properties? 
 
The present chapter focuses on cell biomimicry (Figure 1), i.e. the preparation of complex 
supramolecular assemblies from functional materials that mimic the structure and the function 
of a cell. As mentioned above, such high ordered structures are expected to bring new insights 
in biomedical applications as well as in biotechnology. As creation of such functional cell 
mimics can only be achieved step by step, we have to analyze which features are the most 
crucial. It is worth noting that cell mimics (i.e. biomimetic materials copying some of the 
features of a cell), as opposed to artificial minimally autonomous cells, do not require being 
living, highlighting the contrast of goals between biochemists (or synthetic biologists) and 
materials scientists. For materials scientists, the first and foremost challenge to address lies in 
the controlled formation of these cell mimics, which although non-living, will roughly 
approach the complexity and functionality of living cells.
11,2
 Compartmentalization
12
 is one of 
the key architectural principles of the cell.
11,13
 The similarity found between prokaryote and 
single-compartment liposomes has already been extended to eukaryotes and synthetic 
multicompartment vesicular systems
11
. There is no life without compartmentalization and, as 
according to some of the leading theories, this process has even played a major role in the 
emergence of life.
14
 In eukaryotic cells, organelles of various sizes, in a range of 10 nm to 500 
nm (mitochondria, chloroplasts, golgi apparatus…), are visibly enclosed in the phospholidic 
cellular membrane.
12
 Indeed, segregation of biomolecules in these compartments and their 
exchange through boundaries (thanks to selective transport processes) enable the exquisite 
control over metabolic reactions in space and time required for the proper functioning of cells.
 
Inner compartmentalization also has some additional benefits for the eukaryotic cell: first, it 
allows each compartment to perform specific functions without interference from other cell 
functions due to confinement in various localizations; secondly, due to their confinement in 
various specific locations, it allows enzymes and substrates to reach higher concentrations 
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locally.
13
 The second crucial aspect of life may lay in metabolism, ”self-maintenance” or to be 
more accurate, self-maintaining chemical networks.
1,15
 The metabolism is the set of chemical 
reactions that occur within the cell to sustain life. It is to note the boundary between “living” 
and “non-living” organisms (such as viruses) has long been defined by the possession of a 
metabolic system.
16
 It is only thanks to multicompartmentalization and positional assembly 
that an eukaryotic cell is able to perform multiple, spatially separated, chemical processes 
simultaneously with high accuracy and specificity (every synthetic chemist’s dream!).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 Eukaryotic cell biomimicry: towards cellular structure and function. 
 
The choice of materials for building cell mimics is crucial. One safe option, often chosen for 
minimal cells, lies in liposomes, already considered as biomimetic due to their phospholipidic 
bilayer structure resembling that of biological cell membranes. More recently, many 
researchers started working with polymer-based materials. Indeed, the structural analogues of 
liposomes, coined “polymersomes”17 have been proposed to better mimic the structural 
properties of viral capsids.
18, 19
 Undeniably, their molar masses are much higher than those of 
phospholipids, which confers them an intrinsically thicker membrane, partly responsible for a 
much larger mechanical
16
 and colloidal stability, and a lower permeability.
19
 Therefore, 
polymer vesicles have been actively investigated in a perspective of drug delivery
20
 (or as 
sensors, and nanoreactors
13, 21
) since their discovery in the late nineties’, as they can load both 
hydrophilic (in their internal aqueous reservoir) and hydrophobic components (in their thick 
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membrane). In addition, the nature of each block can be carefully chosen to present a 
biodegradable behaviour
20, 22
 or to respond to various stimuli,
20, 23
 such as pH, temperature, 
ionic strength, etc. In the same way, they can be readily functionalized to target specific 
tissues or cells and provoke cellular internalization.
24
 Finally, the latest techniques in block 
copolymer synthesis allow a perfect control over molar masses for a better mechanical 
properties’ tuning, thus also an exquisite control on the self-assembly properties and 
formation of polymeric self-assembled supramolecular structures (as polymersomes for 
example)
20
. Once the generation of these cell mimics is controlled and optimized, material 
scientists should be able to take advantage of their structure to gain new properties and form 
completely innovative, with previously unmatched efficiency, soft materials.
  
Finally, from the most evident and fundamental point of view, mimics as model systems for 
molecular biologists and biochemists, enable to complement biological studies as they allow 
to study separately parameters closely correlated in Nature.
25,11
 Quantitative measurements in 
vivo are currently still difficult to obtain. Freedom to change the parameters is so limited that 
one cannot investigate them completely for a given mechanism. Going further, a model which 
could enable the study of various cellular mechanisms coupled together, and help to 
understand how complexity is established step by step, would be of outmost relevance.  
For all these reasons, this chapter aims at addressing specifically the field of eukaryotic 
cellular biomimicry, focusing on polymer-based materials, that can be considered as some of 
the most advanced and exciting systems designed over the last years. The first part focuses on 
recent developments to achieve in a controlled manner multicompartmentalized polymeric 
cell mimics, which is the first crucial hurdle from a physical-chemical point of view (section 
2 of this chapter, see Figure 1). The second part presents enzymatic reactions confined in a 
single compartment to build organelle mimics, or even artificial organelles (section 3 of this 
chapter, see Figure 1). Finally, in order to reach the level of control presented by eukaryotic 
cells, the design of the first exciting systems presenting a multicompartmentalized enzymatic 
activity will be described (section 4 of this chapter, see Figure 1).  
2. Structural eukaryotic cell mimicry 
At some point, evolution led to multicompartmentalization by endosymbiosis (the emergence 
of the eukaryotic cells from prokaryotic cells). The mimicking of cellular structures using 
polymer-based building blocks is very recent but at the same time in strong development.
6
 
The mimicking of eukaryotic cellular structure will be presented in the following paragraphs. 
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It follows previous studies already published on surfactant-based vesicles and readers are 
encouraged to refer to reviews for an exhaustive description of these systems based on small  
molecules.
6, 11
 
In addition, long ordered filaments of protein monomers forming the cytoskeleton, that 
polymerize and depolymerize in a reversible fashion, also dynamically control vital cell 
functions
26
; cell migration, attachment and division, and even internal transport of molecules 
to specific compartments.
27,28
 Many experiments were designed to better understand how such 
motor proteins work together with the dynamic assembly and disassembly of actin filaments 
and microtubules to facilitate intracellular transport, organelle positioning, cell polarity, and 
motility. 
16,
 
28
 
29
 The cytosol plays also an important part: intracellular macromolecular 
crowding, confinement and adsorption are inherent properties of biological systems 
30
 The 
mimicking of these relevant cellular self-organized structural features mainly using polymer-
based building blocks will be presented in the following paragraphs. 
2.1 Multicompartmentalization: Mimicking organelles in cells. 
Multicompartmentalization is a key principle of eukaryotic cells that distinguishes them from 
less evolved forms of life. Furthermore, once mimicked, the design of 
multicompartmentalized particles can bring unique properties and large benefits to the 
pharmaceutical field. At some point, evolution led to compartmentalization because a 
compartmentalized structure indeed offers multiple advantages that scientists should aim to 
seek for their synthetic materials. One of the most foreseeable lies of course in a better 
protection
31, 32
 of the inner encapsulated actives that are often very fragile in the field of drug 
delivery. Furthemore, each compartment can be made of a different polymer material, 
enabling independent surface modification, control over extremely diverse functionalities, 
orthogonal disruption or degradation in specific environments for example.
12,33,41
 As a result, 
the controlled formation of such highly ordered structures should also enable to design new 
vectors suitable for other methods of delivery than intravenous injection, such as 
transcutaneous
34
 and oral administration systems 
32, 33, 35,  improving both the patient’s 
compliance and the medical costs.  Regarding intravenous injection, the traditional pathway 
for drug vectors, the challenge for multicompartmentalized systems would of course lie in 
respect of sub-micrometer range. 
On another hand, each compartment can be independently loaded with a different drug, 
opening the door to development of novel anticancer cocktail-type drug delivery systems.
12,31
  
Furthermore, Zasadzinski and coll.
36
 first demonstrated a double membrane or barrier effect 
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in their liposomes in liposomes or “vesosomes”. This proves drug delivery can be better 
controlled with compartmentalized systems because the permeability can be tuned more 
precisely; an active should in principle not be able to cross two or more successive barriers as 
fast as a single one.
33, 36
 Compared to the developments of these lipid-based vesosomes, the 
field of multicompartmentalization is in its early stages regarding the use of polymeric 
materials. Multicompartmentalized systems based on polymers have been reported as early  as 
2000 by McPhail et al.
37
 These authors designed a hybrid vesicle in vesicle system where the 
outer vesicle was made from a 2:1 weight ratio of polymer palmitoyl glycol chitosan and 
cholesterol. The inner vesicles were liposomes. Authors outline a potential application that we 
believe of outmost interest, namely one internal compartment bearing an enzyme, another one 
a prodrug, for site-specific activation. In a more recent approach, Nallani and coworkers
38
 
formed larger polymersomes of poly(styrene)-b-poly(L-isocyanoalanine (2-thiophen-3-yl-
ethyl) amide) (PS-b-PIAT) by the solvent displacement method or nanoprecipitation using as 
an aqueous phase, a suspension of smaller polymersomes made of poly(2-methyloxazoline)-
b-poly(dimethylsiloxane)-b-poly(2-methyloxazoline) (PMOXA-b-PDMS-b-PMOXA) already 
generated by film rehydration. However, the major drawback of this approach resides 
essentially in the poor encapsulation yield of nanoprecipitation. Indeed, transmission electron 
microscopy TEM of resulting suspensions enables to see single inner or outer polymersomes 
along with the desired multicompartmentalized inner in outer polymersomes. The presence of 
both kinds of single vesicles was established by time-resolved scanning confocal microscopy 
and encapsulation of green fluorescent GFP in the inner polymersome, and red fluorescent 
Cy5-IgG in the lumen of the outer ones (see Figure 2). Yellow spots should evidence co-
localization or, in other words, the presence of multicompartmentalized vesicles.  
 
 
 
 
 
 
 
 
 
Fig. 2 Schematic representation of a multicompartmentalized polymersome. The inner vesicle is made of PDMS-
b-PMOXA-b-PDMS (ABA) block copolymers encapsulating green fluorescent proteins (GFPs), while the outer 
vesicle is made up of PS-b-PIAT block copolymers encapsulating the inner vesicle and cyanine-5 conjugated 
immunoglobulin G proteins (Cy5-IgG). Figure adapted from ref 
38
. 
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However, confocal acquisitions also showed numerous vesicles only green or red fluorescent, 
the fraction of multicompartmentalized vesicles being calculated as 45% by flow cytometry. 
To overcome this rather low efficiency, a powerful alternative lies in methods based on 
emulsions or double emulsions. Indeed, the concept of an emulsion is based on two 
immiscible fluids, thus a process based on emulsions involves in theory 100% encapsulation 
efficiency. Chiu et al.
39
 therefore used two successive emulsions. Poly(AAc-co- DSA) 
poly(acrylic acid-co-distearin acrylate) polymersomes were formed by double emulsion using 
THF/CHCl3 as organic phase, with varying volume ratios depending on desired  target size 
(1- 15 µm). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 Illustration of multivesicle assemblies equipped with pH-responsive transmembrane channels from two-
stage double emulsion of poly(AAc-co-DSA). The AAc-rich regions and the bilayer islets within the vesicle 
membrane are not drawn to scale. Scheme from ref 
39
.  
 
The primary inverted emulsion (w1/o) is first emulsified (with strong, thus potentially 
damaging, mechanical stirring input). It is then added to an excess of the same water phase 
(w2=w1 here) under stirring to get the final w1/o/w2 double emulsion. The vesicles can finally 
be formed after organic solvent evaporation. The water phase had to belong to a short pH 
range of 4 to 5.5 as a pH below 4 yielded large precipitates and above 5.5, micelles. To form 
multivesicular assemblies, the suspension of vesicles prepared as just described, was used as 
the first internal w1 water phase of the primary inverted emulsion. Once the vesicles are 
formed, they can be further equipped with transmembrane channels depending on pH (Figure 
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3). Authors admit a lack of control in the number of encapsulated inner vesicles. Based on this 
process and the DIC (differential interference contrast) micrograph provided, one can expect a 
mixture of unilamellar and multilamellar membranes that may have different diffusion 
properties. Even though very original, such a method may not yield the most reproducible and 
homogeneous systems while being difficult to use on a daily basis. 
That is why the recent developments by Weitz and coworkers of microfluidics to address this 
issue seems particularly promising. In a first step, they were able to control the formation of 
multicompartment polymersomes,
41
 or aggregates of polymersomes, before yielding fully 
multicompartmentalized polymersomes (Figure 4). 
 
 
 
 
 
 
 
 
 
Fig. 4 Schematic illustration of the microfluidic device for preparation of double polymersomes containing a 
single inner polymersome. (b) Optical microscope image showing injection of polymersomes into the innermost 
drops of double-emulsion drops, where the breakup of middle phase is triggered by the polymersomes. Figure 
from ref 
40
.  
 
The principle is the same as just described, a sequential double emulsion formation leading to 
vesicles after elimination of organic solvent. The copolymer used was the biocompatible 
poly(ethylene glycol)-b-poly(lactic acid) (PEG-b-PLA). The number of inner polymersomes 
can be controlled by adjusting the size of the orifice of the collection capillary relative to the 
size of the polymersomes and the relative flow rates. Authors present “polymersomes-in-
polymersome”, also called “double polymersomes”, with up to three different dye-loaded 
inner polymersomes. Weitz and coll. also proposed a programmed release of loaded species 
by using an external medium of water/ethanol 50/50 v.% and reinforcing depending on need, 
the polymersome bilayer with up to 50 wt.% hydrophobic homopolymer PLA. One could 
however make the hypothesis there is maybe just in total more mass of PLA to degrade before 
observing disassembly when comparing with classic polymersomes. Triple polymersomes or 
polymersome-in-polymersome-in-polymersome could also be prepared with this technique, 
resembling a set of three Russian dolls one in another. Finally, authors believe their systems 
to be promising for in vivo delivery of biomolecules such as growth factors. While they 
demonstrate a very nice in vitro proof of concept, in vivo circulation fluids cannot be reduced 
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or turned to water/ethanol (50/50 v.%). However size of particles is important for future 
biomedical development and will determine the mode of administration. While it is not 
problematic for the outer polymersomes to be micrometric for an oral administration, it would 
be preferable if the inner polymersomes (≈ 100 µm here) were in the nano-size range for such 
a scenario. For example, fully functional peptides and proteins, which are denatured by 
physiological conditions in the gastrointestinal tract,
42
 have been reported to be taken up by 
Peyer’s patches in the intestine when encapsulated in small liposomes, although only in very 
low concentrations.
43
 To conclude, this approach presents the advantage of enabling a high 
level of control over the formed systems and is probably the most promising for the future 
large scale or industrial developments. Nevertheless, this method is rather tricky and several 
issues still need to be solved before achieving the high throughput production of 
polymersomes by microfluidics: possible coalescence of the internal and external aqueous 
phases, dewetting instability of the organic phase from the copolymer bilayer usually leading 
to excess polymer patched to the vesicles,
44
 and unequal evaporation rate of solvents from the 
organic phase during the rather long drying step of the copolymer membranes with dramatic 
consequences on contact angles.
45,46
  
Finally, Lecommandoux and coll. also demonstrated the generation of polymersomes in a 
polymersome,
33
 with a facile, versatile, reproducible, and low-time and product-consuming 
technique based on the emulsion-centrifugation method. The inner polymersomes were 
formed by nanoprecipitation of poly(trimethylene carbonate)-b-poly(L-glutamic acid) (PTMC-
b-PGA).
47
 This suspension was then loaded in larger polymersomes of polybutadiene-b-
poly(ethylene oxide) (PB-b-PEO) by emulsion–centrifugation,48 a technique invented for the 
formation of giant liposomes with a quantitative loading efficiency
49
. Pautot et al. actually 
demonstrated this loading efficiency to be of 98% with such a technique.
49
 Briefly, a small 
fraction of an inverted emulsion (droplets of water phase, i.e. the nanosize polymersome 
suspension of PTMC-b-PGA, in oil) was poured over an interface of oil phase and water 
phase. The PB-b-PEO diblock copolymer, dissolved in the oil phase, stabilized the emulsion 
droplets (forming the inner leaflet of the final bilayer) and this interface. In a final step, 
centrifugal force caused these droplets to cross the interface and to be enveloped by a second 
leaflet of amphiphilic PB-b-PEO block copolymer, resulting in an aqueous suspension of final 
giant polymersomes loaded with nanosize ones. It is worthwhile to note that this process can 
also potentially be scaled-up, and optimized to a non-sequential, but still batch-mode, 
process.
50
 Confocal microscopy and specific fluorophore labelling could assess the 
multicompartmentalized polymersome structure. Such complex structures can primary be of  
interest for the simultaneous delivery of multiple active components.
31, 32
 To address this 
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point, a solution of two different PTMC-b-PGA suspensions, labelled respectively with red 
and green fluorophores was encapsulated instead of a single nanosize vesicle suspension. The 
two nanosize polymersomes are clearly localized in the same giant polymersome. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 Spinning disk confocal microscopy acquisitions of red (Alexa Fluor 568) nanosize vesicles and green 
FITC-dextran in a blue (Alexa Fluor 405) giant polymersome. From top left to bottom right: blue channel, green 
channel, red channel, overlay blue and green, blue and red, and finally blue, green, and red channels. Scale bar: 
10 µm. Figure from ref 
33
.  
 
As long as the inner polymersome suspensions that are mixed, are concentrated enough, this 
encapsulation can be extended to far more than two different populations. Finally, Marguet et 
al.,
33
 were able to further increase the complexity of this system by co-encapsulating a large 
polymer, FITC-dextran, with a red nanosize vesicle suspension. As the FITC-dextran was 
already green fluorescent, the membrane was labelled in blue, allowing separate imaging of 
the giant vesicles (blue), the inner nanosize vesicles (red) and the loaded dextran (green) in 
the giant lumen (Figure 5). Such a three-compartment encapsulation in vesicles was the first 
reported to date. As explained above, this multiple encapsulation opens avenues for future 
applications in combinatory drug delivery (multi-therapy). Furthermore, authors studied in 
vitro release kinetics of anticancer drug doxorubicin loaded in nanosize vesicles.
 
As expected,
 
the release was significantly faster than when the nanosize vesicles were protected by another 
polymer membrane, i.e. diffusion barrier. In the latter scenario, permeation of doxorubicin 
through the polymeric membranes, induced by the chemical gradient in the release setup, 
could only last longer. By representing the release data differently, with a law established by 
Peppas and Ritger
51
 and extracting the kinetic constants k for each system, it could be 
quantitatively determined that the release rate was indeed about twice slower with an 
additional diffusion barrier. With this additional membrane, better control of release kinetics 
with a resulting controlled permeability tuning could thus be demonstrated. For further 
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information, Nallani and coworkers
52
 exhaustively reviewed the design and structure of 
multicompartmentalized systems, which represent the section here described with a wider  
scope; we focus on systems with more than one layer of amphiphile (as emulsions for 
example).  
2.2 Compartments with a gelly or gelified lumen: Mimicking the cytoskeleton in cells. 
Regarding cell biomimicry, in addition to compartmentalized vesicles that can mimic the 
organelles, cytoplasm (here meaning everything in the cell, except for the organelles for sake 
of clarity) also plays an important role in cellular activity and regulation. In this respect, 
vesicles with a gelly or gelified cavity (to mimic more specifically the cytoskeleton), also 
named “hydrosomes” to acknowledge the hydrogel content, have been investigated for 
approximately a decade. Of course, there are again many interesting properties arising when 
mimicking a viscoelastic, highly complex, cytoskeleton like a potential slower diffusion of 
actives towards the outside environment and above all, a better protection and thus stability 
and shape integrity by absorption of mechanical stress. The most developed approach using 
polymers, especially by Viallat and coworkers, consists in encapsulating a poly(N-
isopropylacrylamide) (PNIPAAm)-based solution in liposomes, which will in situ polymerize 
upon photoactivation into covalently cross-linked gels.
53-59
 Jesorka, Orwar and coworkers 
reported other important contributions to the field using viscous solutions of non-crosslinked 
PNIPAAm that were microinjected in liposomes. Reversible sol-gel transitions were observed 
by heating above LCST,
60
 and by doing so in presence of poly(acrylic acid) PAA, 
poly(sodium 4-styrene sulfonate) PSS and 2,000,000 g/mol dextran.
61
 Very interestingly, 
heat-stimulated compression was successfully conducted on such PNIPAAm sol-containing 
liposomes.
62
 In another work, a poly(ethylene dioxythiophene) (PEDOT) / PSS 
polyelectrolyte mixture previously microinjected in liposomes, was physically cross-linked by 
electrostatic complexation via Ca
2+
 influx (through microinjection, vesicle fusion or 
electroporation).
63
 Electrostatic complexation with calcium ions was also used to create 
alginate gels in liposomes. Smith et al.
42
 for example designed 15-30 µm gel loaded 
liposomes specifically for oral delivery. The encapsulated enzyme seemed better protected by 
the presence of the gel, as demonstrated by enzymatic activity experiments following 
exposure to a simulated gastric pH.  Tiwari et al.
64
 used the pH-dependent solubility and thus 
gelling of PAA in liposomes. Viallat et al.
65
 also used the thermoresponsive (gelling by 
decreasing temperature) agarose to rehydrate phospholipid films by electroformation. In 
addition, they also formed with the same technique what was called “viscous” vesicles by 
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using either a solution of 50,000 g/mol dextran or carboxymethylcellulose.
66
 Long et al.
67
 
rehydrated their liposomes with a mixture of PEG and dextran, which undergo phase 
separation under specific conditions, inducing microcompartments in the liposomes and 
mimicking the crowded internal environment of living cells.
68
 Finally Stupp’s group69 
encapsulated their famous peptide amphiphiles in liposomes by film rehydration for 
protection of these peptides, which can possess bioactive epitopes. The peptides self-
assembled in nanofibers (which give in specific conditions and concentrations, macroscopic 
gels) in situ thanks to a loaded photoacid generator.  
In another perspective,
70
 the same authors pushed further the concept of their “sac” like 
structures, assembled from a complex interaction between these PAs with a high molecular 
weight oppositely charged biopolymer.
71
 By using alginate as the biopolymer (readily 
crosslinkable when introducing calcium ions) and a spray-based production of nebulized 
biopolymer microdroplets, they achieve 100 µm microcapsules. Regardless of any 
cytoskeleton aspect, these also mimic roughly cells in the sense that, they are permeable to 
large proteins which confers them the ability to deliver proteins as the cell does from its 
cytoplasm to the extracellular space. Their ability to encapsulate nanoscale compartments, cell 
components, and macromolecules make these microcapsules interesting candidates for the 
integration of cell-mimetic functions in therapeutic systems. 
Such developments using polymersomes as compartments are more recent and have been 
initiated by Feijen and coworkers
69
. A PNIPAAm solution was encapsulated in 
polymersomes, and taking advantage from its LCST (32°C), a better permeability control
72
 
regarding release of actives was demonstrated for a hydrogel containing polymersome than 
for a bare polymersome (Figure 6). Nanosize polymersomes of poly(ethylene glycol)-b- 
poly(D,L-lactide) (PEG-b-PDLLA) were formed by nanoprecipitation, PNIPAAm being 
dissolved in the organic solvent, and purified by dialysis and ultrafiltration (100,000 g/mol 
cutoff to remove free PNIPAAm). Authors demonstrated colocalization of FITC-PNIPAAm 
and polymersomes at room temperature by Confocal Laser Scanning Microscopy (CLSM) 
and Fluorescence Correlation Spectroscopy (FCS). The sol-gel transition (a coil to 
mesoglobule aggregation
73
) of the FITC-PNIPAAm internalized in polymersomes was 
studied by fluorescence anisotropy and compared with free hydrogels and free FITC; the 
rotational freedom of labelled FITC was strongly hindered, particularly above LCST, proving 
the formation of internal hydrogel. Giant polymersomes for microscopy observations were 
also prepared using chloroform instead of THF for nanoprecipitation. The hydrogel seemed to 
localize preferentially near the membrane, rather than in center of the cavity, probably due to 
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the formation of hydrogen bonds between amide groups of PNIPAAm and ethylene oxide 
units of PEG.
74
 An in vitro release of model compound FITC-dextran (4 kDa) was studied by 
FCS. By comparing results between empty polymersomes and PNIPAAm loaded ones, at 
25°C and 37°C, the conclusion is however that while the release was slower in the presence of 
the hydrogel (1 month versus 6 days), the main parameter affecting the release kinetics was 
the membrane permeability that increases significantly with temperature. Overall release was 
indeed much faster at 37°C than at 25°C regardless of lumen gelation.  
 
 
 
 
 
 
Fig. 6  Schematic 2D-cross sectional illustration of Ps and Hs in which the PNIPAAm solution present in the 
core phase separates and partially turns into a gel at the LCST of the internal PNIPAAm aqueous solution, 
influencing the release rate of incorporated agents. Figure from ref 
72
.  
 
Finally, Feijen and coworkers optimized their characterization techniques recently.
75
 The 
phase behavior of internalized PNIPAAM was monitored by coupling fluorescence lifetime 
(FL) and time-resolved fluorescence anisotropy (TRFA) as a function of temperature, and 
compared to measurements on free hydrogel. They concluded that with increasing 
temperature, internalized PNIPAAm underwent a coil to globule transition, followed by 
intermolecular aggregation and possibly phase separation, before finally hydrogel formation, 
thus providing a deep understanding about gel formation mechanism. 
Gaspard et al.
76
 also reported “polymer hydrosomes” with the aim to extend the gap of 
polymersome dynamic-mechanical and surface properties and thereby the range of cell-like 
behavior. Gels with various crosslink densities were polymerized in situ from various ratios of 
acrylamide/methylenebisacrylamide after encapsulation in PB-b-PEO polymersomes by film 
rehydration with the appropriate pre-gel solutions. Cross-linking density of hydrogels was 
shown to affect only minimally overall polymersome permeability to molecules smaller than 
430 Da. As for the Feijen group, authors observed that the acrylamide hydrogel interiors did 
not seem to affect particularly mass transport. The membrane represents again the primary 
diffusion barrier as evidenced by a noticeable change when increasing copolymer length 
(PB33-b-PEO20 to PB120-b-PEO89). Interestingly however, by increasing cross-linking density, 
the extent of vesicle deformation or surface contact length decreased, which was consistent 
with an observed increased resistance to compression strength.  
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To conclude about this part, and contrary to what could be instinctively expected, a 
cytoskeleton mimic does not seem to tune the diffusion behavior much, this parameter being 
mainly limited and controlled by membrane mass transport (depending from temperature).
72, 
76
 However, as expected and as for the cell, such a mimic improves the mechanical stability of 
the compartment in which it is enclosed.
76
 
2.3 Perspectives: Combining organelle and cytoskeleton/cytosol mimics 
An external microcapsule (150 µm) formed by the layer-by-layer LbL technique contained a 
gel bead enclosing 3 µm internal LbL microcapsules.
77
 Both kinds of microcapsules were 
formed using core templates (calcium carbonate for the inner capsules, the microgels for the 
outer ones) and successive deposition of biopolyelectrolytes dextran sulfate and poly(L-
arginine). The inner polymer-coated CaCO3 microparticles were dispersed in a dextran-
hydroxylethylmethacrylate (dex-HEMA) and dimethylaminoethyl methacrylate (DMAEMA) 
solution. Upon addition of a concentrated PEG solution, both polymers, which do not mix at 
such high concentrations, phase-separated and radical polymerization of methacrylate 
moieties in the final copolymer resulted in spherical gel beads loaded with internal 
microcapsules. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7 Schematic representation of a polyelectrolyte coated gel bead (>100mm) loaded with LbL microcapsules 
of a few micrometers in size. The o’s represent the crosslinks of the gel bead. Figure from ref77.  
 
DMAEMA was copolymerized with dex-HEMA to get positively charged microgels. Then, 
authors only needed to coat the ensemble with the last LbL shell and dissolve the template 
core by EDTA addition. Once these biomimetic structures were formed in a controlled 
fashion, the self-exploding character of this structure could be established. Indeed, in 
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physiological conditions, the dex-HEMA gel beads are degraded in a few days or weeks 
depending on crosslinking density. As a result of this cross-link cleavage (through hydrolysis 
of the carbonate esters connecting the polymerized methacrylate groups with the dextran 
backbone), degradation products dextran and HEMA-co-DMAEMA oligomers increased 
inner osmotic pressure, causing internal swelling until the outer LbL shell cracked at localized 
spots, thereby releasing the inner LbL microcapsules.  Authors outline two particularly 
promising applications for such systems: for time-controlled release of biological matter such 
as stem cells or insulin-producing cells, and as single shot vaccination delivering antigen-
containing microparticles (thus avoiding the multiple injections currently needed to develop 
the immune response).  
Finally, to the best of our knowledge, Marguet et al.
78
 were the first to combine both of these 
structural cell mimics (“organelles” and a very rough “cytoplasm”, mimicking more 
particularly the cytosol with intracellular macromolecular crowding conditions) in vesicles, 
particularly in polymersomes. The goal was to first achieve a completely original and 
innovative biomimetic structure before being able in later work to take advantage from the 
resulting properties. To address this challenge, a suspension of nanosize inner polymersomes 
of PTMC-b-PGA
47
 was encapsulated in giant polymersomes of PB-b-POE together this time 
with highly viscous alginate  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.8 Statistics of displacements (µm) in x and directions of nanosize inner polymersomes in a giant 
polymersome with (green and black) and without (red and blue) 300 mg/mL dextran. Figure from ref 
78
.  
 
or dextran solutions, thanks to the emulsion-centrifugation process. Without cytoplasm 
mimic, the 2D motion of these organelle mimics tracked down in a movie, was confirmed to 
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still be Brownian (as motion stayed isotropic, and data respects a Gaussian, or random, 
distribution) inside the volume of an approximately 20 μm giant polymersome (Figure 8). 
Furthermore we found the same size and diffusion coefficient of inner nanosize vesicles after 
their encapsulation by this particle tracking analysis than by dynamic light scattering on the 
solution before its loading. This result assessed the validity of this tracking analysis and 
confirmed that the nanosize vesicles are not disturbed by their encapsulation. This analysis 
was then further repeated in the presence of “cytoplasm mimic dextran”: this time, their 
motion was proved to be efficiently hindered (Figure 8) as confirmed by an approximately 6.6 
times smaller diffusion coefficient. Furthermore, the concentration of 300 mg/mL of 
polysaccharide dextran brought a viscosity above 0.01 Pa·s, in the range of red blood cell 
cytoplasm viscosity,
54
 a volume fraction near 30%
68
, and an osmotic pressure above 1 MPa 
roughly resembling the intracellular conditions caused by global cellular proteins. By 
reproducing the intracellular “macromolecular crowding effect”, which plays a crucial role in 
the cell machinery, 
30
 this synthetic and simplified approach constituted an appropriate 
cytoplasm, more specifically cytosol, mimic. 
3. Polymersomes hosting enzymatic reactions: Mimicking functional 
organelles. 
“Metabolism” is the set of chemical reactions that occurs within a cell. For eukaryotic cells, 
these reactions are catalyzed by enzymes in the cytoplasm or in specific cellular 
compartments. Inner compartmentalization allows fragile processes to remain protected 
against undesired influences and highly reactive, thus toxic, conditions (as can be found in 
peroxisomes and lyzosomes) to be prevented from harming the rest of the cell. In this context, 
this section focuses on the use of polymer-based materials to tackle the challenge of 
mimicking metabolism, the cell “function”, with enzymes. Enzymes in organelles are indeed 
spatially confined, possibly in environments prone to macromolecular crowding, hence 
normal solution reaction kinetics are no longer valid.
79
 This suggests entrapment of enzymes 
in artificial nanoreactors (i.e. compartments, herein polymersomes, hosting enzymatic 
reactions) may contribute to a better understanding of activity and interactions of these 
enzymes contained in confined spaces, before enabling scientists to come up with powerful 
innovations. For instance, Cornelissen and coworkers proposed that, in the case of enzymatic 
reactions occurring in viral capsids, the reaction velocity is inversely proportional to the 
number of enzymes encapsulated, which seems to outperform free enzymes.
79
 It is important 
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to note that their enzyme, as other ones, is supposed to be more active when immobilized. 
Vancso and coll. reported that enzyme efficiency is increased with decreasing vesicles size. 
They observed a two-orders of magnitude increase of enzyme efficiencies compared to bulk 
reaction; this attributed to enhanced rate of enzyme to substrate and of molecule to wall 
collisions in such confined volumes.
80
  
In any case, nanoreactors need to be able to perform enzymatic reactions in situ, while 
allowing membrane diffusion of substrates and products. The necessary permeability may for 
example be introduced by mixing in a very controlled fashion, two different kinds of 
polymers as vesicle building blocks, one of them designed to disappear, after solubilisation
81
 
in specific conditions or upon degradation. In addition, the enzymes’ activity should not be 
too affected by encapsulation through block copolymers self-assembly, which is mainly 
performed in presence of organic solvents (nanoprecipitation).  
Interestingly, the enzymatic activity in polymersomes is often maintained longer than in free 
solution, certainly due to a shielding of their degradation by microbes and enzymatic 
proteolysis
82, 83
 that constitutes one of the major and most concrete advantages of 
nanoreactors. The field of nanoreactor hosting enzymatic reactions, particularly nanoreactors 
as artificial organelles, is a fast growing area that has already been reviewed in detail very 
recently.
13,21
 In the following section, only the most relevant, recent and challenging systems 
will be discussed, focusing on systems that find potential long-term applications in vivo. The 
first and second parts of this section will distinguish between nanoreactors intended to 
become part of the metabolism, and nanoreactors designed to bring intracellular or at least in 
vivo therapeutic solutions for given amounts of time. In a third part, an overview of what 
nanoreactors are capable of in other applications will also be presented.  
3.1 Functional artificial organelles designed to replace or substitute intracellularly for 
missing functions 
To mimic nature more closely, a prerequisite step consists in controlling the positioning of 
encapsulated Intracellular use of nanoreactors for enzyme replacement therapy to compensate 
for lost, missing or decreased cellular function is of outmost importance. More globally, 
protein therapy aims at intracellularly replacing or complementing faulty ones (like growth 
hormone and insulin for example, or in a therapeutic perspective, use antibodies that will 
block blood supply to tumors) by in vitro produced proteins. This strategy against protein-
deficiency disease is facing some difficulties regarding clinical trials as proteins do not 
present sufficient in vivo stability and are not easily taken up by cells, or in vivo intracellularly 
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trafficked.
84, 85
 An alternative strategy has been envisaged to  overcome these limitations 
where therapy involves the cell internalization and intracellular function of enzymatic 
nanoreactors, thus becoming artificial organelles. For the design of nanoreactors in general, a 
prerequisite step consists in controlling the positioning of encapsulated enzymes in the 
nanoreactor, in a sufficient concentration furthermore (see table 1). It is well known that high 
encapsulation efficiencies of hydrophilic components are complicated to master in 
polymersomes, which is why we believe it relevant to detail a little the different procedures in 
this chapter as well as in Table 1 (which is an experimental overview of section 3).  Indeed, 
the amphiphilic character of enzymes and their often large molar mass render their loading 
even more challenging. In addition, an absolute requirement lies in the preservation of their 
bioactivity during the vesicle formation. This control was demonstrated in the van Hest group 
with encapsulation of glucose oxidase (GOX) in the lumen and horseradish peroxidase (HRP) 
in the membrane.
86
 The strategy for encapsulation in the hydrophilic lumen was inspired from 
a previous work.
87
 The effectiveness of enzyme encapsulation in hydrophobic membrane was 
demonstrated by visualizing incorporation of Alexa Fluor 488 (membrane) and 633 (lumen) 
labelled Candida Antartica lipase B (CALB) by epifluorescence microscopy. Interestingly 
enough, the enzymatic activity assay classically performed on the filtrate of polymersomes 
with membrane-bound Alexa Fluor 488 labelled CALB revealed that no free enzyme was 
present, apparently showing a quantitative membrane encapsulation. So, HRP was 
encapsulated in the membrane by nanoprecipitation (or solvent displacement); PS-PIAT in 
THF is injected in a small volume of HRP in buffer. A large amount of water is then added, 
before lyophilization of the sample. The resulting powder is then redissolved in THF and 
injected in a 5-fold bigger volume of GOX solution in buffer.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 Schematic representation of the multistep reaction taking place in the three-enzyme–polymersome system. 
Scheme of ref 
86
.  
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Finally, the mixture is transferred to an Eppendorf with cutoff filter and centrifuged to 
dryness. Subsequently, polymersomes were redissolved in buffer and centrifuged again until 
no further enzymaticactivity was observed in the filtrate. It is to note that encapsulation of 3-
fold times bigger GOX (160 kDa) in the membrane resulted only in disruption of 
polymersomes. Van Hest and coll. were then further able to perform a three-step cascade 
reaction (Figure 9): external CALB first hydrolyses a specific substrate into glucose, which 
then permeates through the polymersome membrane to be converted by the lumen GOX to its 
lactone and hydrogen peroxide. This peroxide is then converted together with permeating 
2,2′-azinobis(3-ethylbenzothiazoline- 6-sulfonic acid) (ABTS) by HRP in membrane to water 
and a radical ABTS°
+
 whose production can be monitored by UV-vis spectrophotometry. The 
obvious benefit of encapsulation was demonstrated by a prolonged lifetime: the enzyme was 
shown to still preserve 87±5% of its activity after one month whereas there was a complete 
loss in bulk within a few days. It was also evidenced that this cascade reaction could work 
with GOX encapsulated inside one population of polymersomes and HRP in another one, in 
the presence of proteases in the external environment furthermore.
82
 More recently, the same 
group reported a similar multistep cascade reaction, this time with CalB in membrane, GOX 
in lumen and HRP attached to external surface by Huisgen cycloaddition.
88
 Once all these 
techniques were mastered, van Hest and coworkers were ready for the final step of 
internalization in cells.
89
 Indeed, their nanoreactors now functionalized with cell penetrating 
peptide tat were intracellularly routed and checked for activity in mammalian cells. The 
efficient uptake of tat-functionalized nanoreactors through macropinocytosis was 
demonstrated, highlighting a promising starting point for future in vivo use. Enzymatic 
activity of these “artificial organelle” in the cell was finally assayed with the cell-penetrating 
substrate TMB converted in presence of H2O2 and HRP in lumen to a blue precipitate. The 
rate of conversion seemed to be directly dependent in a linear manner from the administered 
dosage of polymersomes. Furthermore, the authors declared the catalytic activity observed in 
the cells was maintained at levels that were higher than those reported for soluble enzymes. 
Other highly interesting nanoreactors were  reported by Montemagno and coworkers. As early 
as 2005, 
90
 the authors were able to recreate an ATP generation process in so-called 
“proteopolymersomes” in which they incorporated the proteins bacteriorhodopsin (BR, a 
light-driven transmembrane proton pump driving an influx of protons in the lumen) and motor 
protein F0F1-ATP synthase (able to hydrolyze ADP to ATP in presence of inorganic 
phosphate thanks to this proton influx). Their method presents the advantage of avoiding 
protein-damaging solvents: it is basically direct dissolution with precise additions of 
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components, followed by vortexing and sonication to favor mixing, dilution, filtration and 
dialysis to eliminate non-encapsulated proteins. 
3.2 Targeted delivery in situ of fragile products generated by nanoreactors. 
“Therapeutic nanoreactors”. 
Better as a “simple” smart drug delivery vector, therapeutic nanoreactors aim at producing 
drugs in vivo, directly at the target site or helping the organism respond to pathological 
conditions such as oxidative stress and inflammation. The ultimate long-term concept of such 
a biologically-inspired nanofactory is schematically depicted in Figure 10 and represents an 
inspiration for material scientists.
91
  
 
 
 
 
 
 
 
 
 
 
 
Fig. 10 Schematic of six mechanisms in the biologically-inspired nanofactory: (1) a structural shell or scaffold, 
(2) transport to convey biomolecules to and from the environment, (3) sensing functionality, (4) encapsulation of 
biochemical machinery, (5) targeting of the factory within the body, and (6) externally triggered degradation to 
terminate a treatment in a controlled fashion. Figure from ref 
91
, perfectly illustrating the ultimate final 
application of this section.  
 
While the field of drug delivery is currently in great development and seems as promising as 
ever, one cannot indeed ignore the challenges encountered: difficult control of release kinetics 
especially without any stimuli-sensitiveness, possible delivery of payload into undesired 
biological compartments, the problematic of controlling polymer degradation, etc.
92
 Only the 
most recent contributions will be discussed in this sub-section. Importantly, Meier and 
coworkers pioneered the concept of nanoreactors, especially polymersomes ones, a decade 
ago
93,94
 but their most recent advances could only be reported after succeeding in the control 
of several necessary steps like robust polymersome formation, successful incorporation of 
active transmembrane proteins or porins, loading of functional enzymes and cell-specific 
targeting. In that aspect, a very interesting work from Ranquin and Meier concerns the use of 
prodrug activating enzymes in nanoreactors (Figure 11).
95
 This selective local enzymatic 
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activation of prodrugs is a means to increase local drug concentration in tumors while 
decreasing toxic side effects, the prodrug being inactive. With this strategy, immunogenicity 
of the enzyme is avoided in vivo while enzyme activity is protected. Diffusion of substrates 
was enabled with incorporation into the membrane of two porines: OmpF has a molecular 
weight cut-off of 600 Da while Tsx allows specific transport of nucleosides and nucleotides. 
The purine-specific nucleoside Trypanosoma vivax TvNH was encapsulated by film 
rehydration: first a dried film of polymer/ porine is generated which can then be rehydrated by 
a TvNH containing buffer. Three natural nucleosides, ionosine, adenosine, guanosine, and one 
prodrug fluoroadenosine (yielding the cytotoxic drug 2-fluoroadenine) were assayed for 
enzymatic activity in nanoreactors. TvNH catalyses hydrolysis of the N-glycosidic bond of 
the β-ribonucleoside separating the free nucleic base and deoxyribose. The reaction is stopped 
by addition of CuSO4 where Cu
2+
 is reduced to Cu
+
 by the reaction product ribose. At  low 
OmpF concentrations activity seems limited by substrate transport. With a 10-fold increase or 
use of more specific Tsx, authors observe this is no longer true (as shown by a 6-fold 
improvement of apparent kcat and Km values). Encapsulation efficiency of TvNH was 
determined to approach 15% by SDS-PAGE. 
 
 
 
 
 
 
 
Fig. 11 Schematic representation of a nanoreactor build up of poly(2-methyloxazoline)-block-
poly(dimethylsiloxane)-block-(2 methyloxazoline) (PMOXA-b-PDMS-b-PMOXA), permeabilized by the 
bacterial outer membrane protein OmpF and encapsulated with Trypanosoma ViVax nucleoside hydrolase 
(TvNH). Figure of ref 
95
.  
 
There are also notable contributions resulting from Hunziker and Meier. The ultimate desired 
long-term application is the exhibition of a controlled and triggered diagnostic signal or 
therapeutic effect upon in vivo activation.
96
 Encapsulated enzyme acid phosphatase is only 
active between pH 4 and 7, thus conferring the nanoreactors a pH-controlled bioswitchability. 
The enzyme and porines were encapsulated by nanoprecipitation and a hydrosoluble prodye 
was converted in situ into fluorescent precipitating ELF97. The fluorescence intensity was 
maximal after 3h, as evidenced by epifluorescence and confocal microscopy. It is to note that 
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kinetics seem 18 times slower than in bulk, certainly, as hypothesized by authors, because of 
diffusion limitation due to OmpF porines whose cutoff is less than twice the substrate 
molecular weight. Finally, this technology was enough mastered to pursue to the next level 
with cell integration.
97
 Rapid in vitro cellular internalization was indeed demonstrated with 
specific cell type targeting, and cytoplasm localization before observation of polymersomes’ 
trafficking to specific sites. The functionality of their nanoreactors intracellularly was 
demonstrated with an encapsulated protease (tripsin) converting a cell-penetrating derivative 
of Rhodamine 110 (BZiPAR) into green fluorescent Rhodamine 110.  
In another very exciting therapeutic perspective, Meier and Palivan worked on enzymes 
inside nanoreactors in order to fight oxidative stress, logically coined “antioxidant 
nanoreactors” (see table 1). Cells reduce oxygen to produce energy, which is one of aerobic 
life’s fundamentals. However as a result, oxygen radicals and derived radicals, i.e. “reactive 
oxygen species” ROS (like the superoxide anion radical, the hydroxyl radical or the 
assimilated ROS hydrogen peroxide) are constantly generated in almost all living tissues, 
being involved in various important physiological signaling processes. However, when ROS 
concentrations reach abnormal high levels, they can potentially damage vital tissue 
constituents, such as DNA, proteins, and lipids, inducing a so-called “oxidative stress” that 
may lead to a number of diseases, including cancer, AIDS, Parkinson’s and arthritis, 
deregulation of physiological signals or chronic inflammation.
98
 To ensure their function as 
signalling molecules, in healthy tissues ROS are balanced by cellular antioxidant defence 
mechanisms, i.e. they are rapidly scavenged by various types of antioxidants such as 
glutathione, vitamin C, and vitamin E. Antioxidant nanoreactors have been designed to in situ 
fight against oxidative stress, by detoxifying ROS species. Interestingly, PMOXA-b-PDMS-
b-PMOXA polymersomes have the ability to let dioxygen and superoxide radical anions 
permeate through. In the first attempts, Cu,Zn-super oxide dismutase (SOD) was used as 
detoxifier.
83,99
 Loaded SOD was confirmed to remain intact and active by circular dichroism, 
electron paramagnetic resonance spectroscopy and with the activity assay of course. SOD 
labeled with Alexa Fluor 488 was analyzed by FCS to confirm its presence in the 
polymersome lumen. Thanks to pulse radiolysis, the rate of dismutation of superoxide radical 
anions at 280 nm could be monitored instantly with high sensitivity. The reaction rate of 
dismutation of superoxide anion radicals inside the nanoreactor was estimated similar to the 
one of enzyme in bulk. Finally with a calibration curve of free SOD activity by pulse 
radiolysis, they were able to estimate a number of 10 enzymes per nanoreactor.  
However, a major conceptual drawback of these systems lied in the fact that superoxide 
radical anions were dismutated into hydrogen peroxide, unfortunately yet another oxidative 
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molecule. Therefore the concept was further extended and improved with a dual enzyme 
cascade reaction resulting in the final products of oxygen and water, thereby a complete 
detoxification.
100
 The system is schematically presented in Figure 12. OmpF porines enabled 
the diffusion of amplex red, the substrate for the second enzyme of the detoxifying cascade, 
namely lactoperoxidase LPO that produces resorufin, a fluorophore.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12 Design of the enzymatic cascade reaction inside polymeric nanocontainers for detection and superoxide 
radical detoxification. A) Schematic illustration of SOD–LPO cascade reaction inside a nanocontainer. B) 
Chemical reactions allowing the detection and detoxification of superoxide radicals: 1) generation of O2C_;  2) 
reactions involving SOD; 3) reactions involving LPO. Figure of ref 
100
.  
 
Cu,Zn-SOD, LPO and OmpF were loaded through nanoprecipitation followed by extrusion 
and dialysis. The number of fluorophore labeled enzyme molecules per vesicle, i.e. enzyme 
encapsulation efficiency, was found by dividing the molecular brightness (count rates per 
molecule) of enzyme-containing vesicles by the molecular brightness of freely diffusing 
fluorophore thanks to FCS. The fraction of all combinations of vesicles (empty lumen, with 
only SOD, only LPO, LPO in excess to SOD, opposite, and finally LPO and SOD in 
stoichiometric amount) was established by combining FCS and FCCS fluorescence cross-
correlation spectroscopy. The fraction of dual-containing enzyme nanoreactors was thus 
measured to be 10%. The polymersomes were finally incubated with THP-1 cells, internalized 
and the concept proven to be completely functional. Impressively, cells treated with 
intracellularly superoxide radical producing paraquat, revealed indeed a high resorufin 
forming signal, thereby proving not only detoxification but also demonstrating biosensor 
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ability. In their most recent optimization, Palivan and coworkers
101
 loaded a dual- enzyme 
mimic of SOD and catalase, Cu
II
ENZm, which gave the same final products than in the 
previous attempt, i.e. O2 and H2O. This molecule being smaller, the encapsulation efficiency 
goes in that case from32 to 46%. Cellular uptake by THP-1 monocytes was evidenced by flow 
cytometry, CLSM and TEM, and estimated to reach 11% after 24 hours even if notably only 
non-functionalized vesicles were involved. After 48 hours incubation, this fraction increased 
considerably, so that a protective antioxidant effect of 23% (cell death decrease) against 
paraquat induced oxidative stress could be demonstrated. 
3.3 Nanoreactors for polymerization and catalysis purposes 
In addition to the use of enzymatic polymer-based reactors as promising systems to mimic the 
cellular function for potential biomedical applications on the cutting edge of technology just 
described, these reactors have also been abundantly designed for other perspectives such as 
biocatalysis, biotechnology or classic Drug Delivery. Van Hest’s group for example imagined 
purely catalytic applications for PS-b-PIAT nanoreactors.
102
 Indeed “simple” in vitro 
enzymatic polymerizations have attracted much interest as non-favorable conditions by 
“classic routes” become possible, such as aqueous medium and room temperature.102 The 
concept described on Figure 13, consists in polymerizing various monomers (caprolactone 
CL, 8-octanolactone OL, 12-dodecanolactone DDL and 4,7,10-tetraoxyacyclotetradecane-
11,14-dione TCDD) with enzyme CalB encapsulated either in the water pool or in the 
membrane (see table 1). 
 
 
 
 
 
 
 
Fig. 13 Schematic representation of enzymatic polymerization in polymersomes. (A) CALB in the aqueous 
compartment (B) CALB embedded in the bilayer. Figure of ref 
102
.  
Starting from the same concentrations of CalB to encapsulate, CalB in the water pool 
seemingly generated a much higher activity than the one in the membrane bilayer. Authors 
hypothesized a restricted access of substrate molecules due to the thickness of hydrophobic 
PS layer. Interestingly, the oligomer polymerized from monomer DDL was quite the same 
(after 1, 3, and 6 days) for CalB in lumen, membrane or free, suggesting encapsulated enzyme 
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is freely accessible with no hindrance from the polymeric bilayer. While this polymer 
precipitates after reaching a certain molecular weight, this was not the case for oligomers of 
OL, where only CalB encapsulated in bilayer yielded far less high molecular masses. 
Polymersomes were completely disrupted after 3 days of polymerization of OL with CalB in 
bilayer, probably because the synthesized oligoesters plasticize this bilayer. For OL with CalB 
in water pool, morphological changes appeared after 3 days before complete disruption after 6 
days.  
The same group has again demonstrated a great level of technological control in confined 
enzymatic reactions by going further in the design of nanoreactors for biotechnological 
industrial applications.
103
 Baeyer Villager monoxygenases (BVMO) belong to a class of 
oxidative enzymes, particularly interesting for the development of “green” biocatalytic 
processes, because they can perform oxidative processes with a high level of chemo-,regio-, 
and/or enantio-selectivity However, the flavin present in their active site needs to be reduced 
after each catalytic cycle, which can be performed through electron supply of NADPH 
nicotinamide adenine nucleotide (phosphate). A cofactor recycling system is here required as 
its stoichiometric use would severely affect reaction efficiency and be highly cost-expensive 
after scale-up. The system design is summarized in Figure 14. Glucose-6-phosphate 
dehydrogenase G6PDH is loaded in the water pool where it converts glucose-6-phosphate and 
NADP
+
 into 6-phosphate- gluconolactone and recycled cofactor NADPH, which activates the 
BMVO phenylacetone monoxygenase PAMO (free in external medium or attached on 
external surface) for conversion of phenylacetone into phenylacetate. After 28 hours, 28% of 
substrate was converted which could be approximately doubled by doubling G6PDH  
concentration. In bulk however, 100% was converted in 30 min; authors attribute this 
difference to the membrane barrier between the two enzymes..  
 
 
 
 
 
 
 
 
 
 
Fig. 14 Diagram depicting the regeneration of cofactor NADP+ by G6PDH inside PS-b-PIAT polymersomes to 
sustain the conversion of phenylacetone catalyzed by PAMO. Two systems with encapsulated G6PDH were 
separately examined: PAMO in solution and PAMO covalently immobilized on the surface. (The CRE2-PAMO 
system is not shown here.) Figure 1 adapted from ref 
103
. 
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When PAMO was attached to the surface outside instead of added to external medium, 
conversion was only 5% after 24h Authors attributed this decrease of reactivity to 
inaccessibility of active sites, deformation of the enzyme following immobilization, or 
hindered diffusion of NADPH through polymersome membrane as a result of a PAMO 
covered surface. Following the same perspective, Cornelissen and coworkers
104
 imagined a 
“continuous-flow polymersome reactor” where enzyme loaded vesicles are immobilized in a 
macroscopic hydrogel, substrate added to the top of the reactor and product collected at the 
bottom. Such a reactor is powerful as it enables recycling of enzyme retaining polymersomes. 
A recent and smart design of Battaglia and Voit
105
 concerns a polymersome nanoreactor with 
pH dependent permeability. While the hydrophilic block is PEG, the hydrophobic one, is 
indeed the pH-sensitive poly(diethylamino ethyl methacrylate) PDMEAEM with a small 
percentage of a photo-cross-linking unit incorporated (needing only 30 s of photoactivation). 
When the polymersomes were cross-linked they showed swelling/deswelling cycles following 
pH switch (from 8 to 6), which could be repeated 5 times. In the swelled state, the 
permeability is sufficient for substrate diffusion and enzymatic conversion in situ  
Enzymatic polymer based reactors have also been used for a quite different perspective that 
consists in using the enzymatic reaction to trigger a specific permeability
81
 or membrane 
disruption in a controlled fashion. Napoli et al.
106
 reported a nice example of such application. 
They incorporated thioethers in the hydrophobic poly(propylene sulfide) blocks of PEG-b-
PPS-b-PEG vesicles that were converted into more hydrophilic sulfoxides and sulfones upon 
exposure to a hydrogen peroxide oxidative environment, changing the hydrophilic ratio and 
thus inducing its solubilization.GOX was encapsulated in the lumen by film rehydration, 
separated by SEC and glucose added to the external environment. With a classic HRP-ABTS 
assay based on H2O2 consumption, the enzymatic activity was assayed as well as a high 
enough membrane permeability to glucose demonstrated. This permeability may be explained 
by a low Tg of 230 K, implying a high mobility at room and body temperature. Indeed a 
really minimal delay of 0.5 s between addition of glucose and oxidation of ABTS was 
assessed. Finally the disruption due to hydrogen peroxide generation by GOX could be 
demonstrated. In the bloodstream there are mM concentrations of glucose that would be 
available to trigger compound release with such systems and the produced hydrogen peroxide 
would be diluted enough to be harmless for patients. Furthermore, whereas the free GOX lost 
activity after 5 to 6 days, the encapsulated one seemed to remain active at least 24 days. 
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Table 1 Nanoreactor polymersome characteristics  
Number of 
enzymes 
involved in 
cascade 
Substrate 
(+ other reactive(s)) 
Enzyme(s) Enzyme(s)’s 
localization 
Encapsulation&purifcation 
methods and  
encapsulation efficiency (EE) 
Product(s) Reference/ 
Main author(s) 
1 TMB (+ H2O2) HRP Lumen SD
a (THF)/ Dialysis Blue precipitate 
89 Brock/van Hest 
Prodye ELF97 
phosphate  
Acid  
phosphatase 
Lumen SEC
b
 Dye ELF97(solid) 
96 
Hunziker/Meier 
BZiPAR Trypsin Lumen  Dye Rhodamine 110 97 Hunziker/Meier 
O2°
- (+ H+) Cu,Zn-SOD lumen SD
 a
 (ethanol)/ SEC 
2-5 enzymes/vesicle. 
H2O2 
83 
Palivan/Meier 
O2°
-(+ H+) 
 
Cu,Zn-SOD 
 
Lumen 
 
Method A
c/SEC 
2-5proteins/vesicle. 
EE
d
 ≈ 43 -61 % depending on 
DP. 
H2O2 
99 
Palivan/Meier 
Natural nucleosides 
(ionosine, adenosine, 
guanosine) 
TvNH Lumen Method A
c/chromatography  
EE
d 
≈15% 
Free nucleotic bases  
and deoxyribose 
95 
Ranquin/Meier 
 
Prodrug  
 2-fluoro-adenosine 
TvNH Lumen Method A
c/chromatography 
EE
d 
≈15% 
 
2-fluoroadenine 
95 
Ranquin/Meier 
phenylacetone 
(+NADPH+ phosphite) 
 
CRE2-PAMO 
 
Lumen SD
a
 (dioxane)/ Method B
e
 
EE
d
 ≈20% 
Phenylacetate 103 
van Hest 
O2°
- 
 
CuIIENZm,  
 
Lumen Method A
c/SEC 
200 enzymes /nanoreactor 
(46% EE
d
) 
O2 + H2O 
 
101 
Palivan 
DIFMU octanoate CalB Lumen SD
a
 (THF)/ SEC+ Method B
e
 Dye DIFMU 
  
81 van Hest 
Glucose GOX Lumen Methods B
e
/ C
f
  Gluconolactone  
(+ H2O2) 
106 
Sommerdijk 
Lactone monomers
g
: 
OL, DDL 
 
CL,TCDD 
 
DIFMU octanoate 
CalB Lumen 
+ Membrane 
 
 
idem 
SD
a
 (THF)+ Method C
f
 
(THF)/Method B
e
 
 
 
idem 
 
Polyesters 
 
No polyesters 
 
Dye DIFMU  
102 
Cornelissen 
van hest, Nolte 
Guaiacol (+H2O2) Myoglobin Lumen Using the tuned permeability  
of their designed reactor 
/ KrosFlo™ 
Oxidized guaiadacol 
 
105 
Battaglia/Voit 
2 phenylacetone 
(+NADPH) 
PAMO Outside and on 
external surface 
via click 
SD
a
 (dioxane)/ Method B
e
 
 
Phenylacetate 
 
103 
van Hest 
glucose-6-phosphate 
(+NADP+) 
G6PDH 
(regenerates 
NADPH for 
PAMO) 
Lumen 
 
SD
a
 (THF)/ Method B
e
 
EE
d 
≈20% 
6-phosphate- 
-gluconolactone 
 
 
 
Glucose 
 
GOX 
 
Lumen  SD
a
 (THF)/ Method B
e
 Gluconolactone (+H2O2) 
 
82 
ABTS (+H2O2) HRP Lumen (2
nd 
population) 
idem Coloured ABTS°+ (+ H2O) 
Rowan/van Hest 
O2°
- (+ H+) Cu,Zn-SOD Lumen SD
a
 (THF) (ethanol) then 
extrusion/ Dialysis 
4±3 SOD/vesicle 
H2O2 
100 
Palivan/Meier 
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 Amplex red (+H2O2) Lacto- 
peroxidase 
idem idem 
8±5 LPO 
Dye Resorufin  
(+O2 + H2O) 
 
3 
Glucose acetate CalB  Membrane 
 
SD
a
 (THF)/ Method B
e
 
EE
d = 17.2±2.96% 
Glucose 
 
88 
 
Glucose GOX  Lumen Method C
f
/ Method B
e  
EE
d
= 25±2.09% 
gluconolactone (+H2O2) 
 
van Hest 
ABTS (+H2O2) 
 
HRP  
 
Outside on 
external surface 
via click 
 
Method B
e
 
EE
cd= 25.5±3.37% 
Coloured ABTS°+ (+ H2O) 
 
 
GAc4
h 
 
CalB 
 
Outside 
 
Glucose 
86
 
 
Glucose  
 
GOX 
 
Lumen 
 
SD
a (THF)/ Method Be gluconolactone (+H2O2) 
 
Rowan/van Hest 
 
ABTS (+H2O2) HRP Membrane Method C
f/ Method Be Coloured ABTS°
+ (+ H2O) 
 
a Solvent displacement (SD) or nanoprecipitation.  b SEC=Size exclusion chromatography  c Method A=Film rehydration, then extrusion.  d 
EE encapsulation efficiency.
  e Method B=Centrifugal filtration with Eppendorf cutoff filters to near dryness and redispersion, etc, until no 
more enzymatic activity detection   f Method C=SD with redispersed lyophilized powder of a first nanoprecipitation.  g 8-octonolactone (OL), 
Dodecalactone (DDL), є-caprolactone (CL), 1,4,7,10-tetraoxacyclotetradecane-11,14-dione (TCDD).  
h
1,2,3,4-tetra-O-acetyl-b-
glucopyranose 
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4. From cell structure mimic to controlled biofunctionality: the ultimate 
biomimetic materials with high-added value. 
Once the structural cell mimicry is controlled, one can bring these structures to their full 
potential by tackling the challenge of functional cell biomimicry. The idea is to combine 
functional organelles as those described in the previous section in such 
multicompartmentalized cell mimics. Indeed, enzymatic reactions, spatially controlled and 
confined in (often crowded) compartments are some of the numerous functions performed by 
a cell. By combining architectural multicompartmentalization (organelles) and metabolism 
mimicry (enzymatic reactions in the above mentioned organelles), biomimetic cellular 
systems may become a powerful biomedical platform for the development of next-generation 
therapeutic carrier vehicles, to substitute for missing or lost cellular function,
12,18,107
 or as 
small-scale bioreactors. 
12,108, 109
 One of the first researchers to adress this challenge were 
Vogel and coworkers, with small molecules based systems. They were able to trigger 
thermally the release and mixing of compounds from smaller lipsomes inside a larger 
liposome, one great property arising from multicompartmentalization.  
 
 
 
 
 
 
 
 
Fig. 15 Consecutive enzymatic reactions in a single nanoreactor. The external nanoreactors surface comprises 
biotin for immobilization on a neutravidin-coated glass slide. Alkaline phosphatase (AP, star) is incorporated in 
the nanoreactor together with two kinds of SUVs,each loaded with a different nonfluorescent substrate for the 
enzyme. The first kind of SUV (Tt 23°C) is loaded with dichlorodimethylacridinone (DDAO) phosphate (dark 
red) and the second kind of SUV (Tt 41 °C) is loaded with fluorescein diphosphate (FDP, dark green). An 
increase of temperature triggers the release of the substrates in two distinct, consecutive steps at the two 
corresponding phase-transition temperatures, first DDAO phosphate at 23C° and then FDP at 41°C. After release 
from the SUVs, the substrates remain confined in the nanoreactor, where they are converted by the enzyme to 
their particular fluorescent products, DDAO (light red) and FDP (light green). Figure from ref 
110 
 
By using  relevant lipid-phase transition temperatures Tt, they were further able to perfect 
their system into a nanofluidic reactor controlling  two consecutive enzymatic reactions with 
the same enzyme.
110 
Indeed at these temperatures permeability increases as a result of the 
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transient defects that are generated by disturbances in lipid packing order. Two kinds of small 
unilamellar vesicles (SUV, 100 nm) (with two different fluorogenic substrates) were loaded in 
a micrometric large unilamellar vesicle  (LUV, 1-10 µm). Phase transition temperatures from 
both SUVs were separated by 20°C, so that by reaching the first Tt, only one of the substrates 
could be released in the reaction vessel (LUV) due to enhanced permeability and be converted 
by the present enzyme into a green fluorescent product. The second substrate (yielding a red 
fluorescent product) was then released by reaching the second Tt (Figure 15). FCS enabled 
discriminating between freely diffusing model dyes in the LUV and those more hindered by 
their encapsulation in the SUVs, thereby giving information about the encapsulation 
efficiencies. By monitoring the kinetics for one reaction, authors declared no significant 
difference was observed between a reaction in bulk (with same conditions of pH, temperature, 
enzyme and substrate concentrations) and the one in the nanofluidic reactor. Finally, the 
authors stressed the need for miniaturized reactors to reduce sample consumption (which may 
be expensive or polluting) and throughput. As volumes as small as attolitric are mixed (from 
the inner nanometer-sized liposomes) in a femtoliter reactor vessel (the larger outer 
liposome), the control over the number of mixed reactants should thus approach this single-
molecule precision!  
 
 
 
 
 
 
 
 
 
Fig. 16 Consecutive Temperature-triggered enzymatic reaction in reusable capsosomes. (a) Absorbance readings 
of an enzymatic assay using capsosomes with β-lactamase-loaded DPPC liposomes (CL(DPPC)-β) incubated at 
room temperature (23 °C) (Δ), 28 °C (▪), or 41 °C (●). The enzymatic conversion was only observed when the 
capsosomes were incubated at the phase transition temperature (Tm) of the liposomal subunits. The retention of 
the functional enzymes inside of the liposomal subcompartments was confirmed by repetitively performing the 
temperature-induced assay.). Figure from ref 
111
.  
 
As a source of inspiration for polymer chemistry, this early work on liposomes has 
highlighted the fruitful combination of multicompartmentalization and enzymatic activity. In 
that respect, exciting innovations in material sciences have been reported from Caruso’s 
group. The concept of “capsosomes”, or polymer layer-by-layer capsules deposited on 
liposomes was first thoroughly demonstrated and reported.
112
 These capsosomes take 
advantage from both kinds of structures while their drawbacks are being counter-balanced: 
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indeed they inherit the very advantageous semi-permeable nature and mechanical stability of 
polymer capsules while the liposomes restrict access to solutes from the outside, therefore 
hindering their conversion by the encapsulated enzyme. The enzymatic reaction was triggered 
by addition of the surfactant Triton X, destroying the liposomes and allowing the reaction to 
take place in the resulting cross-linked polymer capsule. This system was then further 
optimized by maximizing the number of liposomes and cargo retention and above all allowing 
a temperature-triggered reaction.
111
 As for Vogel’s system, the phase transition temperature of 
phospholipids is taken advantage of to trigger remotely the initiation of the reaction by 
controlling the substrate release. The encapsulated enzymes can now furthermore be used for 
repeated conversions as the reaction can be reversibly triggered (see Figure 16). Finally, 
formation of capsosomes with free-floating internal liposome subcompartments was achieved, 
also going one step closer towards structural cell mimicry with “floating” enclosed 
organelles.
113 
As before, these organelles can host an enzymatic reaction upon temperature 
activation (Figure 17). 
 
 
 
 
 
 
 
 
 
 
 
Fig.17 Schematic illustration of the enzymatic conversion of AMC substrate into AMC product using 
capsosomes loaded with the protease subtilisin upon increasing the temperature above T m. At pH 4 the 
liposomes are bound to the membrane while at 7.4 they are free-floating. Figure from ref 
113
.  
 
Finally, formation of capsosomes with free-floating internal liposome subcompartments was 
achieved, also going one step closer to structural cell mimicry with “floating” enclosed 
organelles.
113 
As before, these organelles can host an enzymatic reaction upon temperature 
activation (Figure 18).  
In the field of hollow polyelectrolyte microcapsules, the work of Kreft et al.
114
 with shell-in-
shell reactors also needs to be mentioned. Spherical calcium carbonate microparticles were 
here used as templates, which could be removed in a “biofriendly” way through EDTA 
complexation after polyelectrolyte multilayer build-up. The procedure to get a shell-in-shell 
structure was complex and well-thought, using successive co-precipitation of CaCl2 and 
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Na2CO3, and enabled to retain one enzyme in the lumen of the inner shell (peroxidase POD), 
another one in the lumen of the more external one (GOX or GOD as they name  it) (Figure 
18). Glucose was added outside for hydrogen peroxide generation by GOX in the most 
external compartment. After addition of substrate Amplex Red for the second reaction of the  
cascade, fluorescent resorufin was obtained within a few seconds in the inner compartment 
before diffusing outside of the inner capsule. lumen of the inner shell (peroxidase POD), 
another one in the lumen of the more external one (GOX or GOD as they name  it) (Figure 
18). Glucose was added outside for hydrogen peroxide generation by GOX in the most 
external compartment. After addition of substrate Amplex Red for the second reaction of the 
cascade, fluorescent resorufin was obtained within a few seconds in the inner compartment 
before diffusing outside of the inner capsule. Kreft et al.
114
 also evidenced a powerful 
property resulting from multicompartmentalization: the means to trigger remotely 
bioreactions. They incorporated gold nanoparticles in the inner shell of a similar shell-in-shell 
system that could be activated with a near-infrared laser illumination. This resulted in 
membrane disruption; the contents were released into the outer shell interior, providing a 
route for reactions in confined volumes and intermixing of contents of two or more 
compartments. 
 
 
 
 
 
 
 
Fig. 18 Coupled enzymatic test by using GOD and POD inside shell-in-shell capsules. a) Reaction schemes. b) 
Localization of GOD and POD within shell-in-shell capsules. c) CLSM imaging in situ of resorufin formation. 
Figure of ref. 
114
  
 
Kreft et al.
114
 also evidenced a powerful property resulting from multicompartmentalization: 
the means to trigger remotely bioreactions. They incorporated gold nanoparticles in the inner 
shell of a similar shell-in-shell system that could be activated with a near-infrared laser 
illumination. This resulted in membrane disruption; the contents were released into the outer 
shell interior, providing a route for reactions in confined volumes and intermixing of contents 
of two or more compartments. 
Bäumler and Georgieva
115
 pushed Kreft’s concept further. Indeed, co-precipitation between 
calcium chloride and sodium carbonate was also used to form concentric compartments after 
removal with EDTA. The shells were formed from biopolymer and enzymes cross-linked 
with glutaraldehyde or divinylsulfone, depending on the step. The three-enzyme cascade 
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performed can be seen in Figure 19. Enyzme β-glucosidase was in the most external 
compartment and converted a prodye into fluorescein and glucose. This glucose was then 
hydrolysed to glucuronic acid and hydrogen peroxide by GOX (in an intermediate concentric 
compartment) in presence of dioxygen. Finally, after addition of prodye amplex red, HRP 
produced fluorescent resorufin and dioxygen (necessary for the reaction of GOX) in the 
presence of the generated hydrogen peroxide, in a final inner compartment. As the first and 
the last product of the cascade were fluorescent, one can evaluate the time lag between the 
first and last enzyme starting to react. Interestingly, in one experiment, they also added 
enzyme-lacking “sandwich” concentric compartments, one between the β-glucosidase and 
GOX compartment, and one between GOX and HRP compartment. They could thus compare 
kinetics with and without these additional compartments (of roughly one micrometer) and 
evaluate the effect of component diffusion. Kinetics could be monitored by confocal 
microscopy on single particles, showing fluorescence increases much earlier and faster inside 
the particles  
 
 
 
 
 
 
Fig. 19 Chain reaction of the three-coupled enzymes with fluorogenic substrates for the first and third enzyme. 
Fig from ref 
115
.  
 
as in the background. In both samples, the first product (fluorescein) appeared after about 30s. 
But where the third product resorufin became visible after 60s in the 3-compartment particles, 
it took 300 to 400 s in the case of 5-compartment particles (2 additional “empty” ones). This 
evidences the limiting parameter is clearly the diffusion of the intermediate products through 
the additional spacing compartments. Some experiments were also monitored in time by 
fluorimetry measurements. Authors stressed scattering and inhomogeneous distribution of 
absorbance may influence such measurements. Indeed reaction rate rate was significantly 
increased when followed by microscopy, as compared to a macroscopic scale by fluorimetry. 
Microscopy indeed represents the real concentration of products inside particles and is not 
influenced by its distribution in the surrounding solution. Another very interesting and 
“green” advantage arising is again the possible recycling of enzyme-bearing microparticles. 
After 5 runs, activity is divided by 5, but still present. Also, activity could be preserved over 
months. 
Last but not least, a very smart design by Caruso and coworkers  was constituted by the use of 
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an in situ bioreaction to trigger release of therapeutics. As we emphasize in all this chapter, 
mimicking a biological cell enables to construct new materials, with original and innovative 
properties. Here the conduction of an enzymatic reaction offers new perspective in terms of 
drug delivery. More precisely, the enzyme glutathione reductase in the liposomes of the 
capsosomes reacts in situ upon temperature triggering (i.e. near the lipid transition 
temperature). The enzyme can then reduce glutathione disulfide GSSG to glutathione GSH, a 
major cellular antioxidant. This GSH becomes available to cleave the disulfide bond between 
a loaded conjugate composed of a small therapeutic peptide and a large polymer, thereby 
enabling its subsequent release in the external medium. This can be monitored as the peptide 
is also labelled with a fluorophore. Authors aim to develop such systems further to get 
biomimetic platforms that will combine both enzyme therapy and controlled drug release in 
such a single structure. 
Finally, it is worth mentioning the work of Caruso and coworkers
116
 that have reviewed 
multicompartmentalized structures with a special focus on coupled enzymatic reactions in 
confined volumes.  
In summary, the combination of multicompartmentalized structure and enzymatic activity is 
still at its earlier stage in materials science. Since soft matter scientists are now able to 
combine these two aspects, it is expected that the frontiers of cell biomimicry will be pushed 
further with polymer-based systems, from cell structure mimics towards a controlled and 
powerful biofunctionality. 
5. Conclusions 
 The present chapter aims at demonstrating the relevance of polymer-based materials (with a 
special focus on polymersomes) when addressing the challenge of eukaryotic cell biomimicry. 
Mimicking the multicompartmentalized structure of the cell, i.e. the organelles enclosed in the 
cellular membrane, as well as the cytoskeleton, opens exciting avenues in many different 
research areas, particularly in biotechnology and nanomedicine. Regarding the latter, several 
successive membranes or layers encapsulating an active drug offer obviously a better 
protection as a single one, as well as a finer permeability tuning, hence a better control over 
release kinetics. The inner compartments (the organelle mimics) that loaded in the outer one 
(the cell membrane mimic) do not necessarily need to encapsulate the same content, where the 
various contents can even be incompatible or act synergistically. As a result, combinatory 
drug delivery becomes possible in one single vector. Also, the different kinds of membranes 
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or layers can be designed to present different polymeric natures, so that they disrupt or 
degrade in specific environments in an orthogonal fashion. All this should also enable to 
design new vectors suitable for other methods of delivery than intravenous injection, such as 
transcutaneous or oral absorption
32, 33, 35
 which are much preferable for patient’s compliance. 
Then, Mimicking the rest of cytoplasm (i.e. all but the organelles) should also impart drug 
delivery vehicles with new attractive properties. In particular regarding the cytoskeleton, one 
could expect it to render the overall structure more robust in terms of shape, mechanical 
stability, and to tune/decrease the release kinetics of loaded actives. Surprisingly, while this 
proves to be true for the mechanical reinforcement of the mimics, the membrane of 
polymersomes remains by far the most effective diffusion barrier. Furthermore, the cytosol is 
responsible for creating a very particular environment in the cell; macromolecular crowding, 
confinement and adsorption play an important part in the cell’s life. Thus, materials scientists 
with biomimicry focuses should also provide biologists with appropriate cell models in order 
for the latter, to conduct their studies in more relevant environments, closer to that of the cell. 
 Intracellular enzymatic reactions for example cannot be modeled with ideal (diluted) or 
normal solution kinetics, evidencing the relevance of mimicking the cytosol.  Mimicking 
the other powerful property of cells, the metabolism represents the second step towards cell 
biomimicry. By using polymeric materials, this step can be achieved through the design of 
enzymatic reactions hosted in a compartment, as occurs in biological organelles, in a highly 
controlled, selective and efficient fashion. This field is of outmost interest for biocatalysis and 
biomedecine with the challenges of compensating for lost or missing cellular function (so-
called artificial organelles), or for delivering the reaction product from their manufacturing 
site (the therapeutic nanoreactors) to the in vivo target. Compared to classic therapeutic 
strategies or normal synthetic processes, there are other advantages arising from such an 
advanced technology: protection of enzymes against proteolytic/microbial degradation, or 
harmful environments, and also, one could expect enhanced reaction probabilities and 
efficiencies due to spatial confinement or immobilization of enzymes. Furthermore, 
enzymatic reactions mainly take place in the cell’s organelles, i.e. in a crowded, confined 
environment, thus studying them in such organelle mimics is fundamentally highly relevant. 
 One step further towards cellular structure and function biomimicry consists in using a 
multicompartmentalized structure as scaffold for multiple enzymatic reactions. Hence a 
completely new and powerful level of control arises, as in the eukaryotic cell. Indeed, even 
though a significant progress over cascade reactions in nanoreactors with enzymes placed in 
different locations has been demonstrated in the past years, the level of possibilities to 
immobilize or confine enzymes in a multicompartmentalized structure is more promising and 
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still needs to be fully explored. The manipulation of each individual enzyme involved in 
cascade steps or parallel reactions becomes facile. As a result, multistep reactions should not 
be influenced by toxic intermediates, formation of undesired byproducts and incompatible 
catalytic steps should be prevented. 
. From a materials perspective, the exquisite control in polymer synthesis, self-assembly and 
advanced formulation that is available nowadays would certainly bring a real breakthrough in 
this cell biomimicry field. Therefore, one can expect the growing interest in such biomimetic 
approaches to soon offer many new opportunities in drug delivery, cell-like reactor systems, 
synthetic biology, biosensors and biomaterials, allowing better communication and interaction 
with living systems 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has served as inspiration under a more synthetic form to: 
 
Marguet Maïté, Colin Bonduelle, Sébastien Lecommandoux*, Multicompartmentalized 
polymeric systems : towards biomimetic cellular structure and function, Chemical Society 
Reviews, 2013, 42, p.512-529. 
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In the previous chapter (Chapter 1), a state of the art concerning self-assembly for Cell 
Biomimicry has been presented, with a special focus on polymers as building blocks. Thanks 
to their versatility, their robustness and the current state of polymer chemistry science, we 
believe polymer-based materials (especially polymersomes) to constitute ideal candidates to 
address the challenges of Biomimicry. The cell is certainly one of the most complex and 
exciting systems that scientists are still trying to fully understand; hence this field is 
fundamentally highly interesting. Several successive steps have been identified and 
investigated: 1) mimicking the cell’s structure (its inner compartments), the organelles, 
through multicompartmentalization, and the intracellular milieu, i.e. cytoskeleton/cytosol 
using gels or particular solutions (highly concentrated for example) in one compartment, and 
finally the combination of both. Our contribution to this aspect is detailed in Chapters 2 and 
3. Then 2), achieving enzymatic reactions in a compartment, as occurs in the organelles, in a 
highly controlled, selective and efficient fashion to mimic metabolic function (Chapter 4). And 
finally 3) combining these steps to push the frontiers of Biomimicry further: from cell 
structure mimics towards a controlled cell-like biofunctionality. Our tentative to address this 
challenge can also be found in Chapter 4. It is to note that in order to reach an truly 
autonomous minimal synthetic cell which is the goal pursued in the field of synthetic biology, 
other steps and challenges would need to be faced, such as self-replication, energy transfer, 
selective chemicals diffusion, etc. 
In this chapter (Chapter 2), we demonstrate the formation of multicompartmentalized 
polymersomes (polymersomes in a polymersome) with an internal « gelly » cavity using an 
original and versatile process. Nanosize polymersomes of poly(trimethylene carbonate)-b-
poly(L-glutamic acid) PTMC-b-PGA, formed by a solvent displacement method (or 
nanoprecipitation) are encapsulated with a rough “cytoplasm mimic” in giant/micrometric 
polymersomes of poly(butadiene)-b-poly(ethylene oxide) PB-b-PEO by emulsion-
centrifugation. Such a system constitutes a first step towards the challenge of structural cell 
mimicry with both “organelles” and “cytoplasm mimics”. The structure is demonstrated with 
fluorescence labeling and confocal microscopy imaging yielding movies that feature the 
motion of the inner nanosize polymersomes in larger vesicles. Without “cytoplasm mimic”, 
the motion was confirmed to be Brownian by particle tracking analysis. The inner nanosize 
polymersomes motion was blocked in the presence of alginate, but only hindered in the 
presence of dextran. With the use of such high molecular weight and concentrated 
polysaccharides, the crowded internal cell milieu, responsible for the so-called 
”macromolecular crowding” effect that influences every intracellular macromolecular 
association, seems to be efficiently mimicked. This study constitutes a major progress in the 
field of structural biomimicry and will certainly enable the rise of new, highly interesting 
properties in the field of soft matter. 
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1. Introduction  
Polymer vesicles or polymersomes are resulting from the self-assembly of amphiphilic block 
copolymers in aqueous media, and are often presented as the structural analogues of 
liposomes.
1, 2
 They can load both hydrophilic (in their internal aqueous reservoir) and 
hydrophobic components (in their membrane). Their similarity to liposomes is however 
limited to this closed bilayer structure. Indeed, due to their polymeric nature, polymersomes 
present an intrinsically thicker membrane, therefore with higher hydrophobic component 
loading capacity, which confers them a larger mechanical stability and lower permeability 
compared to liposomes.
3
 These properties, in addition with the inherent chemical versatility of 
polymer building blocks, are responsible for their considerable interest and development
4
 as 
drug delivery systems
5
, more particularly stimuli-sensitive carriers,
6-8
 as sensors and 
nanoreactors
9-13
. 
While liposomes mimic the semi-permeable living cell membrane with their intrinsic 
phospholipid nature, polymersomes’ structure and properties are much closer to those of viral 
capsids.
14
  However, neither liposomes nor polymersomes can be described as cell mimics as 
an essential key towards cell mimicry lies in compartmentalization. Yet, one could question 
the relevance of biomimicry and an elegant answer by Feynman was “what I cannot create, I 
do not understand”.15, 16 From the most evident and fundamental point of view, artificial 
mimics as model systems enable to complement biological studies as they allow to dissociate 
parameters closely correlated in nature.
15
 Moreover, the first step that consists in mimicking 
the multicompartmentalized structure of a cell is already very challenging. It is only once 
their formation is controlled and optimized that it becomes possible to take advantage of these 
mimics to gain new properties with innovative soft materials. As a matter of fact, Nature 
evolved with compartmentalization because such a structure offers multiple advantages. For 
artificial compartmentalized cell mimics, one of the most foreseeable benefits obviously lies 
in a better protection
17, 18
 of inner encapsulated actives, often very fragile in the field of drug 
delivery. Furthermore, several compartments that each contains a different active in the same 
structure open a path to combinatory drug delivery.
17-19
 Such an approach is of particular 
interest in oncology as it enables to load and potentially deliver incompatible drug cocktails 
together.
20, 21
 Going further, while a certain permeability is necessary for drug delivery 
systems, compartmentalization can also circumvent undesirable prematurely drug leakage 
especially in liposomes, as demonstrated by Zasadzinski and coworkers.
22
 Indeed, 
compartmentalized systems can be used to finely tune permeability.
17, 18, 23
 Such complex 
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structure can also impact the way we design a chemical reaction or induce a reaction only 
when different components are mixed.
24-26
 Caruso and coworkers in particular pointed out the 
great level of possibilities arising from microencapsulated reactors, one example being their 
promising capsosomes.
27-29
 
In a perspective of compartmentalization, some very interesting work has already been 
achieved with liposomes but this field is only in its early stages regarding polymersomes. In a 
recent approach, solvent displacement method was used, with the aqueous solution being a 
suspension of smaller polymersomes previously generated by a film rehydration of a lamellar 
forming amphiphilic block copolymer.
30
 The main drawback of this method is essentially 
based on the poor encapsulation yield during the solvent displacement process. To overcome 
this limitation, the most promising alternative lies in methods based on emulsions or double 
emulsions. Chiu et al.
31
 were the first to tackle this challenge with polymersomes; however, 
even though their method consisting of two successive double emulsions was very original, it 
may not yield the most reproducible and homogeneous systems while being difficult to use on 
a daily basis. In order to gain in reproducibility and homogeneity of the preparation, Weitz 
and coworkers developed highly sophisticated microfluidics devices. In a first step, they were 
able to control the formation of polymersome aggregates or multicompartment 
polymersomes
20
 before yielding fully multicompartmentalized polymersomes.
21
 The size of 
the internal polymersomes is however limited to quite larger dimensions (≈ 100 µm), 
depending on the capillary size. In addition, this method is rather tricky since several issues 
need to be solved before achieving the high throughput production of polymersomes by 
microfluidics: possible coalescence of the internal and external aqueous phases, dewetting 
instability of the organic phase from the copolymer bilayer usually leading to excess polymer 
patched to the vesicles,
32
 and unequal evaporation rate of solvents from the organic phase 
during the rather long drying step of the copolymer membranes with dramatic consequences 
on contact angles.
33
 
Regarding cell biomimicry, in addition to compartmentalized vesicles that can mimic the 
organelles, cytoplasm also plays an important role in cellular activity and regulation. In this 
respect, vesicles with gelly or gelified cavity, also names “hydrosomes”, have been 
investigated for approximately a decade. Of course, there are again many interesting potential 
properties arising when mimicking a viscoelastic cytoplasm like a slower diffusion of actives 
towards the outside environment and above all a better protection and thus stability and shape 
integrity, by absorption of mechanical stress. An approach that is often used, in particular by 
A. Viallat and coworkers, consists in encapsulating a poly(N-isopropylacrylamide) 
PNIPAAm based solution, which will in situ photopolymerize into covalently cross-linked 
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gels upon UV irradiation.
34-41
 However, in cells, the cytoskeleton is composed of the protein 
filaments actin, microtubules and intermediate filaments, formed by nucleation-elongation 
processes. The growth of the protein filaments of this cytoskeleton is driven by non-covalent 
interactions, making them very dynamic with constant association/dissociation processes.
15
 
For that reason, non-covalent or physical gels constitute in our opinion a better alternative. 
Limozin and Sackmann
42
 were impressively able to form liposomes with dynamic actin 
networks cross-linked by the natural cross-linkers α-actinin and filamin. Other approaches 
were developed using the LCST character of non-crosslinked PNIPAAm,
43,44
 electrostatic 
complexation,
45-47
 pH-dependent solubility and thus gelling,
48
 polysaccharide based 
systems,
49,
 
50,
 
46, 47, 51
 or more recently peptide amphiphiles
52
 to gelify the inside reservoir of 
liposomes . To the best of our knowledge Feijen and coworkers were the first to tackle this 
aim with polymersomes using PNIPAAm as a gelator.
53, 54
  
The aim of this work is to go on step further towards structural cell mimicry and to combine 
both compartmentalized structures (to mimic organelles) and a “gelly” cavity (as cytoplasm 
mimic) in polymersomes. Such a realization requires an exquisite control of the physical 
parameters and interaction components, together with an efficient process. The achievement 
of this original and innovative biomimetic structure constitutes a first necessary step before 
taking advantage of it to address other challenges in controlled catalysis and chemical 
(bio)reactions. 
2. Experimental Section  
2.1. Materials and reagents 
Poly(butadiene)46-b-poly(ethylene oxide)30 (PB46-b-PEO30) (P9095-BdEO, Mn PB=2,500 g/mol 
and Mn PEO=1,300 g/mol, I=1.04) and amino-terminated poly(butadiene)20 (PB31) (for 
polymersome membrane labeling) (P3977-BdNH2, Mn=1,700 g/mol, I=1.11, f>0.98%) were 
purchased from Polymer Source. Alexa Fluor 568-carboxylic acid, succinimidyl ester 
(A20003-1mg, mixed isomers, 791.8 g/mol) and Alexa Fluor 488 carboxylic acid, 
succinimidyl ester (A20000-1mg, mixed isomers, 643.41 g/mol) were purchased from 
Invitrogen. Alginic acid sodium salt from brown algae (Fluka 71238, 50g) and Dextran from 
leuconostoc ssp. (Fluka 31389, Mr=40,000 g/mol, 100g) were from Fluka Biochemika. 
Sucrose 99% was from Alfa Aesar (A15583 L 13300, 2.5g) and D-(+)-glucose from Sigma 
Aldrich (G5767-500g). Solvents from Sigma Aldrich for fluorophore labeling (DMSO and 
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DMF) were anhydrous. All products were used as received unless otherwise specified. 
Poly(trimethylene carbonate)30-b-poly(L-glutamic acid)19 PTMC30-b-PGA19 diblock 
copolymer was synthesized by ring-opening polymerization (ROP) of δ-benzyl-L-glutamate 
N-carboxyanhydride (NCA) initiated by a primary amine end-functionalized PTMC 
macroinitiator according to a previously described method.
55
 All the experiments described 
were performed on PTMC30-b-PGA19 diblock copolymer (Mn=5,492 g/mol, I=2). 
2.2. Methods 
2.2.1. Synthesis and self-assembly 
Fluorescent dye labeling.  
- Alexa Fluor 568 labeled PTMC30-b-PGA19: After flame-drying of a round-bottom flask 
under vacuum, the following reagents were introduced under inert nitrogen atmosphere: 
primary end-functionalized amine PTMC30-b-PGA19 (99.9 mg, 18.2 µmol), anhydrous DMSO 
(2 mL), DIPEA (140 µL, 804 µmol) and reactive Alexa Fluor 568-carboxylic acid, 
succinimidyl ester (1 mg, 1.26 µmol) in DMSO (120 µL). The reaction was then allowed to 
proceed for one night under static nitrogen atmosphere. The conjugate PTMC30-b-PGA19-
Alexa Fluor 568 was purified by dialysis (5 L, 3 h, MWCO : 3,500 g/mol) after dilution in the 
flask by DMSO for a better recovery. External medium was renewed six times in course of 
dialysis. After lyophilization, the conjugate was recovered in a 97 % yield (determined by 
gravimetry).  
- Alexa Fluor 488 labeled poly(butadiene): After flame-drying under vacuum of a round-
bottom flask, the following reagents were introduced under inert nitrogen atmosphere: 
primary end-functionalized amine PB20 (84.1 mg, 49.5 µmol), anhydrous DMF (2 mL), 
DIPEA (8 µL, 45.9 µmol) and reactive Alexa Fluor 488-carboxylic acid, succinimidyl ester (1 
mg, 1.55 µmol) in DMF (120 µL). The reaction was then allowed to proceed for overnight 
under static nitrogen atmosphere. After concentrating the mixture by evaporation of DMF 
under vacuum, the polymer was precipitated and washed with water. Finally, it was dissolved 
in THF and recovered after drying under dynamic vacuum.  
 
Nanoprecipitation yielding nanosize polymersomes of PTMC30-b-PGA19 for 
encapsulation inside giant polymersomes. For the preparation of fluorescently labeled 
nanosize polymersomes to be tracked by confocal microscopy, we followed a 
nanoprecipitation method described previously. 
55
 Briefly, 4.5 mL Tris Buffer, 50 mM, pH 
7.4 was added slowly at a controlled rate of 2.25 mL/h on a DMSO solution containing 5 mg 
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of PTMC-b-PGA-Alexa Fluor 568 (0.5 mL) under stirring at 500 rpm at 25 °C. The sample 
was then dialyzed with a 50,000 g/mol cut-off in 5 L Milli Q water with 3 renewals. Size and 
polydispersity were characterized by dynamic light scattering (DLS).  
 
Emulsion-centrifugation yielding giant PB-b-PEO encapsulating a PTMC-b-PGA 
nanosize vesicle suspension (Scheme 1). In a typical procedure inspired from Li and col.,
56, 
57
 5 µL of a nanosize vesicle suspension in 380 mOsm sucrose solution was first poured in 
500 µL toluene containing 3 mg/mL PB-b-PEO (including, depending on the experiment, 0 or 
10 wt% of Alexa Fluor 488 labeled PB) in a Eppendorf tube (step 1, Scheme 1). The PB-b-
PEO solution in toluene was previously stirred for at least 2 hours to ensure a complete 
dissolution of the copolymer, as verified by DLS (no intensity scattered). In another tube (step 
2, Scheme 1), 30 µL of the same organic solution was poured over 30 µL of a 380 mOsm 
aqueous glucose solution and allowed to stabilize for 30 min.  
 
Scheme 1. Scheme of the emulsion-centrifugation process yielding either giant polymersomes (Figure 2) or 
polymersomes in polymersomes (when, like here a suspension of nanosize polymersomes (in red) is used as 
inner aqueous phase of the w/o emulsion). 
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Finally (step 3, Scheme 1), the first tube was emulsified with vigorous agitation by hand 
yielding quite homogeneous (see Figure 1) inverted emulsion droplets (alternatively, repeated 
pipetting works as well). Then 50 µL of this emulsion was poured slowly over the second 
interface tube. The sample was then immediately centrifuged at 20 °C at 500g for 4 min and 
the aqueous polymer vesosome suspension was recovered in the lower phase (Figure 2).  
 
 
 
 
 
 
Figure 1. Optical microscopy acquisitions of the w/o emulsion stabilized by poly(butadiene)-b-poly(ethylene 
oxide). From left to right: bright field, epifluorescence (green channel), epifluorescence (red channel) and 
overlay of red and green channels. The green channel features the encapsulated FITC-dextran (1 mg/mL), the red  
channel features Nile Red (0.05 mg/mL) solubilized in toluene. 
 
channel the Nile Red (0.05 mg/mL) solubilized in toluene. 
 
 
 
 
 
 
Figure 2. Microscopy acquisitions of a giant polymersome of poly(butadiene)-b-poly(ethylene oxide). From left 
to right, bright field microscopy, red channel epifluorescence with Nile Red membrane labeling (0.05 mg/mL), 
green channel with 10.000 g/mol FITC-dextran (1 mg/mL), and overlay of red and green. 
 
The process has been described to quantitatively encapsulate hydrophilic solutions,
58
 such as 
FITC-dextran as shown in Figure 2. Of course, any aqueous solution can be encapsulated 
using this method. For experiments regarding “cytoplasm mimic”, the appropriate amount of 
respectively alginate/dextran was added to the nanosize polymersome suspension (at 
380mOsm sucrose) to a final concentration of respectively 10/300 mg/mL. In both cases, the 
centrifugation time was reduced to 3 min. 
2.2.2. Characterization methods 
Dynamic Light Scattering (DLS). DLS measurements were conducted on a Malvern Zeta 
Sizer Nano ZS instrument with 90° angle analysis. The mean hydrodynamic diameter and its 
distribution were determined using Cumulant and CONTIN methods. For particle tracking, 
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viscosity and refractive index were determined for each solution using a rheometer (AR2000) 
and an Abbe refractometer.  
 
Spinning disk confocal microscopy. The spinning disk microscope was a Leica DMI6000 
(Leica Microsystems, Wetzlar, Germany) equipped with a confocal Scanner Unit CSU-X1 
(Yokogawa) using for this experiment objective HCX PL Apo 100X oil NA 1.4 and an 
Evolve EMCCD camera (Roper Scientific, Evry, France). Z-stack analysis was performed 
with a galvanometric stage (Leica Microsystems, Wetzlar, Germany). The diode laser 
excitation wavelengths used were 491 nm and 561 nm and a Semrock emission filter with 
narrow bandpass windows in the blue (420 to 460 nm), green (506 to 536 nm) red (587 to 627 
nm) and near infrared (670 to 730nm) spectral regions was used. Microscopy chambers were 
fabricated by sealing a slide against a coverslip with two layers of Parafilm™ featuring the 
three sides of the chamber. The sample was then injected by capillarity through the last open 
side. Finally, the last aperture was sealed with molten paraffin wax. Experiments were carried 
out in the Bordeaux Imaging Center of the University of Bordeaux Segalen. The help of 
Sébastien Marais is gratefully acknowledged, particularly for 3D reconstruction of z-stacks 
with the Imaris software. 
 
Epifluorescence and optical microscopy. Bright field and fluorescence microscopy images 
of giant polymersomes (Figure 1 and 2) were taken on a Zeiss Axiovert 40 CFL inverted 
microscope with a EC Plan-NEOFLUAR 40x DIC Na 0.75 objective captured with a 2Mbytes 
digital Gigabit Ethernet CCD camera (Viewvorks VG-2M, South Korea). For epifluorescence 
microscopy, a mercury lamp was used as source with excitation and emission filters of narrow 
bandpass windows in the green (464.5 to 499.5 nm for excitation and 516 to 556 nm for 
emission) and red (532 to 544 nm for excitation and 573 to 637 nm for emission) spectral 
regions (provided by Semrock). The samples were placed between a glass slide and a 
coverslip separated by a Parafilm™ spacer as mentioned above for confocal microscopy 
imaging. 
 
Particle tracking. The 2D Brownian motion of inner polymersomes labeled in red and 
encapsulated in a giant polymersome (Movie S1 in ESI) was tracked down. The 2D position 
(xM,yM) for each frame and each nanosize vesicle of the 50s movie (500 frames and τ=100ms) 
was reported. By linking the trajectories (79 in total) for each nanosize vesicle frame by 
frame, we have access to displacements ∆x, ∆y (788 in total) versus time. For the polymer 
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vesosome with the “cytoplasm mimick” Dextran, 187 frames of a longer movie (Movie S2 in 
ESI) were tracked yielding 810 displacements (56 trajectories). 
 
Instrumentation and Measurements for synthesis. 
1
H (400 MHz) Nuclear Magnetic 
Resonance NMR spectra were recorded on a Bruker Avance DPX400 instrument at 23 °C and 
were referenced internally using the residual 
1
H solvent resonance relative to 
tetramethylsilane (δ=0). Mn SEC and (Mw/Mn) values for copolymers PTMC-b-PBLG (3 
mg/mL) were determined by Size Exclusion Chromatography SEC at 60 °C, using 
dimethylformamide (DMF) with LiBr (1 g/L) as eluent (0.8 mL/min), on a Jasco apparatus 
equipped with both Varian refractive index and UV detectors and two PL gel 5 μm mixed-C 
columns.  
3. Results and Discussion 
3.1. Formation of biomimetic compartmentalized polymersomes 
Thanks to the emulsion-centrifugation process
56, 57
 and its quantitative loading efficiency
58
 
(see Scheme 1, Experimental section), a suspension of red fluorescent Alexa 568 labeled 
polymersomes (or nanosize vesicles) was encapsulated in a green fluorescent Alexa 488 
labeled giant polymersome, as shown in Figure 3 where inner red PTMC-b-PGA 
polymersomes can clearly be seen in a green giant PB-b-PEO polymersome. Movie S1
d
 
shows the Brownian motion of these inner nanosize polymersomes. The 3D reconstruction of 
the z-stack observation by spinning disk confocal microscopy of this polymer vesosome, 
evidences the localization of each nanosize polymersome inside the internal volume of the 
larger vesicle (Figure 3, 2
d
). 
 
 
 
 
 
Figure 3. Spinning disk confocal microscopy acquisitions of a polymer vesosome. From left to right, green 
channel (membrane of the giant polymersome), red channel (nanosize inner polymersomes), overlay, and 3D 
reconstruction of z stack in red channel. 
                                                 
d
 Movie si_001 and 
d
 Movie si_002, http://pubs.acs.org/doi/suppl/10.1021/la204018w 
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By analogy with liposomes, such compartmentalized structures can be named polymer 
vesosomes
18, 19, 22, 59
, polymersomes in polymersomes or double polymersomes
21, 60
. Only 
three groups
21, 30, 31
 have tackled the challenge of compartmentalized polymersomes so far. 
We present here an original, facile, versatile, reproducible and low-product consuming 
technique. Solely the microfluidic method recently developed by Weitz and coworkers
21
 
presents in our opinion a better process control. However, the internal polymersome size is 
limited in that case to micrometric one by the process itself and the capillary diameters. The 
obtained morphology roughly resembles to organelles in a cell which are lipid bilayer 
compartments (endosomes, lysosomes, mitochondria...) encapsulated themselves in the 
plasmic membrane.  
One step closer to the challenge of cellular biomimicry consists in adding another component 
with a relevant structure and function, the cytoplasm (here not including the organelles, 
whose mimicry has already been adresses). In addition to the obvious mechanical properties 
given by the cytoskeleton, the high macromolecular concentrations found intracellularly are 
also responsible for the so-called macromolecular crowding effect.
45, 51, 61
 In 2001, R. John 
Ellis and col.
61
 launched a call to biochemists to stop neglecting this “macromolecular 
crowding” in their studies, which is known in polymer science as the “excluded volume 
effect”. All together, macromolecules in the cytoplasm, cytoskeleton and internal 
compartments occupy 20-30 vol.% of a cell, generating a strong steric repulsion between 
them. The consequences on the cell machinery have been rarely considered: for instance, most 
biochemical reactions are studies in dilute (ideal) solutions, while in real cells one should 
consider the activity coefficients for both thermodynamic and kinetic studies. He thus advises 
to use crowding agents under the following criterions: a molecular weight ranging from 
50,000 to 200,000 g/mol, a high water solubility, not being prone to self-aggregation, and last 
but not least, no interaction with the tested system other than steric repulsion. 
In a first attempt, the nanosize polymersome suspension was thus mixed with a highly water-
soluble alginate at a final concentration of 10 mg/mL (Figure 4). For this strongly charged 
natural polymer, the molar mass distribution was reported in the literature: Mn=107,700 
g.mol
-1
 and Mw=231,500 gmol
-1
,
62
 so that the molar concentration of Alginate is 0.1 mM in 
our case. A 2 wt.% solution of this product has a viscosity of 1.07 Pa.s,
63
 therefore the 
viscosity is around 0.5 Pa.s at 10 mg/mL. Thus we can predict a 350-fold reduction of the 
diffusion coefficient compared to the pure sucrose solution (0.00144 Pa.s). Actually, as 
observed in Movie S3
e
 , the motion of inner nanosize polymersomes is not only hampered but 
                                                 
e
 Movie si_003, http://pubs.acs.org/doi/suppl/10.1021/la204018w 
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in fact completely blocked. One can assume that the high alginate concentration provokes a 
phase separation phenomenon induced by depletion layers around the PTMC-b-PGA vesicles 
excluding the alginate chains (Figure 4). The diffusion of spherical particles inside a 
concentrated macromolecular solution with a depletion layer of the chains around the spheres 
has been considered in theory, predicting anomalous diffusion with mean square 
displacements not linear versus time.
64
 The case of our giant vesicles containing nanosize 
vesicles mixed with rather stiff alginate polyelectrolyte chains is even more dreadful since the 
diffusion is totally arrested. The fact that both alginate and the PGA chains (present on the 
outer shell of the nanosize polymersomes) are negatively charged must also play an important 
role in this segregation process, due to additional electrostatic repulsion forces. The 3D 
reconstruction of this vesosome (Figure 4 and Movie S4
f
) clearly evidences different clusters 
of inner PTMC-b-PGA polymersomes in the volume that always seem pushed against the 
“plasmic membrane” mimic; this is presumably due to the alginate chains exerting an osmotic 
pressure Π on them estimated around 260 Pa from the molar concentration of chains. The 
potential between two vesicles brought at contact by depletion attraction can be estimated by 
,
65
 which explains why it overcomes thermal motion.   
Figure 4. Spinning disk confocal microscopy acquisitions of a polymer vesosome with “cytoplasm mimic” 
alginate in the cavity of the giant polymersome. From left to right, green channel (membrane of the giant 
polymersome), red channel (nanosize inner polymersomes), overlay and 3D reconstruction in red channel. 
 
In another set of experiments, a 4,000 g/mol neutral dextran was used as cytoplasm mimic at a 
concentration of 300 mg/mL. This concentration roughly corresponds to an intracellular 
macromolecular concentration of 20-30 vol.% and can be considered realistic to mimic the 
intracellular crowding.
61
 For example, the total concentration of protein and RNA inside a cell 
of Escherichia coli lies between 300-400 mg/mL, in good correlation with our simplified 
synthetic model.
66
 Finally, the choice of dextran is also motivated by the fact that its use is 
accepted in hard particle excluded volume models at high concentration for crowding effect.
61
  
 
 
 
                                                 
f
 Movie si_004, http://pubs.acs.org/doi/suppl/10.1021/la204018w 
TkRR Bav  2202
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Figure 5. Spinning disk confocal microscopy acquisitions of a polymer vesosome with “cytoplasm mimic” 
dextran in the cavity of the giant polymersome. Red channel (nanosize inner polymersomes), and 3D 
reconstruction in red channel. 
The resulting polymer vesosomes obtained in these conditions are reported in Figure 5. As 
observed on Movie S5
g
, motion of the inner polymersomes is now considerably decreased and 
hindered, but not blocked, clearly illustrating this crowding effect at high volume fractions of 
macromolecules in a confined volume. 
3.2. Quantitative analysis of the dynamics of internal vesicles 
The observation of the stochastic motion of the nanosize polymersomes alone seems to be in 
agreement with a Brownian motion, showing that their loading into a giant polymersome does 
not affect their dynamic properties. In order to quantitatively analyze this parameter, the 2D 
positions of each distinct nanosize vesicle in Movie S1 were tracked (τ=100 ms) and their 
displacement from frame to frame calculated. 788 Δx and Δy displacements or in other words 
79 full trajectories could be obtained. The frequency of these displacements versus Δx and Δy 
is plotted in Figure 6.  
In statistical physics, the normal (or Gaussian) distribution (Equation 1) is usually associated 
to random walks like particles in Brownian motion. In the case of pure diffusion (no 
translation), the mean position <x>=µ is zero, while the mean square displacement <x
2
> is 
linear in time with a slope equal to 2σ2 (in one dimension).  
 
2
2
2
)(
22
1
)( 




x
exf     Equation 1 
The presented data can be well fitted with a Gaussian distribution (Figure 6a), attesting that 
the motion of nanosize polymersomes is not affected by their encapsulation in a polymersome 
of approximately 20 µm diameter. However, the outer membrane could have restricted the 
diffusion of the small vesicles in some limiting volume (as a cage). This is not the case 
because the diameter of the giant vesicle is much larger (20 µm) than the mean square 
                                                 
g
 Movie si_005, http://pubs.acs.org/doi/suppl/10.1021/la204018w 
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displacement of the small internal ones and this giant vesicle is also prone to a slight 
translational diffusion itself. Another way to analyze the data consists in representing the 
mean square displacements of some of the longest lasting trajectories in a log-log 
representation (Figure 6b).  
The trajectories represented here have the same slope in log-log representation than a model 
trajectory tDyxr diff  4
222
estimated with the mean Diffusion coefficient (see 
Equation 2) calculated for these nanosize vesicles, again in agreement with purely diffusive 
(Brownian) motion. The scattering of the prefactor ( diffD4 ) for the shown trajectories in blue 
is ascribed to the inherent size-dispersity of the internal vesicles (see Table 1). 
 
 
 
 
Figure 6. (a) Statistics of displacements (µm) in x (red circles) and y (blue squares) directions of nanosize inner 
polymersomes in vesosome corresponding to Figure 3 (Movie S1 ESI). (b) Mean square displacement Δx2 and 
Δy2 (µm2) plotted versus time (s). Blue lines represent the experimental trajectories. The red line features the 
model trajectory with the mean calculated diffusion coefficient. 
 
With the 788 ∆x and ∆y elementary steps, an average diffusion coefficient diffD  can then be 
estimated following equation 2, and be converted into a hydrodynamic diameter RH using the 
well-known Stokes Einstein relation (Equation 3). 
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The obtained diffD and HR  values can now be quantitatively compared to data resulting from 
the nanosize polymersomes initially prepared (Table 1). The values measured in solution by 
DLS are in excellent correlation with the ones determined inside giant polymersomes by  
video tracking, assessing the validity of the method and confirming quantitatively the  
randomness of the vesicles’ motion. 
 
Table 1. Characteristics of nanosize polymersome suspension before and after encapsulation in a giant 
polymersome
a 
Without cytoplasm mimic 
(380 mM sucrose,  =0.00144 Pa.s 
b,e
) 
With cytoplasm mimic 
(dextran 300 mg/mL, 380 mM 
sucrose, 
 =0.0367 Pa.s 
b,f
) 
Mean RH 
(nm)
c
 
PDI
c
 Mean Ddiff
c
 
(µm
2
/s) 
Mean RH
d
 
(nm) 
Mean Ddiff
d
 
(µm
2
/s) 
Ddiff
d
 (µm
2
/s) 
257±9 
(Contin)
f 
 
0.1±0.02 0.718±0.004
 f 
 
271±21
e
  0.55±0.042
e 
 0.082±0.011
 f 
 
a 
For each value, error represents the standard error σ/√n where n represents the numbers of 
trajectories or measurements 
b
 Determined by rheometry 
c
Determined by Dynamic Light Scattering in 
380mM sucrose. PDI means Polydispersity Index.  
 d
 Determined by particle tracking in 380mM 
sucrose with and without dextran 300 mg/mL. 
e
 determined at 21°C. 
f
 determined at 25°C. 
 
It seems visible in Movie S5, that the presence of 300 mg/mL dextran considerably and 
efficiently hinders the motion of the nanosize vesicles. Once again, their 2D positions was 
tracked from Movie S5, yielding to 810 Δx and Δy displacements or in other words 56 full 
trajectories. The frequency of the displacements versus Δx and Δy is plotted in Figure 7a and 
data properly fitted with a Gaussian distribution. The value of the diffusion coefficient of the 
nanosize polymersomes calculated in these “cytoplasm mimic” conditions is nearly 6.6 times 
slower than in low viscosity conditions (Table 1, Figure 7b). This significant decrease is 
however lower than the approximately 30-fold increase of viscosity for this solution of 
dextran compared to the initial aqueous solution. For this dextran T40 (Mr=40000 gmol
-1
), M. 
Prouty and R. Podgornik derived a power law of osmotic pressure versus weight 
concentration,
67, 68
 from which we calculate 5.3×10
5
 Pa for a 300 mg/mL concentration. 
Prepared initially in pure water, the nanosize PTMC-b-PGA vesicles are submitted to 
hypertonic conditions inside the giant PB-b-PEO vesicle: the osmotic pressure exerted both 
by dextran and by 380 mM sucrose is estimated around 1.5×10
6 
Pa. Therefore the 
hydrodynamic size of the PTMC-b-PGA vesicles might decrease by osmotic deflation 
through water permeability across their membrane.  
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Figure 7. (a) Statistics of displacements in x (red circles) and y (blue squares) directions of nanosize inner 
polymersomes in 300 mg/mL dextran in giant polymersome, corresponding to Figure 5 and Movie S5 (ESI). (b) 
Comparison of displacement frequency without and with Dextran: overlay of Figures 6a and 7a. 
 
Another explanation going in the same direction is the increase of the Brownian diffusion 
constant of vesicles due to the crowding effect (the volume taken by dextran chains being 
excluded to them). S. Longeville and coworkers have indeed evidenced by SANS a two-fold 
compaction of coil chains such as PEG in a 30 vol.% solution of a crowding agent such as the 
Ficoll 70 polysaccharide, exerting an osmotic pressure around 3×10
5
 Pa.
69, 70
 Therefore we 
can suspect a similar effect on the hydrophilic blocks of the polymersomes’ membranes (PGA 
for the small vesicles, PEO for the giant vesicles). The two effects combined (osmotic 
deflation and hydrophilic chains compaction by the crowding agent) are explaining why 
particle tracking yielded a 6.6-fold decrease of the diffusion constant of the internal vesicles, 
while the ratio of viscosities with and without dextran is larger (about 30-fold). Finally, the 
viscosity of the dextran system (Table 1) is of the order of magnitude of the usual cytoplasm 
viscosity reported for red blood cells (0.01 Pa.s),
35
 thereby confirming that is was a good 
choice for mimicking the interior of cells on a physical point of view. 
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4. Conclusion 
In this work, we demonstrated the formation of artificial structural cell mimics with 
organelles and a “model cytoplasm” with a facile, versatile, reproducible and low product and 
time-consuming technique. To the best of our knowledge, this is the first report where both 
these aspects have been combined, especially with polymersomes. A suspension of nanosize 
inner polymersomes of PTMC-b-PGA (formed by nanoprecipitation) is encapsulated in giant 
polymersomes of PB-b-POE together with highly viscous alginate or dextran solutions, thanks 
to the emulsion-centrifugation process. The formation of this biomimetic structure was 
evidenced by fluorescence confocal microscopy. Moreover, the 2D motion of these artificial 
organelles was tracked down and confirmed as still being Brownian inside the volume of an 
approximately 20 µm giant polymersome. This analysis was repeated in presence of 
“cytoplasm mimic dextran”, their motion being efficiency hindered as confirmed by a 6.6 
times smaller diffusion coefficient. Furthermore, the concentration of 300 mg/mL of 
polysaccharide (dextran T40) brings a viscosity above 0.01 Pa.s, in the range of red blood cell 
cytoplasm viscosity, a volume fraction near 30% and an osmotic pressure above 1 MPa 
resembling the intra-cellular conditions caused by global cellular proteins. By reproducing the 
intracellular “macromolecular crowding effect” which plays a crucial role in the cell 
machinery, we believe that this synthetic and simplified approach constitutes an appropriate 
cytoplasm mimic. Even with such simplified cell mimics, soft materials with innovative 
properties can arise and extend the domain of possibilities in the fields of cosmetics, fragrance 
encapsulation, drug delivery and fine chemical additives. 
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Annexes 
Supporting Information Available on http://pubs.acs.org/doi/suppl/10.1021/la204018w 
Movie S1 (http://pubs.acs.org/doi/suppl/10.1021/la204018w, si_001) acquired with a spinning 
disk confocal microscopy featuring the polymer vesosome in Figure 3, where the loaded red 
inner polymersomes can be clearly observed in Brownian motion as they are labeled with 
Alexa Fluor 568. Movie S2 (http://pubs.acs.org/doi/suppl/10.1021/la204018w, si_002) with 
the vesosome of Movie S1 reconstructed in three dimensions showing the localization of the 
inner polymersomes in the giant one. Movie S3 
(http://pubs.acs.org/doi/suppl/10.1021/la204018w, si_003) featuring inner red-labeled 
polymersomes blocked in alginate loaded in the giant polymersome of Figure 5. Movie S4 
(http://pubs.acs.org/doi/suppl/10.1021/la204018w, si_004) featuring the 3D reconstruction of 
the vesosome with alginate (“cytoplasm mimick”) in Movie S3. Movie S5 
(http://pubs.acs.org/doi/suppl/10.1021/la204018w, si_005) featuring inner red-labeled 
polymersomes in hindered motion in dextran (“cytoplasm mimick”) loaded in a giant 
polymersome. Movie S6 (http://pubs.acs.org/doi/suppl/10.1021/la204018w, si_006) featuring 
the 3D reconstruction of the vesosome with Dextran in Movie S5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been published in Langmuir: 
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In the previous chapter (Chapter 2), we have demonstrated the formation of structural cell 
mimics, with organelle mimics enclosed in a cytoplasm mimic, enclosed in a larger polymer 
vesicle. 
Cell biomimicry is fundamentally important as it may help to better understand the eukaryotic 
cell. Studying any machine and its components is indeed not always sufficient to completely 
understand its full complexity; it may sometimes be necessary to put it together from its parts. 
This is particularly valid for Life. Feynman with his famous sentence “what I cannot create, I 
do not understand” would certainly have not disagreed. From the most evident and 
fundamental point of view, mimics as model systems enable molecular biologists and 
biochemists to acquire new tools to complement biological studies as they allow to study 
separately parameters closely correlated in nature. Quantitative measurements in vivo are 
currently still difficult to obtain and the freedom to change parameters is so limited that one 
cannot investigate them completely for a given mechanism. Then, the establishment of a 
model which could enable the study of various cellular mechanisms coupled together, and to 
understand how complexity is established, step by step, would be of outmost relevance. In a 
more concrete and applied perspective, such engineered cell mimics could open many 
prospects for therapy as biomedical devices and in biotechnology as bioreactors to synthesize 
pure proteins. In any case, the first and foremost challenge to address lies in the controlled 
formation of these cell mimics, which although non-living, will roughly approach the 
complexity and functionality of living cells. This vision is represented in Chapter 2.  
 
Once the generation of these cell mimics is controlled and optimized, material scientists can 
take advantage of their structure to gain new properties and form innovative, with previously 
unmatched efficiency, soft materials.
 
More particularly, for the biomedical/pharmaceutical 
field, we have identified several potential long-term benefits arising from 
multicompartmentalized polymersomes (or polymer vesosomes). The work presented in this 
Chapter (Chapter 3) highlights two of these properties, that we were able to evidence. Indeed, 
our approach enables multiple encapsulation in these multiple available compartments, 
providing a first path towards multi-therapy, together with an exquisite control over 
permeation properties, tuned for a better control of the system release kinetics. 
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1. Introduction 
Polymersomes are vesicles obtained from the self-assembly of amphiphilic block copolymers 
in aqueous solution as a result of free energy minimization.
1
 Their potential use as drug 
delivery systems
2-6
, sensors, and/or nanoreactors
7-9
 has recently attracted a great deal of 
interest.
10
 Polymersomes exhibit larger mechanical stability and lower permeability than 
liposomes, their structural analogues that often suffer from prematurely induced drug 
leakage.
11
 To circumvent this limitation, J.A. Zasadzinski and coworkers developed 
liposomes in liposomes structures, also referred as “vesosomes”.12 With such a 
compartmentalized structure, a molecule encapsulated in the inner liposomes, would have to 
permeate through two successive membranes, instead of a single one before leaking into the 
outside environment. This double membrane effect was demonstrated by observing the serum 
half-life of ciprofloxacin drug increasing from 10 minutes in single liposomes to 6 hours in 
vesosomes.
13
 Other reports evidenced the biomedical impact of such vesosomes for 
transcutaneous
14
, and oral administration
15, 16
; an important future challenge in drug delivery 
and cancer therapy. More complex or compartmentalized structures in general, have started to 
appear because they enable an unprecedented level of control, in particular in the fields of 
drug delivery
17, 18
 and confined reactors.
19-21
 However, it is still very challenging
22, 23
 to 
encapsulate multiple distinct components in a single compartment
24
 and control their stability 
and release properties.  
Such vesosome structures based on polymers that can be named “polymersomes in 
polymersomes”, have been recently reported. The most recent approach consisted in forming 
the larger polymersomes by film rehydration with a suspension of smaller polymersomes 
previously formed by the solvent displacement method (or nanoprecipitation).
25
 The 
drawback of this technique lies essentially in the poor encapsulation yield during film 
rehydration. In order to overcome this limitation, other options such as emulsions or double 
emulsions techniques have been investigated. The first team taking up this challenge used two 
successive emulsions.
26
 Even if very original, such a process is not the most easy to use and 
may suffer from a lack of reproducibility and homogeneity. Weitz and coworkers formed 
another type of complex polymersomes, aggregates of polymersomes, or multicompartment 
vesicles using microfluidics, such approach allowing a high level of control and 
reproducibility.
24
 
Herein, we demonstrate the generation of polymer vesosomes, i.e. polymersomes in 
polymersomes, with an original, facile, versatile, reproducible and low product-consuming 
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technique. Our method allows multiple compartment encapsulation and the formation of 
systems of controlled permeability, as they present a significant decrease in the release rate of 
an anticancer drug doxorubicin (DOX) encapsulated in the inner polymersomes.  
2. Experimental Section 
2.1. Materials and reagents 
Poly(butadiene)30-b-poly(ethylene oxide)46 (PB30-b-PEO46) (P9095-BdEO, Mn PB=2500 g/mol 
and Mn PEO=1300 g/mol, I=1.04) and amino-terminated poly(butadiene)20 (PB20) (for 
polymersome membrane labeling) (Mn=1700 g/mol, I=1.11, f>0,98%, P3977-BdNH2) were 
purchased from Polymer Source. Alexa Fluor 405-carboxylic acid, succinimidyl ester (1 mg, 
A 30000, 1028.26 g/mol), Alexa Fluor 568-carboxylic acid, succinimidyl ester (*mixed 
isomers*, 1mg A20003, 791.8 g/mol) and Alexa Fluor 488 carboxylic acid, succinimidyl ester 
(*mixed isomers*, 1mg A20000, 643.41 g/mol) were purchased from Invitrogen. Fluorescein 
isothiocyanate isomer 1 (F7250, 250 mg, 389.4 g/mol) and Fluorescein isothiocyanate dextran 
(FD20S-100mg, 20,000g/mol) were received from Sigma Aldrich. Sucrose 99% was from 
Alfa Aesar (A15583 L 13300, 2.5g) and D-(+)-glucose from Sigma Aldrich (G5767-500g). 
Doxorubicin hydrochloride was purchased from Discovery fine chemicals. Solvents from 
Sigma Aldrich for fluorophore labeling (DMSO and DMF) were anhydrous. All products 
were used as received unless otherwise specified.  
 
Poly(trimethylene carbonate)30-b-poly(L-glutamic acid)19 PTMC30-b-PGA19 diblock 
copolymer was synthesized by ring-opening polymerization (ROP) of δ-benzyl-L-glutamate 
N-carboxyanhydride (NCA) initiated by a primary amine end-functionalized PTMC 
macroinitiator according to a previously described method.
27
 All the experiments described 
were performed on PTMC30-b-PGA19 diblock copolymer (Mn=5492 g/mol, I=2). 
2.2. Methods 
2.2.1. Fluorophore labeling and self-assembly 
Fluorophore labeling.  
- Alexa Fluor 568 labeled PTMC30-b-PGA19: After flame-drying of a round-bottom flask 
under vacuum, the following reagents were introduced under inert nitrogen atmosphere: 
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primary end-functionalized amine PTMC30-b-PGA19 (99.9 mg, 18.2 µmol), anhydrous DMSO 
(2 mL), DIPEA (140 µL, 804 µmol) and reactive Alexa Fluor 568-carboxylic acid, 
succinimidyl ester (1 mg, 1.26 µmol) in DMSO (120 µL). The reaction was then allowed to 
proceed for one night under static nitrogen atmosphere. The conjugate PTMC30-b-PGA19-
Alexa Fluor 568 was purified by dialysis (5 L, 3 h, MWCO : 3500 g/mol) after dilution in the 
flask by DMSO for a better recovery. External medium was renewed six times in course of 
dialysis. After lyophilization, the conjugate was recovered in a 97 % yield (determined by 
gravimetry).  
- Fluorescein labeled PTMC30-b-PGA19: After flame-drying of a round-bottom flask under 
vacuum, the following reagents were introduced under inert nitrogen atmosphere: primary 
end-functionalized amine PTMC30-b-PGA19 (200.1 mg, 36.4 µmol), anhydrous DMSO (1.9 
mL), DIPEA (140 µL, 804 µmol) and reactive Fluorescein isothiocyanate (18 mg, 46.2 µmol) 
in DMSO (3.6 mL). The reaction was then allowed to proceed for one night under static 
nitrogen atmosphere. The conjugate PTMC30-b-PGA19-Fluorescein was purified by dialysis (5 
L, 3 h, MWCO : 3500 g/mol). External medium was renewed four times in course of dialysis. 
After lyophilization, the conjugate was recovered in an 81 % yield (determined by 
gravimetry).  
- Alexa Fluor 488 labeled poly(butadiene): After flame-drying under vacuum of a round-
bottom flask, the following reagents were introduced under inert nitrogen atmosphere: 
primary end-functionalized amine PB20 (84.1 mg, 49.5 µmol), anhydrous DMF (2 mL), 
DIPEA (8 µL, 45.9 µmol) and reactive Alexa Fluor 488-carboxylic acid, succinimidyl ester (1 
mg, 1.55 µmol) in DMF (120 µL). The reaction was then allowed to proceed for overnight 
under static nitrogen atmosphere. After concentrating the mixture by evaporation of DMF 
under vacuum, the polymer was precipitated and washed with water. Finally, it was dissolved 
in THF and recovered after drying under dynamic vacuum.  
- Alexa Fluor 405 labeled poly(butadiene): After flame-drying under vacuum of a round-
bottom flask, the following reagents were introduced under inert nitrogen atmosphere: 
primary end-functionalized amine PB20 (81.5 mg, 48 µmol), anhydrous DMF (2 mL), DIPEA 
(20 µL, 115 µmol) and reactive Alexa Fluor 405-carboxylic acid, succinimidyl ester (1 mg, 
0.97 µmol) in DMF (120 µL). The reaction was then allowed to proceed for overnight under 
static nitrogen atmosphere. After concentrating the mixture by evaporation of DMF under 
vacuum, the polymer was precipitated and washed with water. Finally, it was dissolved in 
THF and recovered after drying under dynamic vacuum.  
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Nanoprecipitation yielding nanosize polymersomes of PTMC30-b-PGA19 for confocal 
microscopy. 
Red fluorescent nanosize vesicles. For confocal microscopy acquisitions, 4.5 mL Tris Buffer, 
50 mM, pH 7.4, were added slowly with a push syringe at a rate of 2.25 mL/h over 5 mg of 
PTMC-b-PGA-Alexa Fluor 568 in DMSO (0.5 mL) stirred at 500 rpm at 25 °C. The sample 
was then dialyzed with a 50,000 g/mol cut-off in 5 L Milli Q water with 3 renewals. Size and 
polydispersity (Table S1) were characterized by dynamic light scattering (DLS). 
 
Green fluorescent nanosize vesicles for double loading. Same procedure as above was used, 
but with 0.5 mL copolymer in DMSO taken from a DMSO solution (1.4 mL) of 7 mg 
PTMC30-b-PGA19 and 7 mg PTMC30-b-PGA19-fluorescein. Size and polydispersity (Table 1) 
were characterized by dynamic light scattering (DLS). 
Table 1. Dynamic Light Scattering size measurement of nanopolymersomes at 25°C 
 Red 
polymersomes  
Green 
polymersomes  
 
DH/nm 500 655  
PDI
[a]
 0.06 0.09  
a
 Polydispersity index 
 
Double nanosize polymersome loading. Red (PTMC-b-PGA-Alexa Fluor 568) and green 
(PTMC30-b-PGA19-fluorescein) labeled nanosize vesicle suspensions were mixed at 50% v/v 
(with 380mM sucrose). Prior to mixing and encapsulation by emulsion-centrifugation, both 
suspensions were concentrated by ultrafiltration (MWCO: 1,000 g/mol, 400 rpm) from 4 to 
approximately 1 mL, yielding a final concentration of approximately 4 mg/mL.  
 
Triple fluorophore loading. A 0.5 mL solution of PB-b-PEO in toluene at 3 mg/mL (mixed 
with 10 wt.% PB-Alexa Fluor 405 included) as the organic phase, was used to encapsulate by 
emulsion-centrifugation a 50% v/v mixture of FITC-dextran and red fluorescent nanosize 
vesicles (PTMC-b-PGA-Alexa Fluor 568). FITC-dextran was at 2 mg/mL and the red 
nanosize vesicle suspension was the one obtained by ultrafiltration for the double nanosize 
polymersome loading experiment and diluted first by ¾ (≈ 3 mg/mL). 
 
Emulsion-centrifugation yielding giant PB-b-PEO encapsulating a PTMC-b-PGA 
nanosize vesicle suspension. In a typical procedure inspired from Min-Hui Li’s team28, 29, 5 
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µL of a nanosize vesicle suspension formed by nanoprecipitation with 380 mOsm sucrose 
were poured in 500 µL toluene at 3 mg/mL PB-b-PEO (including, depending on each 
experiment, 0 or 10 wt% of Alexa Fluor 488 or 405 labeled PB) in a classic Eppendorf tube. 
The solution was stirred for at least 2 hours. The complete dissolution was confirmed by DLS 
(no intensity scattered). In another tube, 30 µL of the same organic solution was poured over  
30 µL of a 380 mOsm aqueous glucose solution and allowed to stabilize for 30 min (Mabrouk 
et al.
28
 verified that 10 min were enough for complete coverage of the interface with 
polymer). Finally, the first tube was emulsified with vigorous agitation by hand yielding quite 
homogeneous emulsion droplets (alternatively, repeated pipetting works as well) and 50 µL of 
it was taken and poured slowly and immediately over the second interface tube. Immediately 
following this step, the sample was centrifuged at 20 °C at 500g for 4 min and the aqueous 
polymer vesosome suspension was recovered. Of course, any aqueous solution can be 
encapsulated instead of the PTMC-b-PGA nanosuspension. 
2.2.2. Loading and in vitro release of Doxorubicin 
To conduct the present study rigorously, for this section we did not only rely on volumes as 
indicated by Eppendorf micropipettes to calculate the various concentrations, but we always 
weighed samples to calculate as accurately as possible the actual volume added, thus the most 
precise possible concentration. 
Nanosize polymersomes’ Doxorubicin loading.30 Doxorubicin (DOX) loading was 
performed at a feed weight ratio of 15 % (fwr (%) = mDox/mpolymer in initial solution × 100) by 
nanoprecipitation. 15.4 mg of Dox was dissolved in DMSO (10.1 mL) with block copolymer 
PTMC-b-PGA (102 mg). Tris buffer at pH 7.4 (60 mL; 50 mM) was then quickly added (5 s) 
to the organic phase under magnetic stirring (1000 rpm, 25 °C). Excess drug and DMSO were 
removed by dialysis (4 L, 3 h, 25 °C; MWCO: 3500 g/mol) against Tris buffer (10 mM Tris, 
pH 7.4, ionic strength 150 mM). External medium was renewed two times in the course of 
dialysis. It was verified in a previous work
30
 that all the DMSO was removed during this time 
by elemental analysis. The nanosuspension was then retrieved and concentrated by 
ultrafiltration to a final volume of 4.6 mL. Vesicle concentration after dialysis was 22.2 
mg/mL. For every quantification of doxorubicin from these nanosize polymersomes, the 
suspension was diluted to a final concentration of 0.4 mg/mL (final dilution of 50) to avoid 
saturation of UV-vis spectrophotometer. 
Doxorubicin loading content was determined by absorbance spectroscopy. Loaded vesicles 
were first broken by adding a large excess of DMSO (80 vol% of the final mixture) and by 
vortexing the solution for 5 s. The sample was then subjected to UV analysis at λmax=485 nm. 
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Quantification was performed from the calibration curve of doxorubicin in a DMSO/Tris 
buffer 10 mM, pH 7.4, 150 mM NaCl (80/20 v/v) mixture (Figure S4, undirect method). To 
cross-check this value, absorbance at λmax=485 nm was also directly measured on loaded 
vesicles in Tris buffer. The vesicles alone did not significantly absorb at this wavelength and 
their absorbance spectra (at same copolymer concentrations) could be subtracted from the 
loaded vesicle spectra to extrapolate the absolute absorbance of doxorubicin (see Figure S5). 
Quantification was performed from the calibration curve of doxorubicin in Tris buffer 10 mM 
(Figure S6, direct method). Each experiment was carried out in triplicate, and average values 
established from measurement of four different samples (Table 2). Quantification of the DOX 
loading will be given through the loading efficiency (%) (mass of Dox in vesicles /mass of 
DOX in the initial solution) and loading content (%) (mass of Dox in vesicles / mass of 
polymer). 
Table 2. Characteristics of doxorubicin (Nano-DOX) loaded nanosize polymersomes 
FWR 
/wt.%
 [a]
 
DH/ 
nm 
PDI
 [b]
 Loading 
content/wt.% 
Loading 
efficiency/wt.% 
15 218  0.06  9 ± 0.33
[c]
  
9 ± 0.32
[d]
   
57 ± 2.2
[c]
  
59 ± 2.14
[d]
    
     
a 
Feed weight ratio  
b 
Polydispersity index 
c 
Determined by absorbance of loaded vesicles in Tris Buffer 
d 
Determined by absorbance of vesicles in Tris Buffer broken with DMSO (80%) 
 
Vesosome Doxorubicin loading. After one experiment, the volume of a typical vesosome 
suspension is about 50 µL at 50 µg/mL of doxorubicin, volume that is not sufficient for an in 
vitro release experiment. Thus five suspensions were mixed together for each experiment. The 
doxorubicin loading content was determined by fluorescence measurements. Loaded 
vesosomes were broken by adding 87 v % of a 25/75 v% MeOH/THF mixture and vortexing 
this sample for 5 s. This solvent mixture was chosen because it is the only solvent able to 
break both the PB-b-PEO and PTMC-b-PGA vesicles, as confirmed by DLS. This sample was 
then subjected to fluorescence measurement at λmax=590 nm (λexc=485 nm). Quantification 
was performed from the calibration curve of doxorubicin in a 87 v% [25/75 v.%MeOH/THF] 
/ 13 v.% [Tris buffer 10 mM 380 mM glucose] solution (Figure S7). We further checked that 
different vesosome suspension samples were reproducible (Figure 1) in terms of DOX loading  
content and above all, that after mixing several samples, three successively taken fractions of 
25 µL and the remaining volume of 125 µL yielded the same fluorescence, and thus DOX 
concentration. 
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Figure 1. Fluorescence of Dox in multiple samples of broken veso-DOX with multiple pipetting withdrawals to 
assess reproducibility. 
 
For a typical in vitro release experiment 5 vesosome suspensions were mixed, a fraction of 25 
µL was taken to assess its loading content by addition of MeOH/THF and the rest of the 
sample was used for the experiment. This way, each release experiment was normalized with 
its own precise loading content (measured right before each experiment) in order to compare 
release experiments of veso-DOX, nano-DOX and free DOX. 
 
In vitro doxorubicin release. The required quantity of drug-loaded vesicles or vesosomes 
was put in the donor chamber of a tailor-made drug release device (Figure S1) inspired by 
Franz cells. The whole device was kept in a water bath at 37 or 20°C. A membrane separates 
the donor chamber from the receptor chamber (1.8 mL external medium) (Spectra/Por 
MWCO: 50,000 g/mol). The donor chamber, containing (225 µL) of Dox-loaded 
polymersomes or vesosomes) solution, was this way dialysed against a release medium 
containing 1.8 mL Tris buffer (10 mM Tris, pH 7.4, ionic strength 380 mM glucose) in the 
receptor chamber. The doxorubicin concentration was measured in the receptor chamber 
during release by withdrawing an aliquot (200 µL) from the sampling port. Samples removed 
for analysis every hour were replaced by fresh release medium in order to maintain sink 
conditions. The amount of drug released was estimated from fluorescence measurements at 
λmax=590 nm (λexc=485 nm) and calibration curves of doxorubicin in 10 mM Tris, pH 7.4, 
380mM glucose (Figures S8 and S9). The drug concentration could be directly calculated 
from the measured fluorescence. All experiments were conducted with approximately the 
same initial LC (concentrated DOX and nano-DOX were diluted to the veso-DOX’s LC) but 
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in order to better compare, all the data was still normalized with its respective LC measured 
on the sample prior to the release, by fluorescence (disruption with MeOH/THF for veso-
DOX,) or absorbance (disruption with DMSO for nano-Dox). Each experiment at 37 °C was 
carried out in duplicate, and average values plotted. Error bars represent standard deviation. 
2.2.3. Characterization methods 
Dynamic Light Scattering (DLS). DLS measurements were conducted on a Malvern Zeta 
Sizer Nano ZS instrument with 90° measurements at 25°C. The mean hydrodynamic diameter 
and its distribution were determined using Cumulant and CONTIN analysis methods. 
 
Spinning disk confocal microscopy. The spinning disk microscope was a Leica DMI6000 
(Leica Microsystems, Wetzlar, Germany) equipped with a confocal Scanner Unit CSU-X1 
(Yokogawa) using for this experiment objective HCX PL Apo 100X oil NA 1.4 and an 
Evolve EMCCD camera (Roper Scientific, Evry, France). Z-stack analysis was performed 
with a galvanometric stage (Leica Microsystems, Wetzlar, Germany). To prove the vesosome 
structure, the diode laser used were at 491 nm and 561 nm and a Semrock emission filter with 
narrow bandpass windows in the blue (420 to 460 nm), green (506 to 536 nm) red (587 to 627 
nm) and near infrared (670 to 730nm) spectral regions was used. For double nanosize 
polymersome loading, the same diode lasers were used but with Semrock emission filters with 
narrow bandpass windows in the green (506 to 544 nm) and in the red (573 to 637 nm). For 
triple fluorophore labeling, the same latter filters were used but also in addition, the 405 nm 
diode laser was needed as well as the quad bandpass filter described for the proof of 
vesosome structure, for the blue fluorescence acquisition.  
Microscopy chambers were fabricated by sealing a slide against a coverslip with two layers of 
parafilm featuring the three sides of the chamber. The sample could then be injected by 
capillarity through the last open side. Finally, the last aperture would be sealed with melted 
paraffine wax. 
The experiments were realized in the Bordeaux Imaging Center of the University of Bordeaux 
Segalen. The help of Sébastien Marais is gratefully acknowledged.  
 
Instrumentation and Measurements. 1H (400 MHz) Nuclear Magnetic Resonance NMR 
spectra were recorded on a Bruker Avance DPX400 instrument at 23 °C and were referenced 
internally using the residual 1H solvent resonance relative to tetramethylsilane (δ=0). Mn SEC 
and (Mw/Mn) values for copolymers PTMC-b-PBLG (3 mg/mL) were determined by Size 
Exclusion chromatography SEC at 60 °C, using dimethylformamide (DMF) with LiBr (1 g/L) 
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as eluent (0.8 mL/min), on a Jasco apparatus equipped with both Varian refractive index and 
UV detectors and two PL gel 5 μm mixed-C columns.  
For doxorubicin quantification with absorbance and fluorescence measurements, a 
SpectraMax M2 Ɛt SpectraMax M2e Multimode Plate Readers, equipped with a high powered  
Xenon flashlamp, was used. All measurements were performed at 22°C. 
3. Results and Discussion 
The inner polymersomes are formed by nanoprecipitation of poly(trimethylene carbonate)-b-
poly(L-glutamic acid) PTMC-b-PGA synthesized following a previously reported method.
27
 
This suspension is then loaded in larger polymersomes of poly(butadiene)-b-poly(ethylene 
oxide) PB-b-PEO by emulsion-centrifugation
31
 with a quantitative loading efficiency. The 
procedure for forming giant PB-b-PEO polymersomes was inspired from Li and coworkers
28
. 
Briefly (Figure 2), a small fraction of an inverted emulsion of aqueous solution (here a 
nanosize polymersome suspension of PTMC-b-PGA with 380 mOsm sucrose) in toluene is 
poured over an interface of toluene and an aqueous solution of 380 mOsm glucose. The PB-b-
PEO diblock copolymer is dissolved in toluene at 3 mg/mL and stabilizes the emulsion 
droplet (forming the inner leaflet of the final bilayer) of this interface.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Schematic representation of the emulsion-centrifugation process generating giant polymersomes or 
polymer vesosomes (the smaller red vesicles representing the inner nanosize polymersomes). 
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In a final step, both centrifugal force and denser sucrose (as compared to glucose) inside the 
droplets, force them to cross the interface and to be enveloped by a second leaflet of 
amphiphilic PB-b-PEO block copolymer, yielding the final giant polymersomes or polymer 
vesosomes (if a nanosize polymersome suspension is used as aqueous inner solution). 
The control provided by this process enabled imaging the compartmentalized polymersome 
structure by spinning disk confocal microscopy. In Figure 3 the Alexa Fluor 568 (red) labeled 
inner polymersomes are visibly encapsulated in a green giant polymersome (with 10 wt.% of 
a Alexa Fluor 488 conjugated polybutadiene).  
 
Figure 3. Spinning disk confocal microscopy images of red nanosize vesicles (Alexa fluor 568) in a green giant 
polymersome (Alexa Fluor 488). From left to right: green channel, red channel, overlay and 3D reconstruction 
(red channel). 
 
The red inner polymersomes in Brownian motion can clearly be observed (see Movie S1
g
 ). 
The giant vesicle has also been reconstructed in 3D for better visualization (see Movie S2
b
). 
Such compartmentalized structures are of particular interest for the delivery of multiple 
actives
32
. To address this point, a 50/50 vol.% solution of two different PTMC-b-PGA 
suspensions, labeled with red (Alexa Fluor 568) and green (fluorescein isothiocyanate FITC) 
fluorophores was encapsulated instead of a single nanosize vesicle suspension (Figure 4).  
 
 
 
 
 
 
 
 
 
 
Figure 4. Spinning disk confocal microscopy images of red (Alexa fluor 568) and green (FITC) nanosize 
vesicles in a giant polymersome. From left to right: green channel, red channel, and overlay. 
 
 
                                                 
g 
Movie s1, 
b
 Movie s2 and 
c
 Movie s3 http://onlinelibrary.wiley.com/doi/10.1002/anie.201106410/suppinfo 
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The two nanosize polymersomes are clearly localized in the same giant polymersome; the 
Movie S3
c
 shows the distinct motion of each kind of fluorescent nanosize polymersome. 
Finally, we were able to further increase the complexity of this system by co-encapsulating a 
large polymer, FITC-dextran (20,000 g.mol
-1
), with a red nanosize vesicle suspension (Figure 
5).  
As the FITC-dextran was already green fluorescent, the membrane was this time labeled in 
blue (with 10wt.% Alexa Fluor 405 conjugated polybutadiene), allowing separate imaging of 
the giant vesicles (blue), the inner nanosize vesicles (red) and the loaded dextran (green). 
Such a three-compartment encapsulation in vesicles is, to the best of our knowledge, the first 
reported to date. 
 
 
 
 
 
Figure 5. Spinning disk confocal microscopy acquisitions of red (Alexa fluor 568) nanosize vesicles and green 
FITC-dextran in a blue (Alexa Fluor 405) giant polymersome. From top left to bottom right: blue channel, green 
channel, red channel, overlay blue and green, blue and red, and finally blue, green and red channels. 
 
The double membrane barrier effect of these polymer vesosomes was then studied by 
measuring the release profile of doxorubicin (DOX) as a model drug. DOX was encapsulated 
in the inner PTMC-b-PGA polymersomes.
30
 The resulting suspension was concentrated as 
much as possible in order to have the highest possible drug concentration (loading content of 
9 wt%). In vitro drug release experiments were then conducted on solutions of free DOX, of 
PTMC-b-PGA nanosize polymersomes loaded with doxorubicin (nano-DOX) and polymer 
vesosomes loaded with nano-DOX as inner polymersomes (veso-DOX). These solutions were 
placed in the donor chamber of a tailor-made drug release device inspired by Franz cells 
(Figure S1). The release of DOX was followed by monitoring the absorption and fluorescence 
of the drug (Figure S2).  
A significant decrease of the DOX release rate from nano-DOX to veso-DOX can be 
observed at 37°C (Figure 6). Indeed, in veso-DOX, the drug has not only a PTMC-b-PGA 
polymeric membrane but also a PB-b-POE one to cross. At 20°C the release is negligible in 
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the time frame of the measurement, this temperature being efficient for storage. The data can 
also be represented (Figure S3) by an experimental law established by Peppas,
33
 where mt and 
mf represent the DOX release at time t and infinite time (initial amount in µg) respectively, k 
is a kinetic constant dependent of the matrix and the drug, and n is the release exponent: 
 
   Equation (1) 
The release data consequently analysed can be fitted by a linear regression, thus suggesting a 
fickian, purely diffusive release regime. Moreover, by extracting the kinetic constants k for 
each system, one determines that the release rate of nano-DOX is about twice the one of veso-
DOX, for which there is an additional diffusion barrier. 
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Figure 6. In vitro drug DOX release (wt.%) from top to bottom: free DOX(▼,10.34 µg), Nano-DOX(●, 9.25 
µg), Veso-DOX (■, 9.95 µg) at 37°C, Nano-DOX(x, 9.33 µg) at 20°C and Veso-DOX(▲,11.35 µg) at 20°C 
(experiments performed in duplicate, error bars represent standard deviation). 
4. Conclusion 
In summary, polymersomes in polymersomes (or polymer vesosomes) were obtained with 
an original, versatile and efficient method. Using such an emulsion centrifugation process, 
nanosize vesicles and any other material (nanoparticles, proteins, …) can be quantitatively 
loaded in larger polymersomes. Moreover, this highly controlled technique enabled 
encapsulating different nanosize polymersomes inside larger ones (constituting the first path 
towards the delivery of multiple and/or  incompatible actives), and also encapsulating 
mt
mf
= k × tn
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molecules and (bio)macromolecules in at least three different compartments (in the 
membrane/lumen of the inner nanosize polymersomes, in the cavity and in the membrane of 
the giant vesicles). Finally, the encapsulation of highly concentrated doxorubicin-loaded 
nanosize vesicles was performed. A double membrane barrier effect has been demonstrated, 
allowing a specific stability and disruption in different environments. This strategy presents a 
straightforward approach and new opportunities for the use of these polymersomes in 
polymersomes in biomedical or cosmetic applications, where the encapsulation of multiple, 
distinct and fragile ingredients are required, together with specific release conditions. 
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Annexes 
Description of the videos presented as supporting information on 
http://onlinelibrary.wiley.com/doi/10.1002/anie.201106410/suppinfo 
 
Movie S1 (http://onlinelibrary.wiley.com/doi/10.1002/anie.201106410/suppinfo, movie_s1) 
features the polymer vesosome in Figure 1, where the loaded red inner polymersomes can 
clearly be observed in Brownian motion. The acquisition was done with a spinning disk 
confocal microscope, the red nanosize polymersomes are labeled with Alexa Fluor 568, the 
green giant polymersome with Alexa Fluor 488. 
The vesosome of movie 1 is reconstructed in three dimensions (red channel only) in Movie S2 
(http://onlinelibrary.wiley.com/doi/10.1002/anie.201106410/suppinfo, movie_s2), showing 
the localization of the inner polymersomes in the giant one. 
Movie S3 (http://onlinelibrary.wiley.com/doi/10.1002/anie.201106410/suppinfo, movie_s3) 
features the polymer vesosome with two populations of inner nanosize polymersomes in 
Figure 2. The acquisition was done with a spinning disk confocal microscope, the red 
nanosize polymersomes are labeled with Alexa Fluor 568, the green ones with FITC. The 
distinct motion of each kind of vesicle is clearly visible.  
 
 
 
Figure S1. Tailor-made drug release device inspired from Franz cells 
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Figure S2a. Absorbance of drug Doxorubicin in 
Tris buffer 10mM, pH 7.4, 150mM NaCl. 
Figure S2b. Fluorescence of drug Doxorubicin 
in.Tris buffer 10mM, pH 7.4, 150mM NaCl. 
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Figure S3. In vitro drug DOX release (wt.%): Peppas fit of DOX release from Nano- (●) and Veso-DOX(□) at 
37°C. 
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Figure S6. Calibration curve of Doxorobucin absorbance at 485 nm in 10mM Tris pH 7.4,150 mM NaCl.  
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Figure S7. Calibration curve of Doxorobucin fluorescence at 485 nm excitation, 590 nm emission in 13/87 v.% 
380 mM glucose/[THF/MeOH (75/25 v.%)].  
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Figure S8. Calibration curve of Doxorobucin fluorescence (from 0-0.5µg/mL) at 485 nm excitation, 590 nm 
emission in 10 mM Tris/HCl, pH 7.4, 380 mM glucose.  
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Figure S9. Calibration curve of Doxorobucin fluorescence (from 0.5-4.4µg/mL) at 485 nm excitation, 590 nm 
emission in 10 mM Tris/HCl, pH 7.4, 380 mM glucose.  
 
 
This chapter has been published in Angewandte Chemie International Edition: 
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Polymersomes: multiple loading and permeability control, Angewandte Chemie International 
Edition, 2012. 51,p. 1173-1176. 
 
y=133 +3.24 
 
Chapter 3. Polymersomes in Polymersomes: multiple loading and permeability control 
 
 
113 
References 
 
 
1. Discher, D. E.; Eisenberg, A., Science 2002, 297 (5583), 967-973. 
2. Christian, D. A.; Cai, S.; Bowen, D. M.; Kim, Y.; Pajerowski, J. D.; Discher, D. E., 
European Journal of Pharmaceutics and Biopharmaceutics 2009, 71 (3), 463-474. 
3. Meng, F.; Zhong, Z.; Feijen, J., Biomacromolecules 2009, 10 (2), 197-209. 
4. Cheng, R.; Feng, F.; Meng, F.; Deng, C.; Feijen, J.; Zhong, Z., Journal of Controlled 
Release 2011, 152 (1), 2-12. 
5. Li, M.-H.; Keller, P., Soft Matter 2009, 5 (5), 927-937. 
6. Kim, M. S.; Lee, D. S., Chemical Communications 2010, 46 (25), 4481-4483. 
7. Van Dongen, S. F. M.; Verdurmen, W. P. R.; Peters, R. J. R. W.; Nolte, R. J. M.; 
Brock, R.; Van Hest, J. C. M., Angewandte Chemie International Edition 2010, 49 (40), 
7213-7216. 
8. Renggli, K.; Baumann, P.; Langowska, K.; Onaca, O.; Bruns, N.; Meier, W., 
Advanced Functional Materials 2011, 21 (7), 1241-1259. 
9. Onaca, O.; Hughes, D. W.; Balasubramanian, V.; Grzelakowski, M.; Meier, W.; 
Palivan, C. G., Macromol. Biosci. 2010, 10 (5), 531-538. 
10. Brinkhuis, R. P.; Rutjes, F. P. J. T.; van Hest, J. C. M., Polymer Chemistry 2011. 
11. Bermudez, H.; Brannan, A. K.; Hammer, D. A.; Bates, F. S.; Discher, D. E., 
Macromolecules 2002, 35 (21), 8203-8208. 
12. Walker, S. A.; Kennedy, M. T.; Zasadzinski, J. A., Nature 1997, 387 (6628), 61-64. 
13. Wong, B.; Boyer, C.; Steinbeck, C.; Peters, D.; Schmidt, J.; van Zanten, R.; Chmelka, 
B.; Zasadzinski, J. A., Advanced Materials 2011, 23 (20), 2320-2325. 
14. Mishra, V.; Mahor, S.; Rawat, A.; Dubey, P.; Gupta, P. N.; Singh, P.; Vyas, S. P., 
Vaccine 2006, 24 (27-28), 5559-5570. 
15. Ebato, Y.; Kato, Y.; Onishi, H.; Nagai, T.; Machida, Y., Drug Development Research 
2003, 58 (3), 253-257. 
16. Scholl, I.; Boltz-Nitulescu, G.; Jensen-Jarolim, E., Journal of Controlled Release 
2005, 104 (1), 1-27. 
17. De Geest, B. G.; De Koker, S.; Immesoete, K.; Demeester, J.; De Smedt, S. C.; 
Hennink, W. E., Advanced Materials 2008, 20 (19), 3687-3691. 
18. McPhail, D.; Tetley, L.; Dufes, C.; Uchegbu, I. F., International Journal of 
Pharmaceutics 2000, 200 (1), 73-86. 
19. Bolinger, P. Y.; Stamou, D.; Vogel, H., Angewandte Chemie International Edition 
2008, 47 (30), 5544-5549. 
20. Kreft, O.; Prevot, M.; Möhwald, H.; Sukhorukov, G. B., Angewandte Chemie 
International Edition 2007, 46 (29), 5605-5608. 
21. Chandrawati, R.; Hosta-Rigau, L.; Vanderstraaten, D.; Lokuliyana, S. A.; Stadler, B.; 
Albericio, F.; Caruso, F., ACS Nano 2010, 4 (3), 1351-1361. 
22. Perro, A.; Nicolet, C.; Angly, J.; Lecommandoux, S.; Le Meins, J. F.; Colin, A., 
Langmuir 2011, 27 (14), 9034-9042. 
23. Hanson, J. A.; Chang, C. B.; Graves, S. M.; Li, Z.; Mason, T. G.; Deming, T. J., 
Nature 2008, 455 (7209), 85-88. 
24. Shum, H. C.; Zhao, Y. J.; Kim, S. H.; Weitz, D. A., Angewandte Chemie International 
Edition 2011, 50 (7), 1648-1651. 
25. Fu, Z.; Ochsner, M. A.; De Hoog, H. P. M.; Tomczak, N.; Nallani, M., Chemical 
Communications 2011, 47 (10), 2862-2864. 
Chapter 3. Polymersomes in Polymersomes: multiple loading and permeability control 
 
 
114 
26. Chiu, H.-C.; Lin, Y.-W.; Huang, Y.-F.; Chuang, C.-K.; Chern, C.-S., Angewandte 
Chemie International Edition 2008, 47 (10), 1875-1878. 
27. Sanson, C.; Schatz, C.; Le Meins, J. F.; Brûlet, A.; Soum, A.; Lecommandoux, S., 
Langmuir 2010, 26 (4), 2751-2760. 
28. Mabrouk, E.; Cuvelier, D.; Pontani, L. L.; Xu, B.; Lévy, D.; Keller, P.; Brochard-
Wyart, F.; Nassoy, P.; Li, M. H., Soft Matter 2009, 5 (9), 1870-1878. 
29. Mabrouk, E.; Cuvelier, D.; Brochard-Wyart, F.; Nassoy, P.; Li, M. H., Proceedings of 
the National Academy of Sciences of the United States of America 2009, 106 (18), 7294-7298. 
30. Sanson, C.; Schatz, C.; Le Meins, J. F.; Soum, A.; Thévenot, J.; Garanger, E.; 
Lecommandoux, S., Journal of Controlled Release 2010, 147 (3), 428-435. 
31. Pautot, S.; Frisken, B. J.; Weitz, D. A., Langmuir 2003, 19 (7), 2870-2879. 
32. Al-Jamal, W. T.; Kostarelos, K., International Journal of Pharmaceutics 2007, 331 
(2), 182-185. 
33. Ritger, P. L.; Peppas, N. A., Journal of Controlled Release 1987, 5 (1), 23-36. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4 
 
 
Enzymatic cascade reactions confined in 
Polymersomes in a Polymersome. 
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In the previous chapter (Chapter 3), we have demonstrated the achievement of two of the 
properties arising in the biomedical field with the controlled formation of structural cell 
mimics (polymersomes in a polymersome),i.e. multiple loading and permeability tuning for 
exquisite control over release kinetics.  
After addressing the first step or barrier of structural cell mimicry, we then faced another 
challenge, metabolic function. In this search for increased complexity towards functional cell 
mimicry (the second step) it is then paramount to first achieve the conduction of enzymatic 
reactions inside single compartments, as occurs in a highly controlled, selective and efficient 
fashion in the organelles. Such so-called nanoreactors are also coined artificial organelles. 
Polymersomes are powerful compartments to use for such purposes. Finally, after achieving 
control over these two prerequisites (eukaryotic cell structure and metabolic function in 
organelle mimics), it becomes possible to combine them and push the frontiers of Biomimicry 
further: from cell structure mimicry towards a controlled cell-like biofunctionality. This was 
the last but not least challenge that we faced during this PhD project. We believe that such a 
Research will enrich considerably the fields of drug delivery, (bio)sensors, (bio)catalysis and 
(bio)technology. The first part of this project consisted in the design, study and optimization 
of a nanoreactor biomimetic cascade based on PS-b-PIAT polymersomes, and was performed 
in Nijmegen in collaboration with Prof. Van Hest and his PhD candidate Ruud Peters; in this 
first part of Chapter 4 we present work regarding metabolic function within artificial 
organelles, constituting a major part of the chapter as it revealed rather complex to set up. 
The second part consists in the loading of these nanoreactors in a giant PB-b-PEO 
polymersome and in the study of the final reaction system by confocal microscopy. Although 
this project requests further investigations, we were able to prove the concept of enzymatic 
cascade reactions confined in polymersomes. 
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1. Introduction 
It is only thanks to multicompartmentalization and positional assembly that eukaryotic cells 
are able to perform multiple, spatially separated chemical processes simultaneously with high 
accuracy and specificity. Such a control in confinement of reactive species and (bio)chemical 
reactivity is a source of inspiration to scientists, and a dream for chemists.   
Once structural cell mimicry is controlled (Chapters 2 and 3)
1,2
, one can bring these 
structures to their full potential by tackling the challenge of functional cell biomimicry. The 
idea is to combine functional synthetic organelles (metabolism/functional mimicry) in such 
structural cell mimics. These synthetic organelles, also called nanoreactors, indeed often host 
enzymatic cascade reactions. This field, using polymersomes as single compartments has 
been extensively studied for a decade.
3-6
 However by using a multicompartmentalized 
structure as scaffold for multiple enzymatic reactions, a completely new and powerful level of 
control arises, as for the eukaryotic cell. Indeed, even though significant progress has been 
demonstrated in the past years in cascade reactions using nanoreactors with enzymes placed 
in different locations, the level of possibilities to immobilize or confine enzymes in a 
multicompartmentalized system is in theory improved but still needs to be fully explored.  
Vogel and coworkers were pioneers in this field and developed a system able to release and 
mix reactive compounds from small liposomes inside large ones upon a thermal trigger,
783
 
one great property arising from multicompartmentalization. By using relevant lipid-phase 
transition temperatures (Tt of lipids), they were further able to perfect their system into a 
nanofluidic reactor controlling two enzymatic consecutive reactions.
7 
Indeed above the Tt, the 
liposome’s permeability increases as a result of the transient defects that are generated by 
disturbances in lipid packing order. First prodye dichlorodimethylacridinone (DDAO) 
phosphate is released in the outer vesicle and converted by alkaline phospatase into DDAO, 
then prodye fluorescein diphosphate can be converted after triggered release into fluorescein. 
In this early development, only one enzyme is used to react with the two substrates 
consecutively. By monitoring the kinetics for one reaction by fluorescence correlation 
spectroscopy (FCS), the authors observed no significant difference between a reaction in bulk 
and in the nanofluidic reactor, applying the same conditions of pH, temperature, enzyme and 
substrate concentrations. These observations are particularly important, as the miniaturization 
of reactors allows a  reduction of sample consumption, which may be expensive or polluting. 
As volumes as small as attolitric are mixed (from the inner nanometer-sized liposomes) in a 
femtoliter reactor vessel (the larger outer liposome), the control over the number of mixed 
reactants should approach single-molecule precision!  
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Other exciting innovations in this field are from Caruso’s group. The concept of 
“capsosomes”, or polymer layer by layer capsules (semi-permeable) deposited on liposomes 
(relatively access-restricting under Tt) was first thoroughly demonstrated and reported.
8
 This 
system was then further optimized by maximizing the number of liposomes and cargo 
retention and above all allowing a temperature-triggered reaction.
9
 As for Vogel’s system, the 
phase transition temperature of phospholipids is taken advantage of, to trigger remotely the 
initiation of the reaction by controlling the substrate release. Interestingly, the encapsulated 
enzymes can thus be used for repeated conversions as the reaction can be reversibly triggered.  
 Kreft et al.
10
 also bring a significant contribution in the field of hollow polyelectrolyte 
microcapsules, with shell-in-shell reactors. Spherical calcium carbonate microparticles are 
here used as templates, which can be removed in a “biofriendly” way through EDTA 
complexation, after polyelectrolyte multilayer build-up. The procedure to get a shell-in-shell 
structure is complex and well-thought, using successive coprecipitation of CaCl2 and Na2CO3, 
and enables to retain one enzyme in the lumen of the inner shell (HRP), another one in the  
lumen of the more external one (GOX). Glucose is added outside for hydrogen peroxide 
generation by GOX in the most external compartment. After addition of substrate Amplex 
Red for the second reaction of the cascade, fluorescent resorufin is obtained within a few 
seconds in the inner compartment, before diffusing outside of the inner capsule. The Authors 
emphasize that this test remains however qualitative. Kreft et al. also evidenced a powerful 
property resulting from multicompartmentalization: the means to trigger remotely 
bioreactions.
11
 They incorporated gold nanoparticles in the inner shell of a similar shell-in-
shell system that could be activated with a near-infrared laser illumination. As a result of the 
local heating thus created, this results in membrane disruption: the contents are released into 
the outer shell interior, providing a route for reactions in confined volumes and intermixing of 
contents of two or more compartments. Bäumler and Georgieva
12
 pushed Kreft’s concept 
further. Indeed, coprecipitation between calcium chloride and sodium carbonate was also used 
to form concentric compartments after removal with EDTA. The shells were formed from 
biopolymer and enzymes cross-linked with glutaraldehyde or divinylsulfone. They designed a 
three-enzyme cascade reaction that consisted of enyzme β-glucosidase in the most external 
compartment which converted first a prodye intro fluorescein and glucose. This glucose was 
then hydrolysed to glucuronic acid and hydrogen peroxide by GOX (in an intermediate 
concentric compartment) in presence of dioxygen. Finally, after addition of prodye amplex 
red, HRP produced fluorescent resorufin and dioxygen (necessary for the reaction of GOX) in 
the presence of the generated hydrogen peroxide. Authors stressed scattering and 
inhomogeneous distribution of absorbance may influence fluorimetry measurements 
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(performed at a “macroscopic” scale) as reaction rate was significantly increased when 
followed by microscopy. Microscopy indeed represents the real concentration of products 
inside particles and is not influenced by its distribution in the surrounding solution. Another 
very interesting and “green” advantage arising is again the possible recycling of enzyme-
bearing microparticles. Indeed, after 5 runs, activity is decreased fivefold, but still present, 
and could be preserved over a few months. 
Last but not least, a very smart design by Caruso and coworkers constituted in using an in situ 
bioreaction to trigger the release of therapeutics.
13
 The conduction of an enzymatic reaction is 
actually offering new perspectives in terms of drug delivery. More precisely, the enzyme 
glutathione reductase in the liposomes of the capsosomes reacts in situ upon temperature 
activation (above Tt). The enzyme can then reduce glutathione disulfide GSSG to glutathione 
GSH, a major cellular antioxidant. This GSH becomes available to cleave the disulfide bond 
between a loaded conjugate composed of a small therapeutic peptide and a large polymer, 
thereby enabling its subsequent release in the external medium. This can be monitored as the 
peptide is also labelled with a fluorophore. Authors aim to develop such systems further to get 
biomimetic platforms that will combine both enzyme therapy and controlled drug release in 
such a single structure. 
The purpose of the present work is to take advantage of the multicompartmentalization in 
polymers that we have been able to design to conduct cascade enzymatic reactions with an 
unprecedented level of spatial and temporal control over reactivity. As evidenced in literature 
(see section 3, chapter 1), we need however a diffusion of reactive species through the 
membranes of the inner compartments in a controlled manner. In the fields of materials, 
possibilities to achieve such a property are limited. Either people work with liposomes, 
inducing a controlled permeability at the transition temperature,
7, 14
 or in the polymer field, 
they work with intrinsically semi-permeable walls as in the case of Lbl capsules.
8-10, 12, 13
 
More specifically with polymer vesicles, there are two main kinds of reports. Either people 
are more or less related to the group of Wolfgang Meier who initiated polymersomes of 
PDMS-PMOXA-PDMS poly[-2-methyloxazoline)-b-poly-(dimethylsiloxane)-b-poly-(2 
methyloxazoline)], 
15-20
 able to incorporate transmembrane channels or porins in their 
membranes to allow specific or non-specific diffusion. Or the polymersomes present an 
intrinsic permeability, which is the case of PS-b-PIAT poly[styrene-b-poly(L-
isocyanoalanine(2-thiophen-3-yl-ethyl) amide)] polymersomes developed by Jan van Hest’s 
group. That is why we developed a collaboration with Professor Jan van Hest, who has as a 
result a long experience in the use of PS-b-PIAT polymersomes hosting enzymatic cascade 
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reactions. Indeed, these polymersomes bear the interesting intrinsic property to be permeable 
to molecules below a critical molecular weight threshold (substrates which are small 
molecules, are able to diffuse through the polymer shell, while enzymes that are large 
macromolecules remain confined in the vesicles), as extensively demonstrated by the van 
Hest group.
21-26
 We first present the general design of the enzymatic cascade reaction in 
multicompartmentalized polymersomes investigated (section 3.1). Then, loading and study of 
the enzymatic cascade in PS-b-PIAT polymersomes in solution will be investigated (section 
3.2, functional organelle mimics). Finally, in a last step, we had to exclude one of the 
enzymes from the polymersomes and to keep it free in solution for better efficacy (section 
3.3), which enabled us to have some first results regarding the ultimate goal of this project 
(functional cell mimics, section 4). 
2. Experimental Section 
2.1.Materials and reagents 
Poly(butadiene)46-b-poly(ethylene oxide)30 (PB46-b-PEO30) (P9095-BdEO, Mn PB=2,500 g/mol 
and Mn PEG=1,300 g/mol, I=1.04) was purchased from Polymer Source.  
PS40-b-PIAT50 was purchased from Encapson. Synthesis of non-caged and caged substrate 
was performed by Ruud Peters, PhD candidate from Radboud University, Nijmegen, the 
Netherlands. Cyclohexanone monooxygenase (CHMO), recombinant from Acinetobacter sp., 
expressed in E. coli, (≥12 U/mL, C1622-1ML, suspension in 80% saturated ammonium 
sulfate, 20 mM K-Na-phosphate buffer pH 7, 3.5 mM 1,4-Dithioerythritol) was from Sigma 
Aldrich. The suspension was estimated to have a concentration of 32 mg/mL by Nanodrop 
1000 (Thermo Scientific). Lipase B Candida antarctica, recombinant from Aspergillus oryzae 
(CalB) (9 U/mg, 66228-250 mg) was from Sigma Aldrich. Recombinant histidine‐tagged 
PAMO
27
 and its self‐sufficient analogue CRE2‐PAMO28, 29 were overexpressed and purified 
as described previously, and kindly donated by the group of Marco Fraaije, in Groningen, the 
Netherlands. NADP
+
 dependent Alcohol Dehydrogenase ADH from Thermoanaerobium 
brockii was bought from Sigma Aldrich (A8435).  
β-Nicotinamide adenine dinucleotide 2′-phosphate reduced tetrasodium salt hydrate 
(NADPH) (N1630) and β-Nicotinamide adenine dinucleotide phosphate hydrate (NADP+, 
N5755) were from Sigma Aldrich. Sucrose, ≥99.5% (84097) and D-(+)-glucose (G5767) were 
from Sigma Aldrich. THF was distilled under Ar from sodium/ benzophenone. The water 
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utilized throughout this work for preparation of buffers, for the self-assembly, dialysis of 
polymersomes and enzymatic assays was double deionized with a Labconco Water Pro PS 
purification system (18.2 MΩ). All other reagents and solvents were of the highest quality 
grade available and acquired from commercial sources. Unless stated otherwise, chemicals 
were used without further purification.  
2.2 Instrumentation and measurements 
Typical preparation of enzyme loaded polymersomes 
As a typical experiment, the enzyme solution (merely enzyme dissolved in the buffer or 
commercial suspension) was mixed with buffer (either 50mM Tris/HCl or 20mM phosphate 
at various pH) to a final volume of 2.5 mL (final enzyme concentration 0.2 mg/mL) with 
conditions described in Table 1 depending on the enzyme. To this solution, PS-b-PIAT (0.5 
mg) dissolved in 500 µL of the corresponding solvent was gently added in a drop wise fashion 
under 600 rpm stirring. Depending on the enzyme, we tested THF (the reference), dioxane, 
DMF and dioxane/DMSO 90/10 v.% until the finding THF was optimal for every enzyme, 
and was used from then on. The vesicles were immediately transferred to dialysis bags after 
preparation. Indeed solvents and non-encapsulated enzymes were removed by dialyzing with 
a 1,000 kDa cut-off in 1 L buffer with 5 renewals for at least 36 hours, maximum 48 h 
following a previously published procedure.
17
 Such membranes tend to concentrate the 
thereby purified solutions, which is why after recovery, solutions were adjusted to 2 mL.  
 
Table 1. Conditions for loading of various enzymes during nanoprecipitation 
Enzyme Initial enzyme 
concentration 
Volume of enzyme 
solution 
Cyclohexanone monooxygenase 
(CHMO) 
32 mg/mL  16 μL 
Phenylacetone monooxygenase 
 (wild-type PAMO) 
125 μM 60 μL 
Phenylacetone monooxygenase (fusion 
protein CRE2-PAMO) 
145 μM 39 μL 
Lipase B Candida Antarctica (CalB) 2.5 mg/mL 200 µL 
Alcohol Dehydrogenase (ADH) 25 mg/mL 20 µL 
 
The polymersomes were stored at 4 °C before use and consumed within 5 days after dialysis 
recovery. 
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Emulsion-centrifugation yielding giant PB-b-PEO encapsulating a PS-b-PIAT nanoreactor 
solution.                                                                                                                         
Following a procedure published elsewhere,
2
 5 µL of the nanoreactors suspension with 
substrate and NADPH, in 380 mOsm sucrose solution was first poured in 500 µL toluene 
containing 3 mg/mL PB-b-PEO in an Eppendorf tube (step 1). The PB-b-PEO solution in 
toluene was previously stirred for at least 2 hours to ensure a complete dissolution of the 
copolymer, as verified by DLS (no intensity scattered). In another tube (step 2), 30 µL of the 
same organic solution was poured over 30 µL of a 380 mOsm aqueous glucose solution and 
allowed to stabilize for 30 min. Finally (step 3), the first tube was emulsified with vigorous 
agitation by hand yielding inverted emulsion droplets (alternatively, repeated pipetting works 
as well). Then 50 µL of this emulsion was poured slowly over the second interface tube. The 
sample was then immediately centrifuged at 20 °C at 500 g for 4 min and the aqueous 
polymersomes in polymersomes (PiPs or polymer vesosomes) suspension was recovered in 
the lower phase.  
 
Enzymatic assays by fluorescence in microplate reader. Measurements were conducted on a 
TECAN Infinite Pro 2000. Each experiment presented a total volume of 200 µL. 3 times 60 
µL of each experiment were divided in 3 wells of a black 384 well microplate (Greiner) to 
have triplicates per sample. Temperature was set to 25°C. Excitation was set at 561 nm (with 
a bandwidth of 9 nm), emission at 590 nm (with a bandwidth of 20 nm). Integration time was 
20 µs with 25 flashes. Gain was set either at 100 (part 3.3) or 150 (part 3.2). Generally, 
measurements were performed during 14 hours with a measurement every 10 min. It is to note 
that micropipettes calibrated for water (at a viscosity of about 1 g/mL at ambient temperature) 
were used to pipet DMSO (with a viscosity of about 1.1 g/mL at ambient temperature). By 
weighing the added DSMO volume during stock solution preparation, we can correct a 
theoretical 3 mM stock solution to an actual 2.9 mM concentration (so 3 µM is really 2.9, 
50=> 48.3, 102=> 98.6, 30 => 29 and 45 => 43.5 µM) and a 10 mM stock solution to 9.9 mM 
(so 150 µM is really 148.5 and 300 => 297 µM). 
Dynamic Light Scattering (DLS). DLS measurements of nanosize PS-b-PIAT polymersomes 
were conducted on a Malvern ZetaSizer Nano ZS instrument with 173° backscattering 
measurements at 20°C. The mean hydrodynamic diameter and its distribution were 
determined using Cumulant and CONTIN analysis methods.  
Spinning disk confocal microscopy. The spinning disk microscope was a Leica DMI6000 
(Leica Microsystems, Wetzlar, Germany) equipped with a confocal Scanner Unit CSU-X1 
Chapter 4. Enzymatic cascade reactions confined in Polymersomes in a Polymersome 
 
 
 
123 
(Yokogawa) using for this experiment objective HCX PL Apo 63X oil NA 1.4 and an 
EMCCD camera Photometrics Quantem (Roper Scientific, Evry, France). The diode laser 
used was at 561 nm and a Semrock emission filter with narrow bandpass windows in the red 
(593 to 627 nm) spectral region was used. The experiments were performed in the Bordeaux 
Imaging Center of the University of Bordeaux Segalen with the gratefully acknowledged help 
of Sébastien Marais. 
Transmission electron microscopy (TEM) was performed on a JEOL JEM 1010 microscope 
with an acceleration voltage of 60 kV equipped with a charge-coupled device (CCD) camera. 
Sample specimens were prepared by placing a drop (6 μL) of aqueous vesicle solution on an 
EM science carbon-coated copper grid (200 mesh) for 15 min. The grid was purified from 
salts and other impurities by placing 3 times a drop of MilliQ water on it, which was 
immediately removed by blotting. The grid was finally air dried overnight and analyzed 
without further treatment. 
Inductively coupled plasma – mass spectrometry (ICP-MS) measurements were performed on 
a Thermo Fisher Scientific Xseries I quadrupole machine using 5.0 mL samples containing 
0.49 mg/L InCl3 solutions as internal standard. 
3. Results and Discussion 
3.1 Design of enzymatic cascade, concept and general results 
The aim of this project was to conduct a biomimetic enzymatic cascade in our 
multicompartmentalized structures, our cell mimics, in collaboration with Professor van 
Hest’s Group, Radboud University, Nijmegen, The Netherlands. In order to prove such a 
concept, reaction kinetics needed to be monitored, moreover by confocal microscopy to 
demonstrate that the cascade really takes place inside the multicompartmentalized structure. 
As a result, the final product of the cascade needed to be fluorescent. PhD candidate of 
Radboud University, Ruud Peters, hence designed a complex enzymatic cascade yielding the 
red fluorescent dye Resorufin (maximas: excitation 561 nm, emission 591 nm)(see Figure 1). 
  
The enzymatic cascade, schematized in Figure 2, is following previous work performed in the 
van Hest group using Baeyer Villager MonoOxygenase Enzyme (BVMO).
30
 The proposed 
cascade pathway was inspired by earlier work on the development of fluorescent assays for 
detecting BVMO activity in bacterial cells.
31
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Figure 1. Resorufin dye 
 
The initial Baeyer Villager reaction is followed by ester hydrolysis using Candida Antarctica 
Lipase B (CalB), and lastly by oxidation of an alcohol by alcohol dehydrogenase (ADH) 
followed by spontaneous β-elimination. It also relies on the cofactors NADPH and NADP+ 
that are naturally present in animal and plant cells where they play various roles. Cofactors 
are organic or inorganic components (but not proteins) that bind to enzymes so that these can 
play their catalytic function. NADPH (Nicotinamide adenine dinucleotide phosphate) is the 
reduced form of NADP
+
, thus the reducing agent of the redox couple. The BVMO enzyme 
needs the cofactor NADPH to perform its catalytic function, thereby inducing the oxidation of 
NADPH into NADP
+
. In the last enzymatic step, ADH needs the cofactor NADP
+
, which is 
thereby reduced to NADPH. This resembles oxidation-reduction cycles of NADPH/NADP
+
 
occurring in cells, which is why we describe this cascade as biomimetic. We have identified 
three BVMO enzymes able to work in that cascade, Cyclohexanone monooxygenase CHMO, 
the one originally planned for this cascade, Phenylacetone monooxygenase PAMO, and a 
fusion enzyme CRE2-PAMO that itself can regenerate NADP
+
 to NADPH via the attached 
phosphate dehydrogenase CRE2. Furthermore, this cascade meets the needed requirement of 
producing a dye as final product, and was never conducted so far in polymersome 
nanoreactors. 
 
 
 
 
 
 
 
Figure 2. Scheme of enzymatic cascade 
 
The final aim of this work was to make this cascade react inside multicompartmentalized 
polymersomes. If the eukaryotic cell exhibits such multicompartmentalized reactions, it is 
because such a structure offers much more powerful possibilities than a prokaryotic, single 
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compartmentalized structure. In chapters 2 and 3
1,2
, we emphasize about one of the great 
properties arising from the multicompartmentalization of actives, i.e. a better protection than 
if they are loaded into a single compartment only. This should remain true for the powerful 
and sensitive catalysts that enzymes are. Furthemore, one can, as we planned to in this 
project, segregate various enzymes into various populations of internal compartments, to 
conduct cascade or incompatible reactions in them. Such work may bring a better 
comprehension of the eukaryotic cell; indeed the enzymes are here also confined in inner 
compartments, the structure mimics the eukaryotic multicompartmentalized structure, and a 
crowded environment or cytoplasm mimic can also be added for even more accurate 
biomimicry. From a concrete point of view, we foresee two major long-term applications. The 
first consists in miniaturized reactors for biotechnology. The advantage lies in reduction of 
sample consumption, which may be expensive or polluting, at the same time, the 
multicompartmentalized cascade reaction should be more efficient than if the various internal 
compartments were not enclosed as well in another compartment as they are thus close to one 
another, encapsulated side by side. We also see interesting properties arising in the field of 
drug delivery as some of the few reports published so far on such work, and that have been 
described in the introduction, highlight.  
 
In this work, each enzyme is loaded into PS-b-PIAT polymersomes, yielding 3 different PS-b-
PIAT populations. As previously mentioned, PS-b-PIAT nanoreactors present an intrinsically 
porous nature, enabling substrate and products but not enzymes, to diffuse through them. The 
idea is then to mix these populations together in optimized volume ratios, add everything else 
needed for the reaction, substrate, cofactor, etc, and load this solution into PB-b-PEO 
micrometric polymersomes with the emulsion-centrifugation method as previously described 
(Chapters 2 and 3).
2
 The substrate can be photocaged so that the enzymatic cascade can be 
initiated on demand once the sample is under a confocal microscope, by decaging with a 405 
nm laser (FRAPPA mode). Then, the reaction kinetic should be followed by measuring the 
increase of fluorescence appearing either homogenously in the micrometric PB-b-PEO vesicle 
or first localized in the nanosize PS-b-PIAT polymersomes loaded with ADH, before 
diffusion in the lumen of the outer vesicle (see Figure 3). As a preliminary experiment, the 
free cascade reaction was tested in order to check if we could detect red fluorescence kinetics 
with a microplate reader. 
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Figure 3. Scheme of multicompartmentalized enzymatic cascade 
 
 
When we speak of kinetics throughout this chapter, it is as chemists, thus we mean the 
formation of product (dye), meaning the conversion versus time. However in biology or 
enzymology more particularly, a kinetic plot of an enzymatic reaction is in fact the rate of 
reaction versus the substrate concentration, allowing the extrapolation of various important 
kinetic parameters depending on the model of plot (Km and Kcat in the Michaelis-Menten 
representation for example). Thus we ask readers for clemency as we talk about enzymatic 
reactions throughout this chapter, yet discuss them as classic chemical reactions. 
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Here, one can visualize what we call an “optimal kinetics plot”, as well as the two parameters 
that we needed to improve to prove our final concept: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 : Example of our goal, of what we call an optimized plot. Here absorbance, and not fluorescence, with 
time. From the following web page: 
http://frontal.univ-angers.fr/unspf/2010_Nancy_Galteau_Enzymes/res/Sans%252520nom%25252071.png&w=5
74&h=419&ei=UYNyUOyKKIyDhQfNsYGYDw&zoom=1&iact=hc&vpx=1134&vpy=306&dur=275&hovh=1
92&hovw=263&tx=175&ty=113&sig=104352963191211969135&page=1&tbnh=142&tbnw=185&start=0&nds
p=24&ved=1t:429,r:11,s:0,i:102 
 
Considering the final goal of our physical-chemical project (monitor the kinetics of an 
enzymatic cascade reaction in polymersomes in a polymersome), we needed indeed the fastest 
possible reaction (to detect fluorescence early, as soon as possible), the fastest rate, which is 
represented by the slope parameter. The steeper the slope (the closer to one), the better. This 
is a truly kinetic parameter. The faster the reaction, the sooner the “plateau” is reached; the 
plateau is the timepoint after which conversion is maximal, nothing happens any more, thus 
intensity remains constant. We needed also this plateau to reach the highest possible, most 
intense fluorescence (for optimal and early detection, and/or detection at all). This is a 
thermodynamic parameter, representing the efficiency of the various enzymes involved.  
 
Interestingly, in the free cascade CHMO the BVMO enzyme originally planned gave a very 
steep slope but leveled off very early (i.e. reached its “plateau” at a very low intensity), with 
disappointingly low fluorescence intensity, while wild-type PAMO (stored in the freezer as a 
solution for over a year) gave a less steep curve but with much higher final intensity.  
After one night, the fluorescence intensity induced by the PAMO cascade did not reach a 
plateau yet, indicating good potential as the kinetics did not present optimized behavior. After 
this qualitative proof of concept attesting that the enzymatic cascade was feasible, we decided 
This slope represents the rate, the kinetics of the enzymatic 
cascade. Needs to be steepest possible (approach as close 
as possible 1) for the fastest reaction. 
Plateau. Needs to be at the highest 
possible fluorescence intensity. 
Efficiency of enzymatic cascade. 
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to pursue directly to the nanoreactors as the behavior of enzymes strongly depends from the 
nanoprecipitation process used to load them. In addition, there are some diffusion limitations 
of substrates and products when polymersome membranes are involved, even though they are 
intrinsically porous. 
 
However as a first step, and before testing a fully loaded cascade, we performed two 
experiments where the “new” enzymes (never loaded and studied for application in 
nanoreactors in the van Hest group so far) were checked for loading in PS-b-PIAT 
polymersomes: 
- ADH was loaded with the other two kept free in solution, 
- CHMO or PAMO were loaded with the other two in solution. 
It was encouraging to see we could still detect a kinetic, so it seemed possible to load these 
never tested enzymes in PS-b-PIAT nanoreactors. Interestingly however, results were intense 
and steep for the ADH-loaded cascade (others kept free) whereas they were much lower for 
the BVMO’s, indicating already that nanoprecipitation process was possibly damaging them 
and the first BVMO step would probably be problematic, for sure the limiting step. Table 2 
summarizes the various conditions used for the loading of these “new” enzymes in PS-b-
PIAT, the enzymatic activity tests as well as the preservation of vesicular structure, as 
determined by TEM and DLS analysis. Interestingly, THF was the best solvent for all the 
enzymes tested and chosen as optimal solvent for the following experiments.  
 
Table 2. Various enzymes tested for use in PS-PIAT nanoreactors 
Enzyme 
Solvent 
CHMO PAMO CRE2-
PAMO 
ADH 
THF S 
E 
S 
E 
S 
E 
S 
E 
DMF  
 
S 
E 
 
 
 
 
Dioxane  
E 
 
E 
 
E 
 
 
90/10 vol.% 
Dioxane/ 
DMSO 
 
E 
 
E 
 
 
 
E 
S means structure acceptable by DLS and TEM 
E means enzymatic activity acceptable by fluorimetry measurements 
Highlighted cell means best system 
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Some of these enzymes were also tested for encapsulation efficiencies inside PS-PIAT 
vesicles by ICP-MS measurements and Ru-labelling of enzymes (table 3). Results for ADH 
and the already often loaded CalB in the van Hest group are consistent with the approximately 
20% efficiency always reported by this group. Interestingly, CRE2-PAMO however, presents 
a much lower efficiency of 7 %, which also helps understand the deceiving results observed 
with CRE2-PAMO in the following chapter, especially if on top of that, this enzyme is more 
sensitive to organic solvents than ADH and CalB. 
 
Table 3. Encapsulation efficiencies 
Enzyme  CRE2-
PAMO 
ADH CalB  
Encapsulation 
efficiency 
7±0.35% 24±0.6% 21±0.14% 
Error represents the standard error σ/√n, where n represents the number of estimations, 4. 
 
The repeatability of the nanoprecipitation process was then tested by DLS measurements, 
especially for the optimal THF conditions (Table 4).  
 
Table 4. DLS of all enzymes tested for use in PS-PIAT nanoreactors 
Enzyme 
Solvent 
CHMO PAMO CRE2-
PAMO 
ADH CalB 
THF 200±12.6 
208±12.3 
0.09±0.01 
n=3 
172±5.4 
192±18 
0.13±0.03 
n=2 
176±7.9 
211±17.2 
0.15±0.01 
n=6 
217±9.5 
248±12 
0.17±0.01 
n=8 
196±7 
205±9.4 
0.12±0.01 
n=8 
DMF  140±3.3 
146±4.3 
0.09±0.01 
n=3 
   
Dioxane 187 
214 
0.16 
124 
538 
0.16 
131±0.08 
155±1.3 
0.17±0.01 
n=2 
  
90vol.% 
Dioxane/ 
DMSO 
219 
223 
0.21 
149 
148 
0.13 
 877 
1093 
0.27 
 
1st line is size by Cumulants algorithm, 2nd by Contin,, 3rd is PDI, 4th is the number of samples measured. Each value, error 
represents the standard error σ/√n, where n represents the numbers of measured samples. 
 
Chapter 4. Enzymatic cascade reactions confined in Polymersomes in a Polymersome 
 
 
 
130 
From both the average size measurement and polydispersity index (PDI), we can see that this 
reproducibility (for THF) is relatively acceptable as it is below 0.2. The best results are 
obtained for CHMO, the worst for ADH, which is also by very far the largest enzyme with a 
molecular weight of approximately 150,000 g/mol (CalB is at 60,000, CRE2-PAMO at 
100,000, PAMO at 65,000, and CHMO at 60,000 g/mol). Sizes are also acceptable for 
nanosize polymersomes, especially loaded with such large components.  
Regarding the optimization of the nanoreactor cascade, the primary step lies in the 
determination of the optimal ratios of the different polymersomes that together will give the 
best kinetic parameters. This was performed first with the BVMO’s CHMO and wild-type 
PAMO, as we had initially no CRE2-PAMO. The set of experimental conditions tested first is 
summarized in table 5. Tables 5, 6, 7 are merely here to explain the rationale when addressing 
such Research, thus not detailed; indeed the BVMO enzymes used here are different from the 
CRE2-PAMO of the final system, and furthermore the substrate was not completely purified 
for these preliminary experiments. In sections 3.2 and 3.3, all experimental conditions and 
results will however be thoroughly presented. 
Moreover, we chose to experimental conditions in terms of volume ratios of PS-b-PIAT 
suspensions, as we prepare these suspensions always in the same reproducible way. The 
parameter that is clearly varied throughout the experiment and is palpable, is the volume of 
respective polymersome suspensions. Of course, there are only mathematic operations 
separating those volumes from the final enzyme concentrations in the solution. We indicate 
respective enzyme concentrations for the final concentration ratios in Tables 9 section 3.2 and 
24 section 3.3. 
 
Table 5. First set of optimization of volume ratios for the three enzyme loaded PS-b-PIAT 
polymersomes 
BVMO CalB ADH  
10 10 10 
10 10 1 
1 10 10 
10 1 10 
 
The experiment that led to the most drastic decrease in reaction kinetics gives the indication 
about the rate-limiting enzyme. Then it is possible to tune more finely the other ones. In our 
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case, BVMO’s were limiting so the next step was to perform experiments with increased 
loading of BVMO as described in Table 5. 
 
Table 6. Second set of optimization of volume ratios 
BVMO CalB ADH 
10 1 1 
20 1 1 
10 5 1 
10 1 5 
20 5 1 
20 1 5 
Here, we saw that the volume of ADH could not be higher than the one of CalB, certainly 
because ADH also converts the starting substrate into an alcohol by using NADPH. As a 
result, in order to prevent this side-reaction and because ADH did not look rate limiting, we 
decided to limit the amount of ADH.  
 
Finally, a third set of optimizations was performed as depicted in Table 7. 
 
 Table 7. Third set of optimization of volume ratios 
BVMO CalB ADH 
20 1 1 
50 1 1 
50 1 0.5 
 
The best result was reached with 50:1:0.5 but we stopped the optimization of these ratios 
there because we could not add more BVMO polymersome volume without exceeding the 
final volume of 200 µL decided for our experiment. We did not want to increase that final 
volume as we did not want to consume every polymersome sample (2 mL) just with one or 
two assays. Indeed, even at such ratios, BVMO was still the limiting enzyme apparently, 
perhaps because it gets too degraded during polymersome formation, in presence of organic 
solvent. Also, and for sure, because its encapsulation efficiency is three-times lower than for 
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CalB and ADH (7% for CRE2-PAMO). Results were also disappointing in terms of final 
fluorescence intensity, which was not detectable by confocal microscopy. 
 
These three tables are given to explain the ratios used in the following section with the final 
BVMO, CRE2-PAMO, they explain the rationale when addressing such a work. However 
they are only preliminary experiments and we will detail every experiment and parameter in 
the two following sections. 
 
CRE2-PAMO, an engineered PAMO was shown to be more resistant to solvents, more robust, 
and already tested in PS-PIAT nanoreactors
30
. As a result, we used the conclusions drawn so 
far with the other BVMO’s with the hope to get much better results with CRE2-PAMO and 
finally be able to continue with the last step of the project. 
3.2 Optimization of cascade in PS-PIAT nanoreactors with CRE2-PAMO as BVMO 
However, CRE2-PAMO turned out to not generate much better results than the other two 
BVMO’s, which is why we cannot really present the optimized protocol or some assays 
grouped together. We expected the optimization of the cascade to be much faster; it should 
have represented basically the discovery of optimal respective volume ratios. But in our case, 
BVMO’s really seemed problematic, and above all our enzymatic cascade relies upon two 
cofactors which appeared to complicate everything; thus this involved a lot of experiments to 
reach an optimized system. Above all, the ultimate goal of this project was not to get a 
kinetics plot of the nanoreactor cascade by fluorimetry measurements.  We needed a high 
enough concentration for detection of the multicompartmentalized cascade by confocal 
microscopy, the microplate reader apparently and surprisingly being much more sensitive. 
Considering our ultimate project, we decided to follow a pragmatic approach, by optimizing 
the nanoreactor cascade empirically, using each overnight experiment as input for the 
following set of assays. This work will be detailed in this section. 
3.2.1.First set of enzymatic assays 
This experiment had two main goals:  
 determine whether THF or dioxane was a better nanoprecipitation solvent to load 
CRE2-PAMO. 
 for each solvent condition, test which buffer (Tris/HCl pH 7.5 or Phosphate buffer 
pH 7.6 or 8.5) was optimal. Enzymes are indeed very sensitive to such kind of 
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experimental conditions (buffer, pH of buffer, solvent). Resorufin also needs a 
slightly basic pH (7.5-7.6) for maximal fluorescence . 
 
After each recovery of polymersomes after dialysis, we always checked the actual pH which 
can drift sometimes when diluting concentrated stock solutions of buffers for examples. So 
here, we actually had  Tris pH 7.6 vs Phosphate pH 7.7 vs Phosphate pH 8.7. 
Constant parameters of experiments can be found in Table 8. 
 
 Table 8. Experimental conditions for section 3.2.1 
Conditions CRE2-
PAMO 
CalB 
Vol. 
ratio 
ADH [NADPH] Estimated 
[BVMO] 
[NADPH] 
/[BVMO] 
[substrate] [NADPH] 
/[sub] 
Total 
volume 
1 20 1 0.5 64 µM 0.06 µM* 1,067 3 µM 21 200 µL 
*assuming a 7% encapsulation efficiency and 100 kDa Molecular weight for CRE2-PAMO 
  
Regardless of the nanoprecipitation solvent (THF or dioxane), at pH 8.7 phosphate buffer, no 
enzymatic activity could be detected. By comparing assays performed under exact same 
conditions, activity seems better for polymersomes formed with THF than dioxane. In 
addition, the polymersome morphology is less well-defined when they are formed in dioxane 
(see Table 2). Thus, from then on, we again kept THF as nanoprecipitation solvent. However, 
we could not clearly conclude yet whether Tris pH 7.6 or Phosphate pH 7.7 was best in terms 
of enzymatic activity. We also only used a volume ratio of 20 for CRE2-PAMO to confirm 
already the previous conclusions with the other BVMO’s were transferable to this one, 
without wasting too much enzyme.  
3.2.2. Second set of enzymatic assays 
The aim of this second set of experiments was to definitely determine which buffer between 
Tris/HCl and Phosphate was the best to preserve the highest possible activity. Based on 
previous results, only high volume ratios of CRE2-PAMO of 50 were tested. Estimated 
enzyme concentrations for conditions 50:1:0.5 CRE2-PAMO:CalB:ADH can be found in 
table 9. 
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Table 9. Concentrations of CRE2-PAMO, CalB and ADH in enzymatic cascade for  most 
common 50:1:0.5volume  ratios of PS-b-PIAT polymersomes in section 3.2. 
 Mass used in 
nano-
precipitation 
Mass 
actually 
loaded 
[ ] if final 
polymersome 
volume=2mL 
 
Molecular 
weight 
g/mol 
Volume of 
polymersomes 
in 200µL 
assay 
[ ] in µM in 
enzymatic assay 
[CRE2-
PAMO]/ 
[enzyme] 
CRE2-
PAMO 
7% 
0.5 mg 0.035 mg 0.0175 100,000 150 0.13  
Cal B 
21% 
0.5 mg 0.105 mg 0.0525 g/L 60,000 3 µL 0.013 10 
ADH 
24%* 
0.5 mg 0.12 mg 0.06 mg/mL 150,000 1.5 µL 0.003 44 
 
We also increased the NADPH concentration compared to previous experiments.  
Constant experimental parameters can be found in Table 10. 
 
Table 10. Experimental conditions for section 3.2.2. 
Conditions CRE2-
PAMO 
CalB 
Vol. 
ratio 
ADH [NADPH] 
mM 
Estimated 
[BVMO] 
[NADPH] 
/[BVMO] 
[substrate] [NADPH] 
/[sub] 
Total 
volume 
2 50 1 0.5 0.53  0.15 µM*  3,533 3 µM 177 200 µL 
*assuming a 7% encapsulation efficiency and 100 kDa Molecular weight for CRE2-PAMO 
 
Experimental curves presenting the fluorescence intensity measured by the microplate reader 
as function of time can be seen in Figure 5. Each enzymatic assay of 200 µL is always divided 
in three wells (60 µL) to have triplicates as errors induced by pipetting variations easily 
happen. Presence of CRE2-PAMO also tends to produce foam, thus inducing errors by 
inducing height of total volume variations in wells. We decided to trust the result only when 
at least two kinetics are identical. Results are then plotted as an average of two or three 
identical kinetics with error bars representing standard error (i.e. standard deviation divided 
by the square root of the number of measurements, 2 or 3). For each set, we also monitor a 
blank, i.e. autohydrolysis of the substrate in buffer. To judge results, intensity of plateau is 
compared to intensity of the blank, to know the signal to noise ratio. Although each kind of 
intensity is relative to conditions, the difference between both is indeed absolute. 
From these data, one can conclude that with same parameters (table 9), we have better results 
with Tris/HCl pH 7.6 than with Phosphate pH 7.7.  
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Figure 5.  Fluorescence intensity with time, corresponding to conditions in table 10. 
 Experiments performed in triplicate, sometimes only in duplicate if one is not coherent. Error bars represent 
standard error,           , standard deviation divided by the square root of measurements, 2 or 3. 
3.2.3. Third set of enzymatic assays 
This set of experiments had four main goals:  
 Increase substrate concentration to get an increase in fluorescence intensity. 
 Optimize further CalB concentration by fine-tuning its optimal volume ratio. 
 Find out whether concentrating CRE2-PAMO polymersomes helps. 
 Investigate more the influence of NADPH concentration. 
 
3.2.3.a. Until now we were indeed careful not to waste substrate, using a very small substrate 
concentration of 3 µM which was enough to detect a kinetic with the microplate reader. 
However, to make sure that adding substrate helps and having previously assessed with the 
other BVMO’s the NADPH concentration needs to increase accordingly with substrate to 
improve the kinetic, we performed the experiments summarized in Table 11. 
 
Table 11. Experimental conditions section 3.2.3. 
Conditions CRE2-
PAMO 
CalB 
Vol. 
ratio 
ADH [NADPH] 
mM 
Estimated 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
 
[NADPH] 
/[sub] 
Total 
volume 
µL 
4 50 1 0.5 8.950  0.15* 59,667 50 172 200  
5 50 1 0.5 0.53  0.15* 3,533 3  177 200  
*assuming a 7% encapsulation efficiency and 100 kDa Molecular weight for CRE2-PAMO 
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In figure 6, we can indeed observe an increase in plateau intensity which was nearly 3-fold 
(always compared to its own blank, otherwise the global intensity is 4 times higher), and of 
course the slope much steeper as a result. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Fluorescence intensity with time, corresponding to conditions in table 11. 
3.2.3.b. Using still the usual 3 µM concentration for substrate, we optimized further the CalB 
and CRE2-PAMO volume ratios (see Table 12).  
 
Table 12. Experimental conditions section 3.2.3 
*assuming a 7% encapsulation efficiency and 100 kDa Molecular weight for CRE2-PAMO 
 
 
 
 
 
 
 
 
Conditions CRE2-
PAMO 
CalB 
Vol. 
ratio 
ADH [NADPH] 
mM 
Estimated 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
[NADPH] 
/[sub] 
Total 
volume 
µL 
5 50 1 0.5 0.53 0.15* 3,533 3  177 200  
6 50 5 0.5 0.53 0.15* 3,533 3  177 200  
7 50 10 0.5 0.53 0.15* 3,533 3  177 200  
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Figure 7. Fluorescence intensity with time, corresponding to conditions in table 12. 
 
By using 5 (Serie 6) or 10 (Serie 7) instead of 1 (Serie 5) as CalB volume ratio, not only was 
there no improvement/increase in plateau intensity (Figure 7), but it actually decreased very 
slightly. As a result, on can definitely conclude that the ratio 1 CalB : 0.5 ADH is optimal, at 
least in this cascade.  
For practical reasons we also tried a scenario where instead of filling up to 200 µL with buffer 
as usual, we used CRE2-PAMO loaded polymersomes instead (Series 5 and 8). Result (64 
CRE2-PAMO volume ratio) is the same or maybe very slightly above for the one for 50, but 
again as NADPH concentration changes as well, it is more difficult to draw conclusions.  
 
Table 13. Experimental conditions section 3.2.3 
Conditions CRE2-
PAMO 
CalB 
Vol. 
ratio 
ADH [NADPH] 
mM 
Estimated 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
[NADPH] 
/[sub] 
Total 
volume 
µL 
5 50 1 0.5 0.53  0.15* 3,533 3  177 200 
8 64 1 0.5 0.68 0.19  *  3,579 3  226 200 
* assuming a 7% encapsulation efficiency and 100 kDa molecular weight for CRE2-PAMO 
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Figure 8. Fluorescence intensity with time, corresponding to conditions in table 13. 
 
By using a CRE2-PAMO polymersome suspension that is twice as concentrated as usual 
because the final volume after dialysis is 1 and not 2 mL, the results are slightly improved in 
terms of plateau intensity and slope steepness (Series 5 vs. 9, 6 vs. 10 Figure 9) as NADPH is 
increased accordingly. Results are however not drastically increased, not twice for example, 
as would be expected for a double amount of polymersomes. 
 
Table 14. Experimental conditions section 3.2.3 
Conditions CRE2-
PAMO 
CalB 
Vol. 
ratio 
ADH [NADPH] 
mM 
Estimated 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
[NADPH] 
/[sub] 
Total 
volume 
µL 
5 50 1 0.5 0.53 0.15* 3,533 3 177 200  
9 50 1 0.5   1.06 0.3 * 3,533 3 353 200  
6 50 5 0.5 0.53 0.15* 3,533 3 177 200 
10 50 5 0.5 1.06 0.3 * 3,533 3 353 200  
*assuming a 7% encapsulation efficiency and 100 kDa Molecular weight for CRE2-PAMO 
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Figure 9. Fluorescence intensity with time, corresponding to conditions in table 14. 
 
Finally the most important parameter definitely seems to be NADPH as by increasing 5 times 
its concentration (see Table 15), the plateau is nearly twice (1.6) more intense (see Figure 14, 
serie 11 vs.6).  
 
Table 15. Experimental conditions section 3.2.3 
Conditions CRE2-
PAMO 
CalB 
Vol. 
ratio 
ADH [NADPH] 
mM 
Estimated 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
[NADPH] 
/[sub] 
Total 
volum 
µL 
6 50 5 0.5 0.53 0.15* 3,533 3 177 200  
11 50 5 0.5 2.65 0.3* 8,833 3 883 200  
*assuming a 7% encapsulation efficiency and 100 kDa Molecular weight for CRE2-PAMO 
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Figure 10. Fluorescence intensity with time, corresponding to conditions in table 15. 
 
3.2.4. Fourth set of enzymatic assays 
This experiment had one main goal:  
 Investigate further influence of NADPH concentration. 
 
To keep again the experiment more practical, we chose not to add any buffer, and use about 
62  CRE2-PAMO instead of 50. At the same BVMO concentration (≈ 0.185 mM), adding 
only 3.350 mM NADPH instead of 8.888 mM provokes a decrease of 25% in plateau 
intensity (Table 16). Such a concentration of 8.888 mM presents however the problem to 
involve a lot of expensive NADPH, which is far from ideal. 
 
Table 16. Experimental conditions section 3.2.4 
Conditions CRE2-
PAMO 
CalB 
Vol. 
ratio 
ADH [NADPH] 
mM 
Estimated 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
[NADPH] 
/[sub] 
Total 
volume 
µL 
12 62 1 0.5 3.350  0.185 * 18,108 3 1,117 200 
13 62 1 0.5 8.888  0.185 *  48,043 3 2,963 200 
*assuming a 7% encapsulation efficiency and 100 kDa Molecular weight for CRE2-PAMO 
 
Finally we investigated a two-fold increase of the concentration of a CRE2-PAMO loaded 
polymersome suspension, this time by keeping the same NADPH concentrations and NADPH 
to substrate ratio. The only varying parameter is the NADPH to CRE2-PAMO ratio that is 
twice smaller for the twice more concentrated suspension (table 17). Interestingly, the plot of 
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the less concentrated one was approximately the same as the more concentrated, maybe 
highlighting the NADPH to substrate ratio is far more important than the one to BVMO 
contrary to what was expected from previous experiments. It shows that for these conditions, 
it makes no point to increase beyond the value of 24,022 as NADPH to CRE2-PAMO ratio. 
It is however to note that both suspensions came from different polymersome batches; for a 
better comparison, both suspensions should have been obtained from the same polymersome 
batch although the various polymersomes batches seemed reproducible so far (see Tables 
3&4). 
 
Table 17. Experimental conditions section 3.2.4 
Conditions CRE2-
PAMO 
CalB 
Vol. 
ratio 
ADH [NADPH] 
mM 
Estimated 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
[NADPH] 
/[sub] 
Total 
volume 
µL 
13 62 1 0.5 8.888 0. 185  * 48,043 50 177 200  
14 62 1 0.5 8.888 0.37 * 24,022 50  177 200  
*assuming a 7% encapsulation efficiency and 100 kDa Molecular weight for CRE2-PAMO 
 
To conclude NADPH seems key again, which is surprising as it is only a cofactor, that should 
be regenerated by the ADH reaction, and thus should not play such an important part once the 
cascade functions. 
3.2.5. Fifth set of enzymatic assays 
This experiment had two main goals:  
 Increase substrate concentration to get an increase in fluorescence intensity. 
 Investigate in more detail the influence of NADPH concentration with higher 
substrate concentration. 
As a last chance to finally get a drastic and needed increase in intensity, we increased the 
substrate to the highest volume which seemed acceptable to us as a DSMO/water percentage, 
6.8 µL/193.2 µL. By comparing with the same conditions at the usual 3 µM substrate (see 
table 18), plateau intensity is 4.5-times higher (in terms of fluorescence intensity, 3.5 when 
substracting the intensity of respective blanks to each of them to get the absolute intensity 
increase), and much steeper (series 15 vs. 5 Figure 11). By trying to keep the same molar 
NADPH to substrate ratio of 177, the concentration of NADPH is however much increased, 
from 0.53 mM to 17.474 mM NADPH, which seems barely acceptable.  
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Table 18. Experimental conditions section 3.2.5 
Conditions CRE2-
PAMO 
CalB 
Vol. 
ratio 
ADH [NADPH] 
mM 
Estimated 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
[NADPH] 
/[sub] 
Total 
volume 
µL 
5 50 1 0.5 0.53 0.15 * 3,533 3  177 200 
15 50 1 0.5 17.475 0.15 * 116,500 102  172 200 
*assuming a 7% encapsulation efficiency and 100 kDa Molecular weight for CRE2-PAMO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Fluorescence intensity with time, corresponding to conditions in table 18. 
  
We also tried to investigate a little more the NADPH influence with a higher substrate 
concentration of 30 µM substrate, 10 times the usual amount, as it had become obvious we 
would have to work with a high substrate concentration for the microscopy monitoring (Table 
19). Of course, results are better for 30 µM (Series 16 and 17) than for 3 µM substrate (Serie 
5), but not 10 times higher. By keeping NADPH/substrate to 177, we get an approximately 
2.5-fold increase in plateau intensity (after respective blank substraction, 3-fold in absolute 
terms) (Figure 12). With 30 µM, final intensity was actually at 13000 RFU for the 5.25 mM 
NADPH and only at 9000 for 26.25 mM NADPH, showing with these conditions, we 
overcame the limit where adding more NADPH becomes inhibitory instead of beneficial.  
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Table 19. Experimental conditions section 3.2.5 
Conditions CRE2-
PAMO 
CalB 
Vol. 
ratio 
ADH [NADPH] 
µM 
Estimated 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
[NADPH] 
/[sub] 
Total 
volume 
µL 
5 50 1 0.5 0.53 0.15 * 3,533 3  177 200  
16 50 1 0.5 5.25 0.15 * 35,000 30  175 200  
17 50 1 0.5 26.25 0.15 * 175,000 30  875 200  
*assuming a 7% encapsulation efficiency and 100 kDa Molecular weight for CRE2-PAMO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Fluorescence intensity with time, corresponding to conditions in table 19. 
 
Still, even such a high signal was not high enough to be detected by spinning disk confocal 
microscopy once loaded in giant PB-b-PEO. In order to determine which signal could be 
expected first, two reference experiments were performed. A solution of 24 µM Resorufin in 
Milli Q water loaded in giant PB-b-PEO vesicles enabled to see those vesicles with a red 
fluorescent cavity. Such a 24 µM solution was saturating (i.e. above 60,000 units of 
fluorescence) in the microplate reader at a gain of 100. We had also loaded an assay based 
upon CalB and the substrate carboxyfluorescein diacetate (CFDA). After letting the cascade 
react one night (i.e. at maximal conversion), then loading it in PB-b-PEO polymersomes, the 
vesicles were perfectly visible with green fluorescence this time, by epifluorescence, spinning 
disk confocal, and laser scanning confocal microscopy in Bordeaux. We performed this assay 
in the microplate reader and it went up to 50,000 RFU with a 100 microplate reader PMT 
gain. However in all section 3.2, we were forced to set a gain of 150 as intensities were too 
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low to visualize efficiently the kinetic with the lower gain of 100. We were clearly not 
reaching such fluorescence intensities even with this much higher gain. 
It is indeed crucial to check if the cascade at maximal conversion (which is the case for the 
assay solution, after one night reaction in the microplate reader) can be detected in giant PB-
b-PEO under a confocal microscope. If even then it cannot be detected, there is no hope of 
monitoring a kinetics plot, with points underneath this maximum, and it means we have to 
optimize further. 
3.3. Optimization of cascade in PS-PIAT nanoreactors with free CRE2-PAMO 
Obviously, the problem came from the BVMO enzymes, which were apparently not loaded 
with a sufficient bioactivity remaining. A solution to overcome this hurdle was to keep the 
CRE2-PAMO free in solution while the other ones, CalB, and ADH, were still encapsulated. 
From then on, we were able to use a microplate reader gain of 100 again, instead of the 150 
for section 3.2, which demonstrates the drastic improvement between these two sections. 
In the present section, the global volume per assay is as always 200 µL which is why we will 
not show it anymore. 
3.3.1. First set of enzymatic assays 
This experiment had several main goals:  
 Start afresh with a cascade where CRE2-PAMO was free, and optimize it, in terms 
of enzyme ratios, NADPH and substrate concentration. 
 Determine whether in that case wild-type PAMO or fusion PAMO (CRE2-PAMO) 
was more efficient. 
 
Experimental conditions can be found in Table 20: 
 
 
 
 
 
 
 
 
 
Chapter 4. Enzymatic cascade reactions confined in Polymersomes in a Polymersome 
 
 
 
145 
Table 20. Experimental conditions section 3.3.1 
Conditions BVMO BVMO 
µL 
CalB 
µL 
ADH 
µL 
[NADPH] 
mM 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
[NADPH] 
/[sub] 
19 CRE2-
PAMO 
55.17 70 35 0.2 4 50 3  67 
20 PAMO 62.02 70 35 0.2 4 50 3 67 
21 CRE2-
PAMO 
55.17 70 35 1.5 4 375 3 500 
22 PAMO 62.02 70 35 1.5 4 375 3 500 
23 CRE2-
PAMO 
55.17 70 35 2 40 50 3 667 
24 CRE2-
PAMO 
55.17 70 35 15 40 375 3 5000 
25 CRE2-
PAMO 
55.17 70 35 0.2 4 50 45 4 
26 CRE2-
PAMO 
55.17 70 35 1.5 4 375 45 33 
27 CRE2-
PAMO 
55.17 70 70 0.2 4 50 3 67 
28 CRE2-
PAMO 
55.17 70 70 1.5 4 375 3 500 
*with 100 kDa Molecular weight for CRE2-PAMO 
 
We kept the same volume ratios of CalB and ADH 1:0.5 and started with a reference 
concentration of BVMO, 4 µM
30
. First, we checked by comparing identical conditions, that 
CRE2-PAMO gave better results than wild-type PAMO (experiments 19 vs 20, 21 vs 22, see 
Figure 13). By multiplying the reference of 4 µM by ten, we finally obtained a 30-fold drastic 
increase in intensity. Interestingly, after a whole night Plateau was not reached yet for any 
assay, contrary to before (23 vs 25, 24 vs 26, see Figure 14). By comparing experiments 23 
and 24, an increase in lag time duration becomes obvious with an increase in NADPH 
concentration. However, these concentrations of 40 µM CRE2-PAMO were tested on our 
very low and usual concentration of 3 µM substrate, where the enzyme cannot be considered 
as a catalyst any more…Nevertheless, we can see with the 4 µM assays that CRE2-PAMO is 
still the limiting step (no plateau’s). This and the results of the 40 µM BVMO experiments 
indicate we need to test 40 µM (or more) with appropriate higher substrate concentrations and 
we should be able to extrapolate the conclusions of the 4 µM assays for that. 50 NADPH to 
BVMO was the ratio employed by Silvie Meuwissen
30
 and when we based calculations on a 
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20% encapsulation efficiency of CRE2-PAMO (instead of the real, measured at 7%), our 
classic ratio was 375. 
 
 
Figure 12. Fluorescence intensity with time 
corresponding to conditions in table 20. 
Figure 13. Zoom in Fluorescence intensity  
corresponding to conditions ion  table 20. 
 
For every 4 µM assay, a ratio of 375 NADPH to BVMO instead of 50 (ratio to substrate of 
500 vs. 67 for 3 µM) is beneficial (28 vs 27, 22 vs. 20, 21 vs. 19). Of course, again we also 
believe the ratio of NADPH to substrate to have a certain relevance; unfortunately it cannot be 
kept constant in the same time as the NADPH to CRE2-PAMO, especially when we increase 
the substrate to 45 µM instead of the usual 3 µM. Then, the NADPH to substrate ratio is 
indeed only 33 vs. 4 for 45 µM when going from NADPH/BVMO=375 to 50. Experiments 26 
vs 25 make us conclude as before that a higher NADPH/BVMO of 375 is much preferable, at 
least at low CRE2-PAMO concentrations of 4, with the plot of 26 actually looking nearly as 
good in terms of final intensity as experiment 24 with 40 µM CRE2-PAMO.  Finally, we 
checked that by using twice more ADH (1:1 instead of 1:0.5), there was no change in results, 
meaning ADH is definitely not limiting and we can continue with these CalB:ADH volume 
ratios (experiments 27 vs. 19 with a decrease, 28 vs. 21 with no improvement) 
As a general conclusion from this set of experiment (especially, experiments 25 vs. 19, 26 vs. 
21), we conclude that in the next step we have to increase the CRE2-PAMO final 
concentration to at least 40 µM, highly increase substrate as well (even if it seems 
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problematic), and prefer a 375 NADPH ratio or above. We also need to keep using CRE2-
PAMO instead of wild-type PAMO and continue with CalB:ADH 1:0.5. 
3.3.2. Second set of enzymatic assays 
With this obvious need to increase substrate concentration, we tried to force a higher stock 
solution in DMSO than the one we had and which seemed the maximum possible (3, 
maximum 4 mM) by heating the solution at 50°C, and from then on, heating the stock 
solution before the assays every time up to 50°C until the moment of adding it. 
 
This experiment had several main goals:  
 Optimize the current cascade with higher substrate concentrations. 
 Optimize NADPH for these substrate concentrations. 
 Optimize volume ratios of CalB:ADH for this final system. 
 
Experimental conditions can be found in Table 21: 
 
Table 21. Experimental conditions section 3.3.2 
Conditions CRE2-
PAMO 
µL 
CalB 
µL 
ADH 
µL 
[NADPH] 
mM 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
[NADPH] 
/[sub] 
29 55.17 70 35 0.2 4 50 150 11/3≈3.67 
30 55.17 70 17.5 0.2 4 50 150 11/3≈3.67 
31 55.17 105 35 0.2 4 50 150 11/3≈3.67 
32 55.17 105 17.5 0.2 4 50 150 11/3≈3.67 
33 55.17 70 35 0.4 4 100 150 22/3≈7.34 
34 55.17 70 35 1.5 4 375 150 10 
35 55.17 70 35 0.2 4 50 300 2/3 
36 55.17 70 35 1.5 4 375 300 5 
*with 100 kDa Molecular weight for CRE2-PAMO 
 
With this now acceptable substrate concentration of 150 µM and a NADPH to BVMO ratio of 
50 to limit NADPH consumption (200 µM NADPH), we checked once more with this system 
that our 1:0.5 CalB :ADH ratio was optimal, as 1:0.25, 1.5:0.5 and 1.5:0.25 did not change 
anything (see Figures 14 and 15, experiments 29, 30, 31, 32). Then with this definite1y 
optimal 1:0.5 ratio and 150 µM substrate, we went from 50 (experiment 29) to 100 
NADPH/BVMO (experiment 33, 400 µM NADPH, 2 times faster than experiment 29) to 375 
(experiment 34, 1500 µM NADPH, 6.4 times faster than experiment 29). There is a huge 
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improvement in terms of slope steepness, thus final intensity. We did not correct for the blank 
by substracting its value to the assays, but NADPH 50 gives indeed about 25 RFU/h, 100 
about 50 RFU/min and 375 about 173 RFU/min. 
By increasing the substrate concentration even more, from 150 (experiment 34) to 300 µM 
(experiment 36), and keeping the same NADPH to BVMO of 375 (1500 µM), it is to note the 
plot is exactly the same. It may be because in these conditions, the enzyme is saturated and 
will not convert any more substrate molecules, or because while the NADPH/BVMO stays 
the same, when we have only 150 µM substrate we have twice more NADPH to substrate 
(ratio 10) than when we have at 300 µM (ratio 5). 
The most important conclusion from that set of experiments is that we were able to work with 
high enough, concentrations of substrate, even for 40 µM enzyme.  
 
 
Figure 14. Fluorescence intensity with time, 
corresponding to conditions in table 21. 
Figure 15. Zoom in Fluorescence intensity with time, 
corresponding to conditions in table 21. 
 
3.3.3.Third set of enzymatic assays 
This experiment had several main goals:  
 Optimize NADPH ratio for 40 µM CRE2-PAMO, for a given substrate 
concentration of 300 µM. 
 Investigate the optimal NAPH concentration (important for BVMO and substrate) 
with a lower and safer concentration of 4 µM CRE2-PAMO. 
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Experimental conditions can be found in Table 22: 
 
Table 22. Experimental conditions section 3.3.3 
Conditions CRE2-
PAMO 
µL 
CalB 
µL 
ADH 
µL 
[NADPH] 
mM 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
[NADPH] 
/[sub] 
37 55.17 70 35 0.04 4 10 150 0.25 
34 55.17 70 35 1.5 4 375 150 10 
38 55.17 70 35 2 4 500 150 13.3 
39 55.17 70 35 0.4 40 10 300 1.3 
40 55.17 70 35 2 40 50 300 6.7 
41 55.17 70 35 4 40 100 300 13.3 
*with 100 kDa Molecular weight for CRE2-PAMO 
 
The shape of the plot looks already much more optimized (steeper slope, not too long lag 
phases, etc) (experiments 40 and 41 Figure 16) even if we do not reach a plateau yet. We are 
indeed finally reaching the fluorescence intensities we know will be detected by confocal 
microscopy given our references, as we approach 50,000 RFU with a microplater reader gain 
of 100. 
  
Figure 16. Fluorescence intensity with time, 
corresponding to conditions in table 22. 
Figure 17. Zoom in Fluorescence intensity with time, 
corresponding to conditions in table 22. 
 
For 40µM CRE2-PAMO, we use 300 µM substrate (corresponding to 6 µL DMSO in 194 µL 
aqueous solution, i.e. 3 v. %) with as usual 1:0.5 CalB to ADH. Going from 
NADPH/BVMO= 10 (400µM NADPH, experiment 39) to 50 (2000 µM, experiment 40) to 
100 (4000 µM, experiment 41), the results are improved, impressively first with a 6.8-fold 
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increase in final intensity, then slightly (meaning that [NADPH] apparently becomes optimal 
for these conditions) with 1.2-fold increase from 50 to 100 (Figure 16).  NADPH/substrate 
accordingly goes from 1.3 to 6.7 to 13.3. In order to optimize a bit further without consuming 
too much enzyme and NADPH, we also investigated NADPH ratios again with 4 µM CRE2-
PAMO and 150 µM substrate (Figure 17). With a ratio of 10 (40 µM, experiment 37), no 
activity is detected, for 375 (1500 µM, experiment 34), it is exactly the same as for 500 (2000 
µM, experiment 38) at least for these conditions (NADPH/substrate=0.25, 10 and 13.3). This 
means in these conditions, going above 375 NADPH ratio is unnecessary and between 10 and 
375, 375 is optimal. 
 
As CRE2-PAMO still seemed the limiting step, the cascade was optimized a little further by 
Ruud Peters. 
One easy perspective to try out, was to increase CRE2-PAMO’s volume ratio until it is not 
limiting any more. Until now, for the best assay conditions, 20 µL of buffer were used to fill 
up to 200 µL. Instead of adding 55 µL of fusion-PAMO to reach 40 µM, adding 80 µL to 
reach 60 µM would mean it is not necessary to use some buffer any more to reach the 200 µL 
final volume of the assay. Furthermore pH 8.5 and 9 vs. pH 7.5 were previously checked, but 
they were too high for the enzymes. pH 8 however proved to be beneficial. Finally adding 
right away some NADP
+
 necessary for the last reaction of ADH, also seemed beneficial. 
It was assessed clearly that for 100 NADPH to CRE2-PAMO ratio, there was practically no 
lag phase whereas for 200, there was one but once the resorufin production started, it was 
twice faster and more intense than for the 100. So in theory for microscopy experiments, 100 
should be the ratio used when decaging and 200 when working with the non-caged substrate. 
The final conditions are visible in Table 23: 
 
Table 23. Experimental conditions section 3.3.3 
Conditions CRE2-
PAMO 
µM 
CalB 
µL 
ADH 
µL 
[NADPH] 
mM 
[NADP
+
] 
mM 
[BVMO] 
µM 
[NADPH] 
/[BVMO] 
[substrate] 
µM 
[NADPH] 
/[sub] 
42 60 70 35 12 1.2 60 200 300 40 
43 60 70 35 6 0.6 60 100 300 40 
*with 100 kDa Molecular weight for CRE2-PAMO 
 
Instead of Tris/HCl buffer at pH 7.5, the PS-PIAT suspensions were hence dialysed against 
pH 8 in the final protocol.  
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For the current best conditions in the final system, with 60 µM CRE2-PAMO, 35 µL  CalB 
polymersomes and 17.5 µL ADH, the estimated concentrations of CalB and ADH can be 
found in table 24, based on their respectively measured encapsulation efficiencies (EE). 
Ratios of CRE2-PAMO to these enzymes are also given. 
 
Table 24. Concentrations of CalB and ADH in enzymatic cascade 
 Mass used in 
nano-
precipitation 
Mass 
actually 
loaded  
[ ] if final 
polymersome 
volume=2mL 
 
Molecular 
weight 
g/mol 
Volume of 
polymersomes 
in 200µL 
assay 
[ ] in µM in 
enzymatic 
assay 
[60] µM CRE2-
PAMO/ 
[enzyme] µM 
Cal B 
21% 
0.5 mg 0.105 mg 0.0525 g/L 60,000 70 µL 0.30625 ≈196 
ADH 
24%* 
0.75 mg 0.18 mg 0.09 mg/mL 150,000 35 µL 0.105 ≈571 
*24% was assessed for nanoprecipitation of 0.5 mg of ADH. 
4. Microscopy of multicompartmentalized cascade. Proof of concept of 
cellular function in cellular structure mimic. 
The next step consists in assessing if our multicompartmentalized cascade can be detected by 
means of fluorescence via confocal microscopy. 
The final system is depicted by Figure 18:  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Final system 
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With the conditions as used for experiment 41, we had indeed been able to prove at least full, 
or advanced conversion by confocal microscopy on the multi-compartmentalized cascade in 
Nijmegen, which now made it interesting to try to acquire confocal kinetics.  
After this necessary optimization step of nanoreactors, our ultimate goal was to monitor a 
kinetic plot with a caged substrate, decaged under the microscope with a 405 nm laser, in 
order to control the initiation time of the reaction. However, if this shows to be 
tricky/impossible of if we want to get a feeling about how long it takes before the reaction can 
be detected, we can use what we call “the stopwatch method”. This method consists in (i) 
mixing all components of the cascade and start the stopwatch upon addition of the final 
component, i.e. the non-caged substrate, (ii) let the reaction proceed in a thermomixer™ at 
25°C, (iii) load this nanoreactor mixture at a controlled time point in PB-b-PEO and (iv) start 
monitoring by microscopy eventually which will not be time 0 but adjusted to the correct time 
point thanks to the running stopwatch. We chose to first work with the non-caged substrate, 
get a feeling of the experiment, the kinetics, and the set-up, and address the difficulty of 
decaging later with this knowledge acquired. 
 
In any case, regarding the chambers, and the imaging, one problem lies in the fact that the 
micrometric vesicles, suspended in water, are moving. The chambers we finally decided to 
use after multiple tests on various commercial or tailor-made chambers, were top chambers of 
hydrophobic plastic specially designed by Ibidi® for fluorescence microscopy. However, over 
a prolonged period of time, the vesicles move. This renders impossible imaging overnight for 
example (convenient for the monitoring of slow reactions!), and forced us to be able to 
constantly monitor the samples by transmission and replace them in the center of the frame, 
before each acquisition, during hours. Analysis treatments of movies then also have to be 
manual of course, making the experiment and the analysis time-consuming! 
 
 
 
 
 
 
 
 
 
Figure 19. Ibidi µslides VI
0.4
. 
 
The height of the “tunnels”, which is the section observed with the microscope, is 400 µm, so  
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far much than the PiPs, below 100 µm. We also tested chambers coated with polylysine 
(interacting with PEO), collagen and even their own mixture called IbiTreat™, but no 
improvement was noted, perhaps due to the fact that we have a compact outer layer of PEO. 
Vogel and coworkers
7
 immobilized their liposomes with anchors on coated slides via biotin-
neutravidin bonds. Bäumler et. al.
12
 used the IbiTreat coated µslides (another reference) but 
their systems are Lbl capsules with charged layers, different from our neutral vesicles, and 
able to interact electrostatistically with charged surfaces. 
With these chambers and constant replacing of giant vesicles in the middle of observation 
frame, we have been able to conduct some preliminary experiments with the following set-up 
(Figure 25): 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. Spinning-disk confocal microscopy set-up. 
 
Finally, One problem arising when working with microscopes in Nijmegen or Bordeaux, and 
enzymes, is that either the room is air-conditioned to 20°C or 21°C or/and the microscope is 
enveloped by an isotherm “box” controlled by a device heating at 37°C for biology 
experiments (see Figure 20). 37°C leads to an increase of the sample motion and some water 
evaporation during the timescale of the experiments. Moreover PB-b-PEO is rather permeable 
at such a temperature (see chapter 3). However these devices are unfortunately not able to 
cool and control another temperature than 37°C, which makes it difficult to adjust and control 
the “box” to the desired 25°C. As temperature and its slightest variations is a very important 
parameter for enzymatic reactions, we monitored for each experiment the temperature in the 
isotherm “box” via a probe, with the 37°C heating switched off; it was fortunately always 
about 25°C. 
 
First the cell mimic cascade was monitored by confocal microscopy, with the stopwatch 
method. After 7 hours and 26 minutes of reaction at approximately 25°C, we indeed already 
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observed a cascade activity (Figure 21 and 23) created with the experimental conditions 43 in 
Table 23 (NADPH/BVMO=100)! This was a very important result as it proved the concept, 
the fact that we have enzymatic cascade reactions occurring in PS-b-PIAT polymersomes in a 
PB-b-PEO polymersome. It also shows we can already detect fluorescence after 7h26 of 
reaction even though we could not see a change in fluorescence intensity during the course of 
the day for that set of experiments 
The intensity plot profiles (Figures 22 and 24, profiles of diagonals across the frame) are 
presented to show the background to signal ratio, which gives an idea about the quality of 
fluorescence. A good fluorophore is usually described as being at least 2.5 times more intense 
than the background. This is not yet the case here, which also not that surprising as this 
experiment is much more complex than just the loading of a fluorescent molecule. 
Another sample is shown in another chamber (polylysine coated) in Figure 23, after 7 hours 
28 minutes. We indeed tried to use chambers with an interaction with PEO (here polylysine) 
in order to have them immobilized for practical reasons. An increase of the background nose 
can clearly be observed under these conditions. The interaction between the surface and the 
PiPs is possibly too strong and destabilizes the PB-b-PEO polymersome membrane, leading  
  
 
Figure 23. Spinning-disk confocal snapshot  
of functional cell mimic (conditions 43, 7h28, 
polylysine coated chamber). 
Figure 24. Intensity plot profile of line diagonally 
cutting Figure 28. Both mimics were captured with 500 
ms, 600 electronical gain, and 25% laser power. 
Figure 21. Spinning-disk confocal 
snapshot  
Figure 22. Intensity plot profile of line diagonally 
cutting Figure 26. 
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to leakage of the enzymatic content, thus the generated fluorescent dyes, in the solution.  
In order to improve the experiment, we increased the NADPH to BVMO ratio from 100 to 
200. With 100, there is no lag time, whereas for 200, there is a lag time around one hour. In 
addition, the reaction is about twice faster and twice more intense than with 100. Indeed, the 
results looked promising, also in terms of better signal to background ratio. The figures all 
correspond to a set of experiments performed on one day with conditions 42 of Table 23 (and 
250 ms exposure time, 25% laser, 600 gain). Interestingly, Figure 25 is highly promising as a 
strong fluorescence signal can be observed after only 3h42 of reaction! 
  
 
We also present Figures 27 and 28 (another sample than the one in Figure 25), with multiple 
PiPs to evidence the fact that the phenomenon is not isolated, there are many fluorescent cell 
mimics per sample injected in a chamber. The level of fluorescence looks seemingly 
homogeneous in all the vesicles that are in the same focal plane. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Spinning-disk confocal snapshot of functional cell mimic (conditions 
42, 6h42,). 
Figure 28. Spinning-disk confocal 
snapshot of functional cell mimic 
(conditions 42, 6h59). 
Figure 25. Spinning-disk confocal 
snapshot of functional cell mimic 
(conditions 42, 3h42). 
Figure 26. Intensity plot profile of line diagonally 
cutting Figure 30 
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In another sample corresponding to the same preparation conditions, the monitored intensity 
after about 9h30 of reaction is the highest ever observed so far (see Figure 29-34).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29.Vizualisation of method for extracting  Intensity plot profile of line diagonally crossing a 
Spinning-disk confocal snapshot of functional cell mimic (conditions 42,timepoint 10h34). 
 
We monitored this multicompartmentalized reactor during one hour and it seemed promising 
in terms of intensity increase, as at least to the eyes, an increased intensity was observed 
(Figures 30-34). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30. 9h34. Figure 31. 9h49. Figure 32. 10h04. 
Figure 33. 10h19. Figure 34. 10h34. 
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By analyzing the mean intensity of the global lumen, this intensity seemed to increase for this 
system, for the first time compared to cell mimics observed before this timepoint (see Table 
25 and Figures 35 and 36). 
 
Table 25. Fluorescence intensity with time of Figures  35-39 
Time Area Mean Fluorescence 
Intensity 
Minimum Intensity Maximum Intensity 
9h34 1099.87 2025.553 1547 2516 
9h49 1099.87 2117 1486 2860 
10h04 1099.87 2138.819 1481 2589 
10h19 1099.87 2158.947 1437 2719 
10h34 1099.87 2172.293 1391 2811 
 
However, to estimate the errors bars of these mean intensities, we took three consecutive frames of 
this vesicle at some point to visualize the mean Intensities fluctuations (Table 26). Standard deviation 
is 62.6 and standard error, used to draw the error bars is 36.1 (standard deviation divided by the square 
root of number of measurements, here 3).  
 
Table 26. Fluorescence intensity fluctuations for Figures 35&36. 
Area Mean Fluorescence 
Intensity 
Minimum Intensity Maximum Intensity 
24601 2024.867 1501 2460 
24601 2080.714 1473 2655 
24601 2149.761 1534 2698 
 
While the error bars are important, a slight increase between various timepoints is indubitably 
there. Finally, we do not only have a fluorescence in our polymersomes in polymersomes, 
evidencing the concept, but also a slight increase through time; the enzymatic cascade 
reaction producing a dye is indeed occurring in the cell mimics. It is also exciting to 
sometimes observe bright spots (Figures 31 and 34); they tentatively can be explained by the 
nanosize PS-b-PIAT loaded with ADH, in which the resorufin is generated before diffusing 
out in the lumen of PB-b-PEO. Of course, this was a preliminary experiment that needs to be 
investigated further.  
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Figure 35. Intensity with time of Figures 35-39.  Figure 36. Zoom of Intensity with time of 
Figures 30-34.  
 
Finally, we still need to test photoinitiation, which would be a very elegant way to start the 
reaction on demand, after shelf-storage for example, important for future long-term 
applications. Regarding that aspect, a real hurdle lies in the slowness of the cascade, which is 
also not ideal for the stopwatch method. Indeed in the few examples of enzymatic reactions 
inside multicompartmentalized materials so far, that have been detailed in the introduction, 
detection is instantaneous and overall reaction, fast. Furthermore, we have actually no 
knowledge or experience about decaging this molecule (see Figure 37) with a 405 nm laser 
under a microscope. 
 
 
 
 
 
Figure 37. Photocaged substrate. 
 
 Scientists that bleach on purpose or decage in such a way, usually have a response 
immediately, so they know right away their decaging settings were right. We already know 
this will not be possible for our system and we will have to wait before detection of 
fluorescence. This makes the decaging even more difficult and time-consuming as we know 
for now that we will have to wait at least 3 hours (Figure 25), to detect anything, photocaged 
or non caged substrate; i.e. it takes at least 3 hours to assess if the decaging settings were 
accurate, worked or not. Illuminating a long amount of time to be sure everything is decaged  
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is not an option because even if 405 nm is very far from the excitation spectrum of resorufin 
(maximum at 561 nm), there is a risk of bleaching the fluorescent group of the substrate. 
In principle, it is possible as Ruud Peters assessed the ability to decage the substrate, by 
illuminating a solution in a quartz cuvette with a powerful UV lamp (300 W), and checking 
absorbance (see Figure 38) until it resembles absorbance of the non-caged substrate (after 2 
minutes, this is nearly reached, at about 80%). 
 
 
 
 
 
 
 
 
Figure 38. Absorbance of photocaged substrate with increasing UV illumination time. 
5. Conclusion 
In this chapter, we wanted to make a three enzymes cascade to proceed in PS-b-PIAT 
nanoreactors in PB-b-PEO polymersomes, in collaboration with Jan van Hest’s group. The 
cascade alone is already very original, and rather complex as it involves natural cofactors; a 
BVMO enzyme, CRE2-PAMO, using NADPH, is the first enzyme, followed by CalB, and 
finally ADH, using the NADP
+
 cofactor. This complexity explains the amount of time we 
needed to optimize this mixture well enough for the final objective. This part is rather detailed 
in this chapter. 
After conditions were found that led to a sufficient intensity (which was achieved by letting 
the least efficient enzyme, CRE2-PAMO, free instead of loaded), we could proceed to the 
final objective, loading this nanoreactor cascade mixture via the emulsion-centrifugation (as 
detailed in chapters 2 and 3). The objective was to observe the cascade reaction confined into 
the PB-b-PEO vesicles by confocal microscopy. Results so far generated look very promising 
because a clear and confined fluorescence can be observed, proving the reaction in the PiPs. 
Furthermore, we even observed at least one time a relevant increase in fluorescence intensity, 
really evidencing the generation of resorufin inside the cell mimics. 
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However, these are first experiments that need to be investigated further and thoroughly, in 
order to assess or not reproducibility, repeatability and so on. Indeed, not many and certainly 
not enough, experiments have been performed and monitored so far; we have been limited by 
time as the preparation in itself is already very time-consuming (3 full days) and we cannot 
keep the nanoreactors for too long (especially if we want to compare samples from one day to 
samples from another one). Ideally, we would like to get the initial slope of the reaction (for 
that enough time points are requested to generate a relevant slope), and compare them. 
 
In any case, with a much faster cascade, the experiments would be a lot easier and also take 
less time to acquire valuable proofs. A faster reaction would furthermore be necessary in any 
case for decaging the photocaged substrate with the 405 nm laser, and monitor the 
fluorescence. The faster the kinetics, the sooner it should be possible to detect fluorescence 
intensity by microscopy. It that step takes 3 hours, it seems a little tricky to optimize decaging 
conditions, as one will not know if the decaging step worked, the reaction just being too slow, 
or if one has to keep decaging. In the same time, too much 405 nm laser power, presents a risk 
of bleaching too much the Resorufin group (thus inducing errors). 
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General Conclusion and Perspectives 
The challenge of this PhD project lied in the controlled formation of structural 
eukaryotic cells mimics with polymersomes and polymer-based materials in general, as 
“building blocks”. First and foremost, an appropriate preparation method, had to be chosen 
and developed. Then, it could be used for the formation of the desired objects and 
establishment of corresponding proofs of concepts thanks to relevant characterization tools. 
Finally, the work could be extended to not only structural, but also functional cell mimics 
with the incorporation of enzymatic cascade reactions in situ. 
 The strategy is based on a two-step batch process (Chapter 2); first, biodegradable 
nanosize polymersomes of poly(trimethylene carbonate)-b-poly(L-glutamic acid) (PTMC-b-
PGA) are formed via nanoprecipitation as developed in the laboratory. 
1
 Then, they are loaded 
inside micrometric polymersomes of poly(butadiene)-b-poly(ethylene oxide) (PB-b-PEO) 
during the formation of the latter with the emulsion-centrifugation method. This method is 
based on an inverted emulsion (where the aqueous suspension of inner nanosize PTMC-b-
PGA polymersomes constitutes the water droplets of the emulsion), which suggests a 100% 
encapsulation efficiency, as has been proved in the Weitz group. 
2
 The PB-b-PEO diblock 
copolymer is dissolved in the oil phase and stabilizes the emulsion droplets (thus forming the 
inner leaflet of the final polymer bilayer) at their interface. A small fraction of an inverted 
emulsion is then poured over an interface of oil phase and pure water phase. In a final step, 
centrifugal force causes these droplets to cross the interface and to be enveloped by a second 
leaflet of amphiphilic PB-b-PEO block copolymer, resulting in the final giant polymersomes. 
The control provided by this process enabled to assess the structure of the 
multicompartmentalized polymersomes or “polymersomes in polymersomes” (PiPs) with 
specific fluorophore labeling and spinning disk confocal microscopy as both size ranges were 
chosen to be visible. We also presented a movie where red fluorescent inner nanosize 
polymersomes can clearly been observed moving in the lumen of a green fluorescent outer 
micrometric polymersome
8
. The 2D motion of these structural organelle mimics was tracked 
down in this movie and their motion was confirmed to still be Brownian (as motion stayed 
isotropic, and data respected a Gaussian, or random, distribution) inside the volume of an 
approximately 20 μm giant polymersome. Furthermore we found the same size and diffusion 
coefficient of inner nanosize vesicles after their encapsulation by this particle tracking 
analysis than by dynamic light scattering on the solution before loading. These results 
                                                 
8
 Movie s1, http://onlinelibrary.wiley.com/doi/10.1002/anie.201106410/suppinfo 
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assessed the validity of our particle tracking analysis and confirmed that the nanosize vesicles 
were not disturbed during the encapsulation process. Regarding cell biomimicry, cytoplasm 
confinement plays an important role in cellular activity and regulation. Of course, there are 
again many interesting properties arising when mimicking a viscoelastic cytoplasm, the first 
certainly being a better protection and thus stability and shape integrity by absorption of 
mechanical stress. The highly complex cytoskeleton is far from easy to mimic, as it is 
composed of the actin protein filaments, microtubules and intermediate filaments, formed by 
nucleation-elongation processes. The growth of the protein filaments of this cytoskeleton is 
driven by non covalent interactions, with constant association/dissociation processes, making 
them very dynamic.
3
 In addition to the obvious mechanical properties given by the 
cytoskeleton, the high macromolecular concentrations found intracellularly are responsible for 
the so-called macromolecular crowding effect.
4-6
 In 2001, R. John Ellis and co-workers
6
 
launched a call to biochemists to stop neglecting this “macromolecular crowding” in their 
studies, which is known in polymer science as the “excluded volume effect”. All together, 
macromolecules in the cytoplasm, cytoskeleton, and internal compartments occupy 20−30 
vol.% of a cell, generating a strong steric repulsion between them. The consequences on the 
cell machinery had been rarely considered. For instance, most biochemical reactions are 
studied in dilute (ideal) solutions, while in real cells one should consider the activity 
coefficients for both thermodynamic and kinetic studies. In order to consider these 
parameters,
7
 a suspension of nanosize inner polymersomes of PTMC-b-PGA was this time 
encapsulated in giant polymersomes of PB-b-PEO together with highly concentrated, hence 
viscous, alginate or dextran solutions, thanks to the emulsion-centrifugation process (see 
Figure 1). 
 
 
 
 
 
 
 
Figure 1. Scheme summarizing goals of Chapter 2. 
 
 A movie of these structures was acquired and the motion of the PTMC-b-PGA 
tracked down again. This time, their motion was proven to be efficiently hindered as 
confirmed by a 6.6 times smaller diffusion coefficient (Figure 2). Furthermore, the 
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concentration of 300 mg/mL of polysaccharide dextran increased viscosity above 0.01 Pa.s, in 
the range of red blood cell cytoplasm viscosity,
8
 a volume fraction near 30%, and an osmotic 
pressure above 1 MPa resembling the intracellular conditions caused by cellular proteins. By 
reproducing the intracellular “macromolecular crowding effect”, which plays a crucial role in 
the cell machinery, we believe that this synthetic and simplified approach constitutes an 
appropriate cytoplasm mimic. There have been reports of liposomes in liposomes, cytoplasm 
mimics in liposomes or polymersomes, capsules or liposomes in capsules (as detailed in 
chapter 1), and even capsules in a capsule with a cytoplasm mimic. However, to the best of 
our knowledge, the combination of these two mimics had never been reported so far in 
polymersomes.  
 
 
 
 
 
 
Figure 2. Addition of a cytosol mimics brings a decrease in rate of displacement and Brownian motion of 
organelle mimics. 
 
In Chapter 3, we investigate benefits resulting from a multicompartmentalized 
structure for drug delivery and the biomedical field in general. Such a structure should be of 
particular interest for the delivery of multiple active components.
9
 To address this point, a 
solution of two different PTMC-b-PGA suspensions, labeled respectively with red and green 
fluorophores was encapsulated instead of a single nanosize vesicle suspension (Figure 3). The 
two nanosize polymersomes are clearly localized in the same giant polymersome
9
.  
 
 
 
 
 
 
 
Figure 3. Multiple organelle loading, green population left, red in the middle, overlay right. 
 
                                                 
9 
Movie s3, http://onlinelibrary.wiley.com/doi/10.1002/anie.201106410/suppinfo 
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As long as the inner polymersome suspensions that are mixed are concentrated 
enough, this encapsulation can be extended to far more than two different populations. 
Finally, we were able to further increase the complexity of this system by co-
encapsulating a large polymer, FITC-dextran, with a red nanosize vesicle suspension (Figure 
4). As the FITC-dextran was already green fluorescent, the membrane was this time labeled in 
blue, allowing separate imaging of the giant vesicles (blue), the inner nanosize vesicles (red) 
and the loaded dextran (green) in the giant lumen. Such a three-compartment encapsulation in 
vesicles was, to the best of our knowledge, the first reported to date. This multiple 
encapsulation strategies open avenues for future applications in multiple drug delivery. Such 
an approach is especially interesting in oncology amongst others, with the new possibility of 
loading (thus potentially delivering) various, even incompatible, components (like an 
anticancer drug cocktail) in one larger vector, hence in a high enough drug payload to get a 
large and synergetic therapeutic response. 
 
 
 
 
 
 
 
 
 
 
Figure 4. Multiple compartment loading. 
 
In a sustained and controlled drug delivery approach, we were then able to study the in 
vitro release kinetics of anticancer drug doxorubicin loaded in the nanosize vesicles.
 
As 
expected,
 
the release kinetics were significantly decreased when the nanosize vesicles were 
protected by an additional polymer membrane of PB-b-PEO, i.e. additional diffusion barrier. 
In the latter scenario, permeation of doxorubicin through the polymeric membranes, induced 
by the chemical gradient in the release setup, could only last longer. By representing the 
release data differently, with a law established by Peppas and Ritger
10
 and extracting the 
kinetic constants k for each system, it could be quantitatively determined that the release rate 
was indeed about twice (≈2.3) slower with an additional diffusion barrier. With this additional 
membrane, we could thus demonstrate the following properties arising: a better control of 
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release kinetics with a resulting controlled permeability tuning, and a better protection of 
loaded actives in theory. Moreover, thanks to their polymeric nature, these two successive 
membranes could now be designed to allow a specific stability and orthogonal disruption in 
different environments. Such designs would be crucial for challenging means of 
administration than the intravenous one, like transcutaneous,
11
 and oral administration,
12
 the 
future challenges in drug delivery and cancer therapy. Our strategy thus presents a 
straightforward approach and new opportunities for the application of these polymersomes in 
polymersomes in biomedical or cosmetic applications, where the encapsulation of multiple, 
distinct and fragile ingredients are required, together with specific release conditions. 
The last and most complex property to master, which arises from such structures, is 
the ability to use the inner compartments as reactors. Such a structure can for example impact 
the way we design a chemical reaction or induce a reaction only when different components 
(confined in various inner compartments) are mixed. In the last chapter (Chapter 4), we 
therefore strove to replace in our cell mimics, our internal structural “organelles” by 
functional ones, in which enzymatic reactions take place (Figure 5). 
 
 
 
 
 
 
 
 
 
Figure 4. Scheme summarizing chapter 4. 
 
 The choice of complex enzymatic reactions, instead of any classic chemical reaction, 
was of course relevant in a perspective of Cell Biomimicry and also in a “green chemistry” 
perspective pursued by the laboratory. Indeed, in the confined, crowded environments of the 
cell, reactions are not occurring in ideal (dilute) solutions. This is what we wished to address 
and model, going from a structural to a functional Cell Biomimicry. 
A biomimetic cascade reaction based upon three enzymes destined to function in three 
different PS-b-PIAT polymersome populations was designed in collaboration with Professor 
J. van Hest’s group. The idea was to load the cascade mixture (including substrate and 
cofactor(s)) in PB-b-PEO polymersomes, ideally initiate the reaction via decaging of a 
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photocaged substrate, under a confocal microscope, and follow the increase of the final 
product’s red fluorescence intensity. This chapter focuses mainly on the optimization of the 
nanoreactor cascade, as these functional artificial organelles, based on PS-b-PIAT nanosize 
polymersomes loaded with enzymes, need to communicate together in the right concentration 
ratios for an optimal reaction. This step indeed revealed to be a little problematic given the 
final objective. In the end, we were however able to provide a relevant proof of concept: when 
observing the functional cell mimics by confocal microscopy, with a reaction based upon the 
non-caged substrate, red fluorescence was actually detectable after a few hours. This 
ambitious project requires however some further investigations. There is definitely a 
challenge in mastering reactions on attoliter volumes, as well as a potential long-term 
industrial interest arising (if reactives are fragile, very expensive or polluting for instance). 
Such investigations open avenues in the Biotechnological field, and in the construction of 
complex therapeutics and therapeutic artificial cells,
13, 14
 in addition to the use of these 
systems simply as relevant models for a better comprehension of Nature’s cell.  
 
 Regarding perspectives, this original project is paving the way for numerous 
possibilities.  
1) Cell models for biology, biochemistry and biophysics studies. Sometimes, using 
actual cells (to develop a technique, a method for example), which are expensive, may not be 
necessary; robust and accurate models would be sufficient. Furthermore, a biological cell is so 
complex, that studies would perhaps sometimes benefit from the use of models, in order to 
investigate only a limited number of phenomena at the same time and understand them 
correctly; complexity can not always be understood at once, but may be established step by 
step. However, existing models or modellings may be described sometimes as too limited. 
Enzymatic reactions are for example mostly studied in test tubes, in dilute (ideal) solutions, 
when they are actually happening in confined and crowded compartments of the cell, as 
emphasized throughout this thesis. That is why, accurate and relevant cellular models are 
required and we believe our structural, and furthermore our functional, cell mimics to 
constitute one possible response to such challenges. 
 
2) Loading of magnetic nanoparticles for hyperthermia (release of actives triggered 
by application of alternating magnetic field inducing local heating thus increase of 
permeability) is in growing expansion. The concept of “theranostics” implies co-loading 
actives (therapy) and magnetic nanoparticles for diagnosis. The challenge lies however in the 
actual co-encapsulation of these species in a high enough concentration. A 
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multicompartmentalized structure as ours, offers a wide range of possible compartments: 
multiple inner compartments (not necessarily made of the same material), giant 
polymersome’s lumen and membrane. Moreover, it is especially interesting to use the 
emulsion-centrifugation method to load quantitatively an aqueous suspension of magnetic 
nanoparticles in the lumen of giant PB-b-PEO polymersomes; usually their loading is 
problematic because of the low encapsulation efficiencies of classic methods. This way, a 
significant number of particles could get loaded, enough to generate responsive (to magnetic 
field) giant polymersomes. This was assessed by loading a suspension at 0.1 v.% (pH 7.7, 
poly(acrylic acid) coating, ρapparent=1.004 g/mL, RH=0.55 nm with a PDI of 0.17) maghemite 
nanoparticles and observing their responsiveness to a magnet moving near the microscopy 
chamber (see Figures 5 and 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Giant PB-b-PEO polymersomes loaded with magnetic nanoparticles (giving this yellowish-brownish 
cavity). From top to bottom: timepoint 0.1s with magnet moving to the left so that vesicle has moved left on time 
point 11.15 s. Then magnet moves right and vesicle follows until timepoint.20.49 s. 
 
 
Fig. 6. Other polymersomes evidencing the dependence of size (thus number of inner particles) on the response 
to magnetic field. From top left to bottom right: timepoint 20.6 to 22.07 then 26.78 s with magnet moving to the 
right. Then from the timepoint 26.78 to 28.59 to 34.61 s, the magnet is describing a cercle. Finally, from 34.61 to  
20.06 s 22.07 s 
28.59 s 34.61 s 36.21 s 
26.78 s 
0.1s 
11.15 s 
20.49 s 
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36.21 s, the vesicle is moving to the right again. The largest vesicle is moving visibly faster than the other ones, 
that are smaller.  
 
The experiment revealed to be successful: the vesicles were yellowish-brownish and 
reactive to magnets (the larger, hence the most particle-containing in number, the more 
reactive).  
Going further, a potential limiting parameter with the emulsion-centrifugation method, 
lies the presence of concentrated sucrose (130 mg/mL), especially when working with 
biological material (actual cells cannot survive such a high concentration for example). If 
concentrated enough, the loading of inert colloids like magnetic dense nanoparticles could 
enable the same goals but avoid the presence of sucrose. Indeed, while water has a density of 
1 g/mL, maghemite particles are at about 5 g/mL. Sucrose and glucose are used in the process 
because their difference in density helps the sedimentation of the vesicles in the current 
centrifugation conditions. Suppressing sucrose completely in the inner droplets hence implies 
also suppressing completely glucose in the lower solution of the interface. To calculate the 
density of the maghemite nanoparticle suspension needed to give the same conditions as our 
sucrose, we need to calculate first the difference of density between sucrose and glucose, both 
at our working concentration of 380 mM: 
 
 
So, an aqueous suspension of maghemite nanoparticles to use instead would thus need to be at 
ρwater + Δρsucrose-glucose=ρmaghmeite fluid =1.065 g/mL  
Given the apparent density of a maghemite nanoparticle suspension  
ρapparent maghemite =ρapparent maghemite·Φmaghemite+ρwater(1-Φmaghemite), this suspension should be at a 
volume fraction of: Φmaghemite=1.6 vol.%  
The application of such parameter is currently under investigation. 
To finish, we see a last interesting possibility generated by loading magnetic particles: the 
ability to manipulate them via magnetic field application. This can either bring to deformation 
of the vesicles (with constant field), hence more or less important increase in permeability that 
can be tuned of demand. Such work is fundamentally interesting (how much can it be 
deformed while staying intact for example) but is also exciting in a potential long-term 
application of drug delivery, a fine and precise tuning of permeability is important to control 
sustained or burst release kinetics on demand. This deformation on vesicles has been for 
example published with liposomes before,
15
 raising another question, will it be possible to 
deform polymersomes the same way than liposomes? And if yes, it would be interesting to 
study their differences in behavior: this can also be a way to have access to the membrane 
waterfluidmaghemiteeglusucrose mLg
L
mol
mol
g
    cos /065.0380.0)180342( 
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properties. Because of otherwise too limited encapsulation efficiencies, the authors were 
forced to microinject in every single liposome the magnetic content, a classic method. This is 
tedious and as it has to be performed under a microscope, the sample already in a microscopy 
chamber cannot be retrieved out of it and used for biomedical purposes. In another 
perspective, the ability to have a vesicle responsive to a magnetic field gradient, i.e. a vesicle 
following the motion of a magnet for example, raises exciting potential long-term applications 
where the vector could be commanded in vivo perhaps, but more simply and feasibly ex vivo, 
in vitro, for cell cultures for example, etc. 
 
3) The development of fully biocompatible and/or biodegradable 
multicompartmentalized polymersomes for future applications. The group in which this 
project was conducted, usually works with at least biocompatible (preferably biodegradable or 
better bioresorbable) polymers, whether the projects involve concrete in vitro or in vivo 
studies right away or not (like this one). Originally for this project, PTMC-b-PEO was 
supposed be used instead of model copolymer PB-b-PEO. PTMC was synthesized from TMC 
via ring-opening polymerization from diethyle zinc. It was then later clicked to PEG via 
Huisgen 1,3 Dipolar cycloaddition and copper catalyst. The range of copolymers synthesized 
was PMTCx-b-PEO45 with x=37, 32, 23 and respective approximate molar hydrophilic ratios 
of 33, 36 and 44 %. To stabilize an inverted emulsion of water in oil, the amphiphile has to 
more lipophilic than hydrophilic, meaning a low HLB (between 3 and 6, maximum 8). So 
theoretically, the lower this hydrophilic ratio, the better it should stabilize the emulsion. 
However, these three copolymers revealed themselves unable to stabilize the toluene/water 
interfaces of the process, droplets would coalesce immediately. Possibly, PTMC-b-PEO was 
just not amphiphilic enough and with a low enough HLB to stabilize that interface in the 
given conditions. Increasing the concentration from 3 to 6 mg/mL did not improve anything. 
We checked other biocompatible or biodegradable polymers available at the laboratory were 
not more suitable: but Dow Corning 5329® did not stabilize the droplets, PEG-b-PLA (1000-
b-750 g/mol reference 24378 from Polysciences, Inc.) was not even soluble in toluene and 
PEG-b-PCL (2000-b-5000 g/mol, I=1.3 reference P5042-EOCl from Polymer Source) seemed 
to stabilize the emulsion but no vesicles could be retrieved at the end of this process. While 
this was not problematic for the proofs of concept we wanted to establish (which is why we 
pursued the work with process model copolymer PB-b-PEO), that did not involve in vitro or 
in vivo studies, it would be interesting to find a suitable biodegradable polymer for the future, 
especially for biomedical applications but also to allow a controlled biodegradation. 
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The difficulty lies in the fact that the process requires an organic, oil phase, able to dissolve 
the copolymer. Furthermore, this phase needs to be less dense than water and immiscible with 
water. The last two requirements alone, suppress a lot of possibilities. The best strategy would 
perhaps lie in, first the choice of the best, least toxic suitable organic phase (for liposomes, 
oils can be used). Then, a copolymer would have to be carefully designed to, on one hand be 
soluble in this organic phase, but on the other hand, not too well soluble, as it has to be 
amphiphilic enough to stabilize the various interfaces. It would be in any case and perhaps 
more importantly, interesting to find another suitable solvent than the toxic, reprotoxic even, 
toluene; possible traces of toluene in the final aqueous PiPs suspension were indeed not 
problematic for the present work, but could be for future studies. 
The solvents that we judged to meet the process requirements and tested in order to make use 
of PTMC-b-PEO were: silicon oil, squalene, mineral oil, dodecane, and cyclohexane. 
Unfortunately, the copolymer was soluble in none of them. 
 To finish, we were however able to get successful with a blend of PB-b-PEO/ PMTC37-b-
PEO45 50/50 wt.% and 25/75% (75/25% was not stable) with the current conditions. This is 
interesting to know, as PMTC has been shown in earlier work in the laboratory to be 
biodegradable, in acidic or basic conditions, and prone to lipase degradation as well. In 
principle, a certain permeability, porosity could thus be tuned over time (with specific 
conditions where the PB in the membrane blend would remain intact), possibly leading to 
complete disruption at some point. 
 
4) Process improvement. This process in itself was also sufficient for this project; the 
idea was to use a method able to generate the needed low quantities on a laboratory scale to 
establish proofs of concept. In industry, it is only once proofs of concepts have been 
established on the laboratory scale, that it becomes time and worthwile to pursue with larger 
scales (various pilot units, and finally production unit) by scaling-up the method or sometimes 
by changing it completely just to improve it or for the actual scale-up. Furthermore, the 
quantities were maybe already too low for this project as in the end, we retrieve about 50 µL 
of a very diluted suspension of cell mimics, which was problematic for the in vitro drug 
release and may be limiting for further studies. Hence, to push this work further, in terms of 
quantities generated, also if possible with a safer solvent as traces of toxic toluene may 
remain, maybe a completely new process has to be designed or the current process has to be 
scaled-up and/or improved; Abkarian et al. 
16
 for example, using phospholipids, improved it 
into a process that was still batch-mode, but one-pot, not sequential any more, and not too 
greedy in terms of most inner aqueous solution (which may contain biological material) to 
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load. For the biomedical and biotechnological field, where expensive and rare drugs, proteins, 
enzymes, etc, may need to be loaded, small batch modes seem optimal.  
 
With a better, improved process, various applications for the biomedical field could then be 
investigated. 
5) Multicompartment systems as the ultimate multifunctional vectors. Thanks to 
the exquisite state of current polymer science, each kind of membrane of the 
multicompartment system could now actually be carefully designed to bear different ligands, 
present a specific texture (rough or smooth, generating different responses of the immune 
system), and above all a specific chemical nature to control release kinetics; each kind of 
membrane could present a specific degradability or stimuli-sensitiveness (to pH, T, ionic 
force, redox) in an orthogonal fashion, so that destabilisation or degradation (thus release) can 
be triggered consecutively. Single polymersomes have been designed and investigated as 
smart and functionalized vectors for a decade now, and this knowledge can be made of use for 
multicompartmentalized polymersomes. By using our method, the most important challenge 
perhaps would lie in choice of suitable copolymer for the outer membrane, i.e. a copolymer 
soluble in a process relevant organic phase. 
 
6) Challenge of global size and different administration pathways. Actually 
designing, generating and studying in vitro and in vivo such multicompartmentalized systems, 
makes another important challenge arise, namely the choice of delivery pathway. Nanovectors 
are injected intravenously; the technological challenge for classic single compartment vesicles 
already lies in achieving a suitable final size, below 200 nm. Above that size their elimination 
out of the body is indeed too fast to observe any benefits. For a multicompartmentalized 
structure, a process enabling an outer membrane size below 200 nm is even more challenging. 
With our method, the emulsion droplets are templating the outer polymersomes, so in order to 
get nanometric sizes, one would need to drastically decrease the droplets size, for example via 
sonication (although it is not really recommended on supramolecular self-assembled 
amphiphilic structures, and inner structures would already be suspended in the droplets). Or if 
the polymer has a low enough Tg, one could extrude the final multicompartmentalized 
structures as was performed on multicompartmentalized liposomes (or vesosomes) in 
Zasadzinski’s group. Going further, we believe another important challenge for the use of 
vectors in the biomedical field lies in other methods of delivery, like transcutaneous and more 
importantly, oral administration. By taking the example of cancer therapy, oral administration 
would hugely improve patient’s compliance, day to day treatment and life, and also health 
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costs. In that perspective, it would be interesting to design a multicompartmentalized system, 
able to remain intact until its arrival in the intestine. Nowadays, many oral classic 
formulations, such as tablets and capsules, present coatings of so-called gastro resistant 
polymers; polysaccharides (chitosan or dextran), acrylic copolymers (Eudragit®), or 
cellulosic derivatives (cellulose acetate phthalate CAT, cellulose acetate trimellitate CAP and 
hydroxypropyl methylcellulose phthalate HPMCP), etc.
17
 Using such polymers for the outer 
membrane (or for an additional coating) should thus also confer the system the ability to resist 
very acidic gastric pH (< 5) but to be degraded or disrupted later, in the intestine at 
physiological pH of 7.4. This would provoke the release of the inner robust compartments; 
these could be classic nanovectors possibly functionalized for effective targeting and below 
100-200 nm. Then we can imagine several potential possibilities. Either, these nanovectors 
would then need to find a way into blood circulation through intestine tissue while remaining 
intact.
18
 Either, and this would be the only acceptable theory for opponents to this intact 
crossing hypothesis, the nanoparticles could be internalized by various intestinal cells and the 
active would only then be released to the bloodstream; it would not be a nanovector drug 
delivery scenario anymore. There is also research about particles able to adhere to the 
intestinal mucus, either via electrostatic interactions (as one of its main components, the 
mucin protein is negatively charged) or via disulfure bridges, enabling a localized high 
aggregation, thus concentration, and a potential delivery to the bloodstream (also probably 
with destruction of nanoparticles). The approach would then be more pragmatic for 
pharmaceutical needs for efficient oral administration of particular actives with a high enough 
bioavailability. More simply, we can imagine their aggregation into “gastric patches”, against 
ulcers, or other similar issues. 
 
7) Multi-therapeutic vectors. Sometimes, a therapy involves not only one active, but 
two or more that may interact differently together than alone, synergistically. Current 
treatment for HIV is based on tritherapy for example. Cancer treatment also involves 
combination therapies, for example the liposomal doxorubicin Myocet™ used in combination 
with cyclophosphamide against metastatic breast cancer. We have addressed the challenge of 
multiple encapsulation in this work. Each inner compartment can be individually loaded with 
a different component, which can be incompatible, degrade one another, etc, some of them 
can act synergistically once at the target site, etc. It would now be interesting to proceed 
further, from multiple encapsulation to actual multiple delivery, prove this concept. Moreover, 
if such systems would be injected intravenously, it should logically increase the drug payload 
at the target, enough to get a therapeutic response while decreasing polymeric carrier mass. 
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All the various desired therapeutics would reach the right target at the same time. So, once the 
process is ready for such a challenge and/or submicrometer range is possible, it would be 
interesting to really investigate such scenarios in vitro and in vivo, and assess feasibilities. 
 
8) Last but least, we believe the field of multicompartmentalized reactors full of promises, 
particularly for the biomedical field and as bioreactors, which still has to be fully and 
thoroughly explored. 
 
 Microreactors for chemical and /or enzymatic catalysis in biotechnological industries 
are interesting as they should enable miniaturized reactions to take place, potentially limiting 
waste production, sample consumption, safety issues as the quantities of toxic, polluting 
reactives or intermediates are miniaturized as well. Moreover, confinement in compartments, 
or reactions of so small volumes may have influences on the way the reactions proceeds, 
maybe improve some parameters compared to the macroscopic scale, etc. There is currently 
some research about continuous flow chemistry that tries to address these challenges, 
revealing the potential of this approach. 19 
 This concept can also be transferred to the biomedical field, in the same way artificial 
organelles are being designed to function intracellularly. As Caruso’s group has been pointing 
out for their capsosomes, multicompartmentalized structures can indeed serve as biomedical 
platforms. We can imagine reactions on prodrugs for example, where, while travelling in the 
body to the target size, a reaction would proceed (initiated ex vivo or in vivo on demand) to 
give a cytotoxic and/or unstable reaction product in the end, upon arrival on the target size. 
Moreover, in combination with multi-therapy, several different compartments could be loaded 
with several different prodrugs. As in one of Caruso’s last report detailed in chapters 1 and 4, 
one can also imagine the reaction of a large prodrug macromolecule into a small drug, hence a 
molecule small enough to permeate rapidly outside, in a release triggering reaction 
mechanism. One can also think of systems where a reaction in situ will conduct to the 
degradation or disruption of one or more polymer membranes, to generate the desired release 
of species; in that case these species would need to remain unaffected by the reaction. More 
simply polymer membranes have been reported to get degraded by enzymes.
1
 One can also 
design a system where any kind of disturbance generated by one kind of reaction, would lead 
to release of the inner contents in the outer lumen and thus initiation of a second (set) of 
reaction(s), thus controlling volume ratios and initiation time. This concept has been reported 
by Vogel and coworkers (Chapters 1 and 4), even though in their case a permeability tuning, 
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not a reaction was responsible for release, hence initiation. Such a concept is also highly 
useful for microreactors. 
Technologically, multicompartmentalized reactors represent the most difficult hurdle to 
overcome, but who knows how fast and successfully this research will expand. 
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